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ABSTRACT OF DISSERTATION

RNA AS A UNIQUE POLYMER TO BUILD CONTROLLABLE
NANOSTRUCTURES FOR NANOMEDICINE AND NANOTECHNOLOGY

RNA nanotechnology is an emerging field that involves the design, construction
and functionalization of nanostructures composed mainly of RNA for applications in
biomedical and material sciences. RNA is a unique polymer with structural simplicity
like DNA and functional diversity like proteins. A variety of RNA nanostructures have
been reported with different geometrical structures and functionalities. This dissertation
describes the design and construction of novel two-dimensional and three-dimensional
self-assembled RNA nanostructures with applications in therapeutics delivery, cancer
targeting and immunomodulation. Firstly, by using the ultra-stable pRNA three-way
junction motif with controllable angles and arm lengths, tetrahedral architectures
composed purely of RNA were successfully assembled via one-pot bottom-up assembly
with high efficiency and thermal stability. By introducing arm sizes of 22 bp and 55 bp,
two RNA tetrahedrons with similar global contour structure but with different sizes of 8
nm and 17 nm were successfully assembled. The RNA tetrahedrons were also highly
amenable to functionalization. Fluorogenic RNA aptamers, ribozyme, siRNA, and
protein-binding RNA aptamers were integrated into the tetrahedrons by simply fusing the
respective sequences with the tetrahedral core modules. Secondly, I reported the design
and construction of molecularly defined RNA cages with cube and dodecahedron shapes
based on the stable pRNA 3WJ. The RNA cages can be easily self-assembled by singlestep annealing. The RNA cages were further characterized by gel electrophoresis, cryoelectron microscopy and atomic force microscopy, confirming the spontaneous formation
of the RNA cages. I also demonstrated that the constructed RNA cages could be used to
deliver model drugs such as immunomodulatory CpG DNA into cells and elicit enhanced
immune responses. Thirdly, by using the modular multi-domain strategy, molecular
defined RNA nanowires can be successfully self-assembled via a bottom-up approach.
Only four different 44-nucleotide single-stranded RNAs were used to assemble the RNA
nanowire. The reported RNA nanowire has the potential to be explored in the future as
the carrier for drug delivery or matrix for tissue engineering. Fourthly, the construction of
RNA polygons for delivering immunoactive CpG oligonucleotides will be presented.
When CpG oligonucleotides were incorporated into the RNA polygons, their
immunomodulation effect for cytokine TNF-α and IL-6 induction was greatly enhanced,
while RNA polygon controls induced unnoticeable cytokine induction. Moreover, the
RNA polygons were delivered to macrophages specifically and the degree of
immunostimulation greatly depended on the size, shape, and the number of payload per
RNA polygon. Collectively, these findings demonstrated RNA nanotechnology can
produce controllable nanostructures with different functionalities and result in potential
applications in nanomedicine and nanotechnology.

KEYWORDS: RNA Nanotechnology, pRNA, Three-way Junction, Nanostructures,
Nanomedicine
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Chapter 1: Introduction and Literature Review
The literature review section of this chapter was reproduced (with some
modification) with permission from Hui Li, Taek Lee, Thomas Dziubla, Fengmei Pi,
Sijin Guo, Jing Xu, Chan Li, Farzin Haque, Xing-Jie Liang, Peixuan Guo. “RNA as a
stable polymer to build controllable and defined nanostructures for material and
biomedical applications.” Nano Today. Volume 10, Issue 5, October 2015, Pages 631–
655. Special thanks to Dr. Taek Lee for help in preparing Figure 1.7, 1.8 and Table 1.2,
and Sijin Guo for help in preparing Table 1.1.
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1. Brief Summary
Chapter 1 begins this dissertation with an overview of the hypothesis and
summarizes the research progress and current state of ribonucleic acid (RNA)
nanotechnology and RNA nanomedicine. The unique properties of RNA as a polymer are
introduced. The current methods for the construction of various RNA nanostructures and
the applications of these RNA nanostructures in nanotechnology and nanomedicine are
also reviewed.
Chapter 2 studies the design and self-assembly of multifunctional 3D RNA
tetrahedrons based on the pRNA-Three Way Junction (3WJ) motif. The 3D structures of
the assembled RNA tetrahedrons are examined by both atomic force microscopy (AFM)
and cryo-electron microscopy (EM). The sizes of the RNA tetrahedrons are tuned by
changing the number of RNA base pairs per edge. Several functional modules including
aptamers, ribozyme and small interfering RNA (siRNA) are incorporated into the RNA
tetrahedron and their biological functions are examined. In vitro cell binding and in vivo
biodistribution studies are performed to show that the RNA tetrahedron functionalized
with EGFR-aptamer can target to xenograft breast cancer. These results indicated that 3D
RNA nanoparticles have the potential to deliver imaging modules and therapeutics for
cancer diagnosis and therapy.
Chapter 3 reports the design and self-assembly of RNA cube and dodecahedron
cages with defined shapes and sizes by using the pRNA 3WJ as the basic building block.
The 3D structures of the assembled RNA cages are examined by cryo-EM and AFM. In
addition, the designed RNA cube cages are applied to deliver immunoactive cytosinephosphate-guanine (CpG) DNA to macrophage cells and induce immune responses.
2

Chapter 4 studies the design and bottom-up self-assembly of RNA nanowire with
length in the micrometer scale. The constructed RNA nanowire is examined by cryo-EM,
negative staining transmission electron microscopy (TEM), fluorescent microscopy and
AFM. This study showcased an example of the expansion of RNA nanostructures to
RNA microstructures.
Chapter 5 reports the design, construction and characterization of RNA polygons
as multivalent nanocarriers of vaccine adjuvants such as CpG DNA for immune
modulation. It was found that the sizes and shapes of the RNA nanostructures played
important roles in the induction of immune responses. This study illustrated that RNA
nanoparticles have the potential to be developed as potent immunomodulators or vaccine
adjuvants.
Chapter 6 briefly summarizes the main conclusions of this dissertation and
discusses the future directions and prospects in RNA nanotechnology and RNA
nanomedicine.

2. Hypothesis
The central hypothesis of this dissertation is that RNA is a unique polymer that can
be used to build controllable and defined nanostructures for applications in nanomedicine
and nanotechnology.

3

3. Literature Review
Introduction
Polymers have been extensively used by humans since the earliest recorded history.
Tree saps, tar and plant fibers, all represent the earliest natural polymeric materials used
by humans [1]. Since the 1950s, through continued synthesis and manufacturing
improvements, synthetic polymers have dramatically improved in quality and strength to
the point where they, in many cases, can have mechanical properties that better match
desired use, as compared to alternative natural counterparts. Synthetic polymers have the
manufacturing advantages of rapid production rates and synthetic simplicity. However,
owing to the inherently random nature of most polymerization mechanisms, chain
polydispersity and controlled shaping remain two of the key limiting hurdles that have
led to increased variable performance and overall reduced control of the final properties
[2-4]. As such, there has been much effort towards developing synthetic building blocks
and schemes that can create monodisperse polymer systems [5-7]. These, however, are
typically very expensive, time consuming and difficult to control.
As a result of these developments, we are at another unique turning point in the
evolution and design of polymers. We once again turn towards nature as our inspiration
for the development of advanced biomaterials. By applying what we have learned about
the complexity and versatility of nucleic acid structures, it is now possible to create
materials with revolutionary properties previously considered unattainable through
synthetic strategies. Recent advances in RNA chemistry, RNA biology and RNA
nanotechnology have shown that RNA as a biopolymer not only shares the common
characteristics of other polymers, but also possesses a range of unique properties
4

advantageous for applications in nanotechnology as well as biomedical and material
sciences [8-14].
Herein, we will (1) delineate the physiochemical properties of polymers that can be
applied to RNA, (2) introduce the unique properties of RNA as a polymer, (3) review the
current methods for constructing RNA nanostructures for diverse applications, and (4)
discuss the future prospects including challenges, solutions and new directions of this
nascent field.

Physical and chemical properties of polymers in relationship to RNA
nanotechnology
The word (poly)-(mer) means (many)-(parts) and refers to macromolecules
consisting of a large number of repeating elementary units covalently joined together.
These ‘mers’ control the inter-chain interactions and dictate the final polymer
characteristics. Given the large variations in polymer morphologies, multiple ways are
used to describe polymer structure. Polymers can be formed from one type of monomer
(homopolymers) or of various monomers (heteropolymers). Heteropolymers can be
further described by the arrangement of the monomers along the backbone, including
alternating, random, and block formations. Heteropolymers also adopt more elaborate
structures, including star, ring, branched, dendrimeric, crosslinked, ladder, and others
[15-23]. These large arrays of potential structures and chemical diversity offer a rich
repertoire of available properties from which one can custom-design a polymer for a
desired application.

5

Biological macromolecules, as natural building blocks, are critical for the
functioning of living organisms. RNA is one of the five most important biological
macromolecules in addition to DNA, proteins, lipids and carbohydrates. With some
aspects similar to DNA, RNA, which is composed of four nucleotides including
adenosine (A), cytosine (C), guanosine (G) and uridine (U), is special in its homogeneity.
RNA is a homopolymer of nucleotide, but is also a heteropolymer of A, U, G, and C.
Each nucleotide contains a ribose sugar, a nucleobase, and a phosphate group. The
nucleotides are covalently linked together through 3’ → 5’ phosphodiester bonds
between adjacent ribose units, giving the directionality to the sugar-phosphate backbone
that defines RNA as a polynucleic acid. The phosphate moieties in the backbone are
negatively charged, making RNA a polyanionic macromolecule at physiological pH.
RNA molecules are typically single-stranded. However, Watson-Crick (canonical) basepair interactions (A:U and G:C), wobble base pairing (such as G:U) [24] or other noncanonical base pairing such as twelve basic geometric families of edge-to-edge
interaction (Watson-Crick, Hoogsteen/CH or sugar edge) with the orientation of
glycosidic bonds relative to the hydrogen bonds (cis or trans) [25-28], all together give
rise to various structural conformations. Unique RNA structures include loops, hairpins,
bulges, stems, pseudoknots, junctions, etc., which are essential elements to guide and
drive RNA molecules to assemble into desired structures [12, 29-32]. On the contrary,
synthetic polymers are usually formed via a polymerization reaction, a chemical process
through which many monomers form covalent bonds between each other and finally form
a long chain or network, imparting them with their desired structural properties.
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Generally, the properties of polymers are strongly dependent on their monomer
chemistry. Moreover, the molecular weight and 2D structure (e.g., linear chain-shaped
structure or branch-shaped structure) also play important roles in determining the
characteristics and properties of a specific polymer. Important properties of chemical
polymers include [1]: (1) rheological properties, (2) solubility, (3) volumetric and
viscometric properties, (4) stress-strain relationships, (5) electrical properties, (6) thermal
properties, (7) optical properties, (8) stiffness, (9) flex life, (10) hardness, and (11)
chemical resistance. Various physical or chemical tests can be readily performed to
characterize these properties for RNA polymers.
Traditional synthetic polymers are heterogeneous and have typical polydispersity
index greater than 1 [33, 34]. In contrast, RNA is synthesized by either in vitro
transcription or solid phase chemistry. Both approaches are based on stepwise reactions
and will generate RNA polymers with defined sequences, structures, and molecular
weights. This leads to a polydispersity index of 1 of a specific RNA. Structurally, the
average molecular weight determines the mechanical property of the polymer. However,
as polydispersity increases, the increased lower molecular weight chains can act as a
lubricating/solvating system, reducing its mechanical strength and integrity. As increases
in temperature result in increased molecular motion, these weak associations begin to
destabilize and reduce mechanical integrity. Such polymers are classically referred to as
thermoplastics [35], as their mechanical strength weakens with increased temperature.
However, this property also means they can be intentionally deformed at higher
temperatures and then regain their structural properties once cooled. Thermodynamically,
the RNA molecule is relatively more stable at lower temperature and intends to dissociate
7

or misfold at higher temperatures. Thus, RNA displays the typical thermoplasticity of
polymers. Boiling-resistant RNA has been discovered and constructed [36], suggesting a
potential application of RNA in molding technology.
Chemical polymers have a wide range of applications in biomedical and material
sciences. Specific applications include, but are not limited to [1, 37-50]: (1) sutures for
surgery, (2) dental devices, (3) orthopedic fixation devices, (4) scaffolds for tissue
engineering, (5) drug formulation (e.g., controlled release of drugs, excipients for drug
stabilization or solubilization), (6) biodegradable vascular stents, (7) biodegradable soft
tissue anchors, (8) implantable biomedical devices, (9) flexible transparent displays, (10)
field effect transistors, (11) solar cell panels, (12) printing electronic circuits, (13) organic
light-emitting diodes, and (14) supercapacitors. Usually, an ideal chemical polymer for
biomedical and industrial applications should exhibit the majority of the following
properties: (1) non-toxic, (2) no or low immunogenicity (if applicable, for in vivo use), (3)
biodegradable and metabolizable, (4) mechanical features that fit the needs of the specific
application, (5) easily sterilizable, (6) processability, (7) scalability, (8) electrical
conductivity, and (9) thermostability. RNA as a polymer favorably displays many of
these properties, as described below.

Unique properties of RNA as a polymer to build nanostructures
The 2’-hydroxyl group makes RNA dramatically different from DNA
The characteristic of RNA that defines and differentiates it from DNA is the 2’hydroxyl on each ribose sugar of the backbone. The 2′-OH group offers RNA a special
property, which can be either an advantage or a disadvantage. From a structural point of
8

view, the advantage of this additional hydroxyl group is that it locks the ribose sugar into
a 3’-endo chair conformation. As a result, it is structurally favorable for the RNA double
helix to adopt the A-form which is ∼20% shorter and wider rather than the B-form that is
typically present in the DNA double helix. Moreover, the 2’-OH group in RNA is
chemically active and is able to initiate a nucleophilic attack on the adjacent 3’
phosphodiester bond in an SN2 reaction. This cleaves the RNA sugar-phosphate backbone
and this chemical mechanism underlies the basis of catalytic self-cleavage observed in
ribozymes [51]. The disadvantage is that the 2’-OH group makes the RNA susceptible to
nuclease digestion since many ribonuclease (RNases) recognize the structure of RNAs
including the 2’-OH group as specific binding sites. However, such enzymatic instability
has been overcome by applying chemical modification to the 2’-OH group (see the
sections Enzymatic stability of RNA and Methodology II: Chemical modification of
RNA).

Thermodynamic stability of RNA
From a thermodynamic point of view, the stability of the double helix of RNA can
be evaluated by measuring the Gibbs free energy (ΔG0) required for double helix
formation, or conversely, double helix unwinding (ΔG0 = −ΔG0helix formation =
ΔG0helix unwinding). Remarkably, the RNA double helix is more thermodynamically
stable than the DNA double helix considering ΔG0 for RNA double helix formation is,
on the average, −3.6 to −8.5 kJ/mol per base pair stacked and ΔG0 for DNA double helix
formation is −1.4 kJ/mol per base pair stacked [52]. Moreover, the presence of special
motifs such as bends, stacks, junctions and loops in the tertiary structure of RNA may
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also further improve its stability [8]. In addition, various proteins, such as RNA
chaperone proteins, and metal ions, such as Mg2+ may also interact or coordinate with
RNA and significantly contribute to the stability of RNA [53, 54].

Enzymatic stability of RNA
In biological systems, the instability of RNA is mainly the result of enzymatic
degradation by RNases. The presence of RNases in living organisms is universal,
suggesting that RNase-mediated RNA degradation is a vital process for normal biological
function. Several important roles of RNases have been revealed, including degrading
surplus cellular RNA [55, 56], editing messenger RNA, processing microRNA and other
non-coding RNA during their maturation [57, 58], defending against the invasion of viral
RNA [59], and providing crucial machinery for RNA interference (RNAi) [60, 61].
RNases can be divided into two major categories: (1) endo-ribonucleases that cleave
phosphodiester bonds within the RNA backbone [62]. Examples include RNase A,
RNase H, RNase I, RNase III, RNase L, RNase P, RNase PhyM, RNase T1, RNase T2,
RNase U2, RNase V; (2) exo-ribonucleases that cleave phosphodiester bonds at either the
5’ or the 3’ end of an RNA chain [63]. Examples include polynucleotide phosphorylase
(PNPase), RNase PH, RNase II, RNase R, RNase D, RNase T, oligoribonuclease,
exoribonuclease I, exoribonuclease II. RNA is indeed very sensitive to degradation by
RNases, which confers a very short half-life and thus a poor pharmacokinetic profile to
most RNA molecules. This degradation limits the in vivo application of RNA molecules
as therapeutics. However, chemical modifications of RNA can overcome this
shortcoming. For example, the substitution of the 2’ hydroxyl group with a Fluorine (2’10

F), O-methyl (2’-O-Me) or Amine (2’-NH2) dramatically increases the stability of RNA
in vivo by preventing degradation by RNases [64-66]. Recent studies also showed that the
stability of siRNA in serum is also highly depended on the specific RNA sequences and
the degradation of both short and long RNA duplexes mostly occurred at UA/UA or
CA/UG sites [67].
Synthetic polymers always show good stability against various enzymes. However,
biodegradable polymers that can be degraded by enzymes such as proteases,
oxidoreductases and phospholipases are more beneficial for therapeutic applications [68].
Nanocarriers composed of enzyme sensitive polymers can control the site of cellular
uptake of carriers and drug release to improve drug efficacy [69-71]. Synthetic polymers
can also be designed to be non-degradable or degradable under certain physiological
conditions. For example, Poly(lactic-co-glycolic acid) (PLGA) (which is generally
regarded as safe) is approved by the Food and Drug Administration (FDA), as it can be
degraded in the body by hydrolysis and has now been widely used to fabricate
nanoparticles for drug delivery. Poly (beta-amino ester) is another class of degradable
biomaterial developed by the Langer group [72], which can bind negatively-charged
RNA or DNA and facilitate gene transfections. Although biodegradable polymers are
highly attractive for drug delivery purposes, their degradation rate is very hard to control
and the pharmacokinetic and biodistribution profiles of the nanocarriers can be elusive.
Synthetic polymers usually are composed of repeated same subunit, while RNA is the
repetition of four subunits A, U, G and C in a specific sequence order. Therefore, RNA
polymers might be advantageous concerning controllable biodegradability [73, 74]
simply by tuning the ratio and location of 2′-modified nucleotides in the RNA sequence.
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The versatile and plastic properties of RNA
The versatility of RNA is highly evident given the diversity of structural
repertoires available in nature, which include simple structures such as helical stems and
single stranded hairpin loops to more complicated structures such as multi-way junctions
and pseudoknots [75-84]. Persistence length is a basic mechanical property used in
polymer science to measure the flexibility and stiffness of a polymer. If a polymer is
shorter than the persistence length, the molecule will basically be a rigid rod. From a
mechanical perspective, the persistence length of dsRNA (62–63 nm) is slightly longer
than dsDNA (45–50 nm) in an aqueous solution [85, 86]. The stretch modulus of short
dsRNA (<150 bp) is ∼100 pN, which is 3 times lower than dsDNA of similar length, is
based on AFM and tweezer studies [87]. Interestingly, RNA was observed to shorten
upon twisting with two-orders of magnitude slower timescale compared to DNA, which
in contrast lengthened with a faster timescale. More recently, single molecule force
spectroscopy was used to study ∼10 nm long dsDNA containing ribonucleoside
monophosphates (rNMPs) located at specific positions within the DNA strands [88]. The
results demonstrated that the perturbation of stiffness and the plastic properties by
guanosine 5’-monophosphate (rG) intrusions is location and sequence dependent, and can
either soften or stiffen the DNA complex. Molecular dynamics (MD) simulations
indicated that the perturbations are from local structural distortions arising from hydrogen
bonding between the OH group of rG and electronegative sites of either the phosphate
backbone or vicinal base. However, many factors such as sequence, local structural
environment, and metal ion concentrations [89, 90] can significantly influence RNA
versatility, stiffness and plasticity at the molecular level [91]. The balance of the ion12

mediated electrostatic force and the non-electrostatic (chemical) forces determine the
equilibrium structure of the RNA. It is common to find that one RNA molecule can exist
in more than one conformation, and one kind of RNA molecule can display multiple
bands in native gel electrophoresis due to the redistribution of modular motif and local
thermal energy. The versatile and plastic properties of RNA as a polymer have been
applied to the construction of RNA polygons by stretching the internal angle of the threeway junction (3WJ) of phi29 DNA packaging motor from 60 ° to 90 ° to 108 ° to transit
from triangle, square, and pentagon structures, respectively [92].

RNA can form complex 3D structures in nanoscale
While most biologically active DNAs are double-stranded, in contrast, most RNAs
in living organisms are single-stranded. However, RNA molecules contain selfcomplementary sequences which facilitate the self-folding of these RNAs. In addition to
Watson-Crick base pairing, non-Watson–Crick base pairs and coaxial stacking of helices
also play important roles in promoting RNAs folding into complex 3D structures [12, 53].
This remarkable folding capability not only provides the structural basis for the diverse
biochemical functions of different RNA molecules, but also provides huge opportunities
for designing novel RNA nanostructures. For example, the subdomain IIa-1 RNA of the
internal ribosome entry site (IRES) from hepatitis C virus (HCV) has a unique 90 ° bend
L-shaped structure. Molecular modeling using this L-shaped motif showed that a planar
square shaped 3D nanoparticle can be formed with four repeating L-shaped motifs, as
verified by gel shift assay and fluorescence resonance energy transfer (FRET) assay [93]
(Figure 1.1I). Moreover, it has been found that proteins, small molecule ligands (such as
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thiamine pyrophosphate (TPP) and flavin mononucleotide (FMN)) as well as monovalent
and/or divalent metal ions are also important mediators of RNA folding, which could add
another layer of complexity to the assembly of RNA nanostructures [53, 94].

Toolkits and methodologies for the construction of RNA nanostructures
The diverse function of RNA molecules in cells such as ribozymes, riboswitches,
microRNAs, long non-coding RNAs and aptamers had attracted increasing attention in
the scientific community. All these properties of RNA originated from nature that RNA
can adapt different structures and spatial conformations. The laws of how nature
manipulates RNA structures can also be explored to construct artificial RNA
nanostructures. Besides the template-guided folding of RNA nanostructures that is
similar to the tactics in DNA nanotechnology, self-assembly of RNA building blocks is
another leading approach for bottom-up RNA nanotechnology. A wide variety of RNA
nanostructures has been successfully constructed based on different assembly principles
and approaches (Figure 1.1). In this section, I will review several toolkits and
methodologies that have shown great success for constructing multifunctional RNA
nanostructures.

Toolkit I: Hand-in-hand interactions involving RNA loops
Taking the construction of a wooden table as an analogy, external dowels are used
to link variety of wood blocks into a structure. One of the unique properties of RNA is its
folding into loops and hairpin structures. RNA loops can serve as inter-RNA mounting
dovetails, thus external dowels are not necessary for self-assembly into a unique structure.
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The packaging RNA (pRNA) in the phi29 DNA packaging motor [95-103] forms a
hexameric ring structure through interlocking of two looped regions in each pRNA
molecule, named the right- and left-hand loops (Figure 1.1A). The loop close to the 5’end of the pRNA is defined as the right-hand loop, while the loop close to the 3’-end of
the pRNA is defined as the left-hand loop. The left-hand and right-hand were brought
together from interlocking interaction among four nucleotide sequences in the loops.
Single pRNA molecule with self-complimentary sequences in the loops can be used to
construct homodimer nanoparticles, or several pRNAs with the right-hand loop matching
the sequence of the left-hand loop in another pRNA can be used to construct heterodimer
nanoparticles. Through the interlocking loop interactions between different pRNA, dimer,
trimer, and hexamer RNA nanoparticles have been created [104-113]. The interlocking
loop sequences were further extended to increase the thermodynamic stability of
generated RNA nanoparticles [114]. A toolkit with a set of hand-in-hand loop sequences
has been designed and tested for constructing stable RNA polygonal nanoparticles. Loop
extended RNA pairs with confirmed dimer formation capability were used as building
blocks for higher order RNA oligomer nanoparticles (Figure 1.1B). Using a reengineered
loop extended pRNA toolkit, pRNA dimer, trimer, tetramer, pentamer, hexamer, and
heptamer were constructed with highly efficient self-assembly, as shown by gel shift
assays and AFM imaging [114].
Other loop–loop interactions have also been reported to build various RNA
nanostructures. For example, noncovalent loop–loop contacts based on RNAI/IIi kissingloop complex have been used to build RNA nanorings which are thermostable,
ribonuclease resistant and capable of delivering RNA interference modules [85, 115, 116]
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(Figure 1.1E). Moreover, RNA kiss-loops were also used to build square-shaped
tetrameric RNA nanoparticles and three-dimensional polyhedrons based on rationally
designed RNAs [117-119] (Figure 1.1D and F). In addition, micrometer-scale RNA
filaments have also been constructed by the rational design of tectoRNAs incorporating
4-way junction (4WJ) motifs, hairpin loops and their cognate loop–receptors [120, 121].

Toolkit II: Foot-to-foot interactions involving palindrome sequence and sticky ends
pRNA nanoparticles can also be constructed through the foot to foot interaction
between pRNA monomers. While hand-in-hand interaction involves the “left” and “right”
hand and the interaction is “multiple” and “intermolecular”, foot-to-foot interaction
includes only one foot that is the one unique palindrome sequence by self-dimerization
interaction of the identical RNA molecule. The foot domain is located in the helical 5′/3′
open region of pRNA. Extending this region with helical sequences does not compromise
the entire pRNA molecule folding. A palindrome sequence reads the same whether from
5’ → 3’ direction on one strand or from 5’ → 3’ direction on the complementary strand.
Extending the 3’ end of pRNA monomer with a palindrome sequence can serve as a
sticky end for linking two pRNA monomers, and is denoted as a foot-to-foot interaction
[113]. The foot-to-foot interaction by palindrome sequences can also be utilized to bridge
RNA nanostructures, motifs, or scaffolds for constructing RNA hexamers, octamers,
decamers, and dodecamers (Figure 1.1K). A pRNA array was constructed by combining
hand in hand-loop-interactions and foot-to-foot palindrome sequence interactions [113]
(Figure 1.1C). Recently, strategies involving both loop–loop interaction and sticky-end
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cohesion were also reported to assemble three-dimensional and structurally well-defined
RNA nanoprisms by re-engineering pRNA [122].

Toolkit III: Grafts of motifs from naturally-occurring RNA molecules
Synthetic RNA nanoarchitectures can be designed with the known naturallyoccurring three-dimensional RNA motifs. Particularly, some RNA motifs in nature
exhibit extraordinary stability, which could provide advantages in the assembly of RNA
nanostructures. For example, the phi29 motor pRNA [54, 111, 123], tRNA [119], 5S
RNA [124], and RNAI/II inverse kissing complexes [116] have been used to create
synthetic RNA nanostructures [36, 93, 119, 125, 126]. The central domain of the pRNA
molecule contains a 3WJ core structure [54]. This 3WJ can be assembled from three
individual RNA fragments with high efficiency in the absence of metal ions [124]. The
3WJ motif itself creates a branched structure that allows for constructing multifunctional
RNA nanoparticles with different functional moieties at each end of the branches. Since
the 3WJ motif has three branches, RNA nanoparticles can also be designed and fabricated
via branch extension [114] of the 3WJ motif (Figure 1.1L). The 3WJ core retained its
original folding and the conjugated RNA module on the branches can fold into their
authentic structure and remain functional [124, 127]. For example, after incorporation
into the 3WJ motif, hepatitis B Virus (HBV) ribozyme retain its capacity to cleave its
RNA substrate and generate smaller cleavage products, and malachite green (MG)
binding aptamer was also able to bind MG to emit fluorescence as shown in the
fluorescent spectra (Figure 1.2A and B). This property makes the pRNA 3WJ structure
an extraordinary nanocarrier for targeted gene delivery [124]. Moreover, an X-shaped
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motif from the central domain of the pRNA was discovered through extending the righthand loop with a double-stranded sequence [73]. The X-shaped pRNA motif can be selfassembled from four RNA oligos and it creates a scaffold that allows for the conjugation
of four RNA functional moieties at the same time. Functional RNA modules such as
survivin siRNA preserved their target gene knock-down effect after being fused to the Xshaped structure (Figure 1.2C). Branched hexavalent RNA nanoparticles were further
constructed from three 3WJ motifs, integrated by one 3WJ core motif structure or by
palindrome sequence mediated linking of two pRNA-X cores [114].
Recently, Khisamutdinov et al. reported using RNA as an anionic polymer to build
programmable self-assembling boiling-resistant RNA nanostructures based on pRNA3WJ [36] (Figure 1.1N). A triangular shaped RNA nanoparticle was designed and
prepared by carefully joining extended helices to the thermodynamically stable pRNA3WJ motif of the bacteriophage phi29 DNA packaging motor. The step-wise selfassembly of the triangle RNA nanoparticles was confirmed by native polyacrylamide gel
electrophoresis (PAGE) analysis, and AFM imaging revealed the triangular shape of the
nanoparticles as expected. The constructed nanoparticles are thermodynamically
ultrastable and robust. Functional motifs including siRNA, ribozyme, folate and
fluorogenic RNA aptamers retained their activities after conjugation to the RNA
nanoparticles. Moreover, these RNA triangles could be used as building blocks to
construct supramolecular complexes, such as RNA hexagons and patterned hexagonal
arrays. The pRNA-3WJ is also highly tunable [92]; the naturally preserved angle between
the helices H1 and H2 of pRNA-3WJ is ∼60° and this angle can be stretched to form
square-shaped (90° angle) and pentagon-shaped (108° angle) nanoparticles with pre18

designed sequences (Figure 1.3A). The polygons were formed in an one-step selfassembly manner with efficiency >90%, as demonstrated by gel shift assays. The
different sizes and shapes of the polygons were also confirmed by dynamic light
scattering (DLS) and AFM. The equilibrium dissociation constants (KD) for triangle,
square and pentagon are 18.8 nM, 20.3 nM and 22.5 nM, and the melting temperature
(Tm) values are 56 °C, 53 °C and 50 °C, respectively, revealing structure and shapedependent thermodynamic features. In a recent paper by Jasinski et al, the authors
showed that square-shaped RNA nanoparticles with fluorogenic and ribozymatic
properties as well as different sizes can be successfully constructed by utilizing the
pRNA-3WJ at each corner and different length RNA duplexes at each edge of the square
RNA nanoparticles [126] (Figure 1.3B). DLS and AFM determined the sizes of the small,
medium, and large square RNA nanoparticles are 4.0, 11.2, and 24.9 nm, respectively.
The physiochemical properties of the nanoparticles can be easily tuned, as the utilization
of 2′-F RNA as the core strand significantly increased the melting temperature as well as
the nanoparticle's resistance to serum-mediated degradation.
Naturally occurring stable RNA-protein complexes were also explored as building
blocks for nanostructures. For example, the assembly of archaeal box C/D small
ribonucleoproteins (sRNPs) comprising the L7Ae protein from Archaeoglobus fulgidus
and a box C/D RNA has been utilized to build an equilateral triangle shaped synthetic
RNA protein complex [128] (Figure 1.1H). The construction relies on the interaction
between ribosomal protein L7Ae and the Kink-turn motif in box C/D RNA. L7Ae can
bind to the box C/D K-turn motif through hydrogen bonding with high specificity and
affinity [129]. It was reported that using RNA-protein complex as building block for
19

nanostructures enhanced its stability in serum comparing to pure unmodified RNA based
nanoparticles [130]. The ribonucleoprotein (RNP) nanostructure could serve as a scaffold
for protein or RNA functionalities. For example, an affibody peptide, which can
recognize human epidermal growth factor receptor 2 (HER2), was connected to a RNP
triangle through fusing to a L7Ae protein, and the functionality of the affibody peptide
was still retained. siRNA targeting to GFP gene can be conjugated to the RNP triangle
through extending the RNA strand and the GFP siRNA on RNP nanoparticles still can be
processed by dicer and knock down GFP expression in cells.

Toolkit IV: RNA origami
DNA origami, which involves the folding of a long template single stranded DNA
aided by multiple short staple DNA strands, was reported in 2006 [131]. A wide range of
2D and 3D nanostructures have been successfully constructed using the DNA origami
technique [132-136]. In 2014, a similar approach for RNA origami was reported to fold
single stranded RNA into RNA tiles and further assembled into hexagonal lattices [137]
(Figure 1.1M). A variety of RNA tertiary motifs, including the 180° kissing loop motif
of the HIV-1 DIS [138], the 120° loop–loop complex of RNA i/ii inverse loop [115], and
the tetraloops GNRA and UNCG [139] were used to mediate internal RNA tertiary
interactions, resulting in organized and scalable RNA crossover tiles. The designed RNA
origami nanostructures are also robust, which could form by either annealing or cotranscription on mica. In contrast to DNA origami, this RNA origami approach does not
need short staple strands to facilitate the folding of the origami structure, but using RNA
modules such as kissing loops to replace the role of staple strands. Interestingly, a
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different RNA origami approach which is a direct extension of the DNA origami to RNA
was also reported in 2014 [140] (Figure 1.1P). In this study, a single-stranded RNA
scaffold and multiple staple RNA strands were used to assemble defined RNA
nanostructures including a 7-helix bundled RNA tile and a 6-helix bundled RNA tube.
The authors also showed that functional modules such as biotin could be introduced into
the RNA origami structures by chemical modifications of the scaffold strands.

Toolkit V: RNA/DNA hybrid nanostructures
RNA/DNA hybrids can also be used to construct functional nanoarchitectures.
Similar to split-protein systems, RNA/DNA hybrids can be computationally designed for
activating different split functionalities in the presence of respective equivalent strands
[141-144] (Figure 1.4A). Toehold interactions were used to trigger disassociation of
RNA/DNA hybrids and re-association of the double-stranded RNA and DNA. The
thermodynamics and kinetics of the toehold interactions can be tuned to control the
dissociation and re-association processes. RNA interference modules as well as other
functionalities such as fluorophores and RNA aptamers can be successfully triggered
inside mammalian cells. This RNA/DNA hybrids concept has also been applied to other
nanostructures such as nanorings and cubes [115, 116, 145-147], and the spilt
functionalities still retain their authentic functionalities. Because the RNA/DNA hybrid is
more enzymatically stable than RNA, this approach has the potential to improve the
pharmacological profiles of RNA-based nanoparticles. Moreover, controlled release of
the split functionalities opens a new avenue for the development of nucleic acid-based
switches to modulate cellular functions in vivo.
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Methodology I: Rolling circle transcription
Typically, the design and production of RNA nanoparticles have relied on the
production of discrete RNA strands that can be assembled in a controlled and predictive
fashion to generate nanoparticles with a defined structure and stoichiometry. Hammond
and colleagues have departed from this approach with an innovative strategy that
generates monodisperse spherulitic RNA particles from extremely high molecular weight
RNA strands by using a rolling circle transcription (RCT) approach [148, 149] (Figure
1.1J). They created a circular DNA construct containing a siRNA gene without any
terminator sequences and proceeded by a T7 promoter. As a result, T7 RNA polymerase
can continuously transcribe the circular DNA hundreds of times to generate a tremendous
number of copies of the tandem RNA unit. As the continuous RNA strand is transcribed,
magnesium pyrophosphate crystals are simultaneously generated, and the RNA strands
attach to the crystallite surfaces to form composite structures; each structure grows in
length to become fiber-like, then, forms sheet-like lamellae. The lamellae, typically ∼10
nm thick, finally condense into spherulites with diameters varying from a few
micrometers to hundreds of micrometers, referred by the author as RNAi microsponges.
To achieve efficient cellular uptake, Polyethylenimine (PEI) was introduced to condense
the RNAi-microsponge from 2 µm to 200 nm, and to protect the RNA from degradation
by RNase. The PEI introduced a positively charged outer layer to the microsponges to
facilitate cell binding and entry. It was also demonstrated that the spherulitic RNAimicrosponges produced ∼21 nucleotides (nt) siRNA fragments after incubation with
Dicer and could transfect a cancer cell line and silence firefly luciferase expression. Gene
expression knockdown in vivo by intratumoral injection of the PEI-condensed RNAi22

microsponges was also reported. This innovative approach opens new directions to RNA
nanoparticle self-assembly and siRNA delivery. However, the therapeutic potential and in
vivo safety of this approach requires further evaluation, as PEI has been shown to cause
well-known adverse side effects, such as high cytotoxicity [150, 151]. In addition, further
reduction of the size of the particles is recommended to avoid non-specific healthy organ
accumulation.
In material sciences, polymeric membranes are at the forefront in the chemical and
biotechnology industry because of their versatile applications such as water purification,
dehydrogenation of natural gas, dialysis of blood, and removal of cell particles [152].
Recently, Lee's group demonstrated rolling circle transcription can also be applied to the
synthesis of macroscopic RNA membranes that has the potential as a controlled drugrelease system [153] (Figure 1.1O). The RNA membrane was fabricated by T7 RNA
polymerase transcription system with a combination of complementary rolling circle
transcription (cRCT) and evaporation-induced self-assembly (EISA). The circular DNA
template and complementary circular DNA template were prepared with long linear DNA
and the promoter DNA for starting the rolling circle transcription (RCT). Upon addition
of T7 polymerase to these two circular DNA templates, thousands of copies of single
stranded RNA and single stranded complementary RNA were continuously generated.
The two complementary RNA strands hybridized to each other thereby forming the
double stranded RNA for the large-area of RNA membrane. After the cRCT process, the
water in the RNA membrane was evaporated and the dried RNA membrane was
concentrated by the EISA process. The self-assembled RNA membrane was fabricated
densely on the tube wall during the evaporation process. The durability of the fabricated
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RNA membrane was tested under various harsh conditions, including RNase and DNaserich environments. In addition, they confirmed the application of the RNA membrane as
an enzyme-responsive drug-release system with doxorubicin and siRNA. The results
showed that the RNA membrane can provide a high drug-loading efficiency and can be a
great candidate for membrane-based drug delivery.

Methodology II: Chemical modification of RNA
A great deal of work on chemical modifications aiming to improve the chemical
stability and in vivo properties of RNA has been reported [154-157]. Common chemical
modifications of RNA can be categorized into five classes: (1) Modification of internucleotide phosphodiester backbone. This type of modification is the most classic and
simplest method to improve the performance of RNA in the biological environment. For
example, creation of a phosphorothioate (PS) linkage by replacing one non-bridging
oxygen atom on the phosphate backbone with a sulfur atom substantially increases the
stability of RNA in vitro and in vivo [158]. Other backbone modifications such as
boranophosphate, phosphoramidate and methylphosphonate have also been explored to
enhance the resistance to nuclease-mediated degradation [159-161]. However, cytotoxic
side-effects were also observed if extensive modifications were applied [162]. (2)
Substitution of 2′-OH group. This is the most widely used approach since it is welltolerated and can enhance nuclease resistance as well as reduce immunogenicity. For
example, the naturally occurring 2′-O-methyl (OMe) modification is nontoxic and is able
to prevent immune activation while conferring biological stability simultaneously [162]
and [163]. Guo's lab also reported that incorporation of 2′-fluoro nucleotides into the
24

pRNA scaffold allows the creation of stable and RNase-resistant RNA nanoparticles with
correct folding and authentic biological activities. The melting temperature of 2′-F RNA
was further enhanced compared to unmodified RNA [164]. The chemically modified
pRNA-based nanoparticles have shown promising applications in cancer therapy [36, 66,
165-168]. Recent study also showed that 2′-F modified pRNA nanoparticles are resistant
to
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I and
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Cs radiation with clinically relevant doses, which is a required property for

applying these RNA nanoparticles as delivery vehicles for targeted radiation therapy
[169]. Other options for 2′-modification like 2′-fluoro-β-d-arabinonucleotide (FANA)
have also shown promise in gene silencing applications [170]. (3) Locked nucleic acids
(LNA) and unlocked nucleic acid (UNA). LNA is another class of 2′-modification in
which 2′-O and 4′-C is linked via a methylene bridge. This locked linkage constrains the
ribose ring into the C3′-endo conformation, which confers both significant increase in
thermostability and enhancement in nuclease resistance [171]. Successful applications of
LNA such as 2′-amino-LNA have been studied by Astakhova et al. to show great promise
in the development of biosensor, aptamer and other nanomaterials [172]. Antisense
oligonucleotides (ASO) containing LNA also has been reported to have higher potency
and specificity [173] and [174], but would also cause liver toxicity in mouse models if
LNAs were extensively incorporated into the sequence [175]. In the other hand, UNA is
an acyclic and structurally flexible-RNA analogue in which the C2′–C3′ bond is absent.
As a result, the binding affinity of UNA towards its complementary strand is decreased
[176]. (4) Modification of ribonucleotide base. This approach is less commonly used than
other modification approaches described thus far. However, recently RNA tube
nanostructures have been reported to be constructed successfully by using RNA scaffolds
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with 5-biotinylated modified and 5-aminoallyl modified uracil [140]. Other common
modified bases such as 2-thio-, 4-thio, 5-iodo-, 5-bromo-, dihydro-, pseudo-uracil and
diamino-purine also have been demonstrated to confer enhancement in stability as well as
specificity of base-pairing interactions [156, 177, 178]. (5) Modification of ribose moiety.
This modification strategy, for example, altritol nucleic acid (ANA) and hexitol nucleic
acid (HNA), is mainly applied in siRNA design to enhance potency and nuclease
resistance [179]. Besides these classes, other novel methods such as photocaging
modification have been used to control RNAi induction [180]. The particular effect of
various chemical modifications on RNA are summarized in Table 1.1. It is expected that
the rational choice of precise chemical modifications will greatly contribute to the
development of RNA nanostructures for applications in biomedical sciences and material
sciences. Moreover, the strategy of combining different modification approaches also has
the potential to improve the properties of RNA more dramatically.

Methodology III: Computational approach
The first step in RNA nanoparticle construction is the consideration of the
blueprint [181]. This requires an understanding of the assembly and folding mechanism
in the bottom-up assembly. Designing the sequence of the building block is critical for
successful RNA nanostructure assembly, which can be achieved by experience and
brainstorming taking into consideration RNA folding, complementation, hand-in-hand
interaction, foot-to-foot interaction, and the use of thermostable motifs, kissing loops,
sticky ends, helices and stem loops. All RNA nanoparticles constructed based on phi29
motor pRNA were achieved via experience and brainstorming without computer
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algorithm other than the traditional RNA folding program developed by Zuker 30 years
ago [182]. It is expected that computer algorithms will facilitate RNA nanoparticle
construction. A variety of computer programs such as NanoFolder, NanoTiler and
RNA2D3D are available to facilitate the in silico design of RNA sequences (these
sequences may contain inter-strand and intra-strand pseudoknot-like interactions) capable
of self-assembly into multi-sequence RNA nanostructures and the 3D modeling of such
structures [183-185]. For example, by utilizing computational modeling and sequence
optimization, three-dimensional cubic RNA-based scaffolds can be successfully designed
and engineered with precise control over their shape, size and composition [145].
Moreover, online RNA structure databases such as RNAJunction database also provide
useful RNA structures for designing RNA nanostructures [186].

Application of RNA as a polymer in biomedical sciences
RNA as a natural and biocompatible polymer has many advantages for biomedical
applications. It carries a negative charge at physiological conditions, which disallows
nonspecific passing through negatively charged cell membrane. With the conjugation of
chemical ligands and/or RNA aptamers, RNA nanoparticles can be designed for specific
cell targeting. It is less toxic compared with protein-based nanoparticles since it can avoid
antibody induction (protein-free nanoparticle), allowing repeated treatment of chronic
diseases. It also does not induce an interferon response nor cytokine production [92, 187].
RNA nanoparticles designed with a size range 10–40 nm display favorable
pharmacokinetic properties [187], such as extended half-life in vivo (5–12 h compared to
0.25–0.75 h for siRNA), clearance: < 0.13 L/kg/h, volume of distribution: 1.2 L/kg.
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As a building block for nanoparticles, RNA can be synthesized with defined
structure and stoichiometry. Multivalent RNA nanoparticles can be constructed using
special RNA motifs as building blocks that combine therapy, targeting, and detection, all
functionalities in one particle.

RNA as a biocompatible nanomaterial for tissue engineering
Tissue engineering is a new area with large amounts of active research and some
recent success. Biocompatible nanomaterials are needed for various applications in tissue
engineering, such as scaffolds or arrays that can function as temporary matrices and/or
niches for the controlled deposition, infiltration, proliferation, and differentiation of cells.
It would also be advantageous if these nanomaterials could be highly biocompatible and
mimic the natural tissue microenvironment in vivo.
Shu et al. reported that nanometer scale 3D RNA arrays can be assembled by using
pRNA as building blocks [113] (Figure 1.1C). By rational design, the authors
incorporated palindrome sequences (nucleotide sequences that read the same 5′ → 3′ on
one strand and 3′ → 5′ on the complementary strand) into the 3′-end of the pRNA. The
palindrome sequences served as links for bridging two pRNAs via foot-on-foot
interactions. Loop–loop interactions were further used to link pRNA molecules into a
chain. The formation of pRNA arrays was analyzed by PAGE and it was found that the
arrays were too large to run into the gel and got trapped in the gel wells. The shape of the
pRNA arrays was further characterized by AFM. Under AFM imaging, the pRNA arrays
presented as bundles with micron scale. These RNA arrays are unusually stable and
resistant to a wide range of temperatures, salt concentrations, and pH environments. The
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microstructures of the RNA assays are also tailorable by changing the RNA nucleotide
sequences. Since RNA molecules are highly biocompatible and not toxic, these RNA
arrays have the potential to be good tissue engineering scaffolds.

RNA nanoparticles for targeted therapeutic delivery
Targeted delivery is a major challenge that nucleic acid therapeutics is facing.
RNA nanoparticles with chemical ligand and nucleic acid aptamers have shown great
promise in this regard. The utilization of RNA nanostructures as a platform for targeted
therapeutics delivery has been successfully demonstrated by a series of studies using the
phi29 pRNA system. In 2003, Hoeprich et al. constructed a pRNA-based carrier to
deliver hammerhead ribozymes [188]. Upon conjugation to the pRNA 5′/3′ ends, the
HBV ribozymes were able to fold correctly and almost completely cleaved the polyA
signal of HBV mRNA in vitro. Targeted therapeutics delivery to specific cancer cells can
be achieved by using ligand-conjugated RNA nanoparticles as carriers. Furthermore, the
cargo in vivo release profile from RNA nanoparticles can also be controlled through the
rational design of RNA nanoparticles. In 2005, Guo et al. reported the construction of
chimeric pRNA dimer with one subunit harboring folate and the other subunit harboring
a gene silencing siRNA targeting survivin [109]. Incubation of these pRNA dimers with
cancer cells resulted in receptor-mediated binding and entry to cells and induced efficient
gene silencing. Animal trials showed that ex vivo delivery of the pRNA dimer harboring
both folate and survivin siRNA could suppress tumor development. Khaled et al. studied
the fabrication of a protein-free 20–40 nm pRNA trimer which could harbor three
functional modules including siRNA, CD4 aptamer or folate ligands and a fluorescent
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dye per nanoparticle [112]. They showed that the pRNA trimer could also bind and enter
into cells and modulate gene expression and apoptosis both in vitro and in vivo. In 2006,
Guo et al., reported incorporating a folate-AMP into the 5′-end of phi29 pRNA and
showed that folate conjugated pRNA dimer nanoparticles were able to deliver survivin
siRNA into nasopharyngeal epidermal carcinoma cells and silence the target gene [189].
The pRNA system can also be used to deliver anti-virus siRNAs. Zhang et al., developed
a folate-linked pRNA conjugated with the siRNA targeting the Coxsackievirus B3
(CVB3) protease 2A (siRNA/2A) [190]. They observed that the modified pRNA could
achieve a similar antiviral effect to that of siRNA/2A alone and also strongly inhibited
CVB3 replication.
The latest advance in the utilization of phi29 pRNA for therapeutics delivery is the
discovery of a phi29 pRNA 3WJ motif with unusual thermodynamic stability. The slope
of the melting temperature curve of the three-fragment RNA complex is close to 90°,
indicating extremely low ΔG of the phi29 pRNA-3WJ complex [124]. The pRNA 3WJ
motif was used as a RNA scaffold to construct bi-, tri-, and tetra-valent RNA
nanoparticles with very high chemical and thermodynamic stability [73, 124, 181]. The
resulting RNA nanoparticles are resistant to denaturation in 8 M urea and do not
dissociate at ultra-low concentrations. Each arm of the 3WJ or X-motif can harbor one
siRNA, ribozyme, miRNA, or aptamer without affecting the folding of the central core,
and each daughter RNA molecule within the nanoparticle folds into respective correct
structure with authentic biological function. The effects of gene silencing progressively
increased with increasing number of siRNA modules in the RNA nanoparticle [73].
These RNA nanoparticles can specifically target subcutaneous tumor xenografts [73, 124,
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168], as well as orthotopic breast cancer [174] and intracranial glioma tumors [165]
without detectable accumulation in liver, lung or other healthy organs or tissues (Figure
1.5A–C). A recent study also showed that the pRNA-3WJ nanoparticle conjugated with
folate can specifically target colorectal cancer metastasis in the liver, lungs and lymph
node simultaneously in vivo, without accumulation in normal liver or lung parenchyma
[166] (Figure 1.5D). Pharmacological analysis in mice indicated that the pRNA
nanoparticles display favorable pharmacokinetic (PK) and pharmacodynamic (PD)
profiles, with in vivo half-life extended 10-fold compared to siRNA alone and did not
induce adverse immune response including cytokine, interferon, antibody, and other toxic
effects [187]. The regression of gastric cancer and breast cancer by RNA nanoparticles
harboring siRNA [73, 124, 168] or anti-miRNA [174] has also been reported recently.
A recent paper also reported the development of novel immunomodulators by
engineering rationally designed RNA polygonal nanoparticles [92]. When immunological
adjuvants

CpG

DNA

were

incorporated

into

the

RNA

polygons,

potent

immunostimulation (cytokine TNF-α and IL-6 induction) was observed both in vitro and
in vivo, compared to controls. Moreover, the RNA nanoparticles could deliver CpG DNA
to macrophages specifically and the degree of immunostimulation significantly depended
on the size, shape, and the number of payload per RNA nanoparticle. This finding
demonstrates that RNA nanotechnology, such as developing RNA nanoparticles based on
pRNA, has great potential to develop novel immunomodulators.
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RNA nanoparticles for controlled drug delivery
Many pre-clinical studies are evaluating RNAi as novel therapeutics for different
diseases. However, one concern is that single gene targeted therapy might eventually fail
due to mutations over time or development of alternative signaling cascades or escape
pathways. Multivalent RNA nanoparticles can be a very promising vehicle for delivery of
multiple siRNAs to suppress multiple genes simultaneously. A recent publication by
Afonin et al. showed that several RNA and RNA/DNA nanocubes could be
functionalized with multiple double stranded RNAs and the siRNAs can be conditionally
released through ssDNA toehold-mediated interactions. Furthermore the RNA nanocubes
can be tracked intracellularly through FRET (fluorescence resonance energy transfer)
studies using fluorophores [191]. In addition, spherical nucleic acid (SNA) nanoparticle
conjugates developed by the Mirkin group have also shown promise for systemic siRNA
delivery for treating diseases such as glioblastoma [192, 193] (Figure 1.4D). Spherical
nucleic acids are densely packed and highly oriented nucleic acids covalently conjugated
to the surface of a spherical nanoparticle core. In vivo studies on glioma-bearing mice
showed that SNA nanoparticle conjugates targeting the oncoprotein Bcl2Like12
effectively increased intratumoral apoptosis, and reduced tumor burden and progression
without adverse side effects [193].
DNA origamis have been exploited as a carrier for the chemical drug doxorubicin
through

noncovalent

intercalation

interactions.

The

DNA

origami/doxorubicin

nanoparticles were able to enter into doxorubicin-resistant cancer cells and circumvent
their drug resistance [194]. Furthermore, the DNA origami/doxorubicin nanoparticles
showed a slow drug release profile at pH 7.4 under physiological conditions but showed
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enhanced release capability in pH 5.5 which is similar to the pH of acidic subcellular
organelles in tumors [195]. As we discussed in previous section (Toolkit IV: RNA
origami), RNA origami structures have been reported [137, 140]. With favorable
thermodynamic stability and excellent serum stability after chemical modifications, RNA
origami is expected to be more favorable than its counterpart DNA origami as a drug
carrier for achieving controlled drug release.

RNA nanoparticles for vascular targeting
A critical feature to drug delivery is the transportation of therapeutics to their
intended target sites. As almost all cells in the body are within ∼100 µm of the
vasculature, the vascular delivery route represents a promising mean for site specific
therapeutics delivery [196]. Owing to the significant heterogeneity in endothelial cells,
both temporally and regionally, it has been observed that the vascular endothelium has
unique expression of surface markers that are highly regionally variant. In other words, it
is potentially possible to target unique endothelial zip codes to locally accumulate
nanocarriers [197].
Current strategies for vascular targeting of nanocarriers have primarily focused on
antibody and peptide based strategies, targeting to surface markers CD31 (PECAM-1)
[198] and [199], inflammatory markers (ICAM-1, VCAM-1) [200-205], and
thrombomodulin [206]. Targeting of CD31, ICAM-1 and VCAM represents a unique
opportunity as the binding of nanoparticles to their sites highlights a novel endocytic
mechanism termed as CAM mediated endocytosis [199, 207]. The use of antibodies as
targeting agents is technically challenging owing to their size, cost of production and
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potential immune responses. RNA aptamers have already shown exciting advantages in
vasculature targeting. High affinity aptamers (56 pM) against P-selectin have been
developed [208]. Microbubbles coated with a low density (1000 copies/µm2) of P-selectin
aptamers demonstrated high adhesion even under shear rates as high as 1700 L/s. The
real promise of vascular-targeted RNA nanoparticles comes from the combination of the
high binding affinity to carrier sizes below 70 nm. The capillary bed represents the
greatest promise of vascular targeting, where there already exists a highly active
transcytosis mechanism, with approximately ten thousand times more caveolae than other
endothelial cells [209]. These 70 nm endocytic vesicles are an exciting target for drug
delivery [210] yet require a carrier system like RNA nanoparticles that are
simultaneously small and have high affinity to permit transcytosis and tissue bed delivery.

RNA nanoparticles as non-invasive medical detection reagents
Functional RNA structures such as aptamers can be used for developing noninvasive molecular and cellular imaging reagents which may have applications in the
diagnosis of various diseases including cancer, cardiovascular diseases, and infectious
diseases. Considering it is relatively easy to conjugate a fluorophore, radionuclide,
quantum dot (QD), gold nanoparticle, or other imaging functional groups to RNA, RNA
molecules with high binding affinity to their targets hold great potential as a platform to
construct imaging probes which can specifically detect their targets in vitro and in vivo.
Fluorescent RNA nanoparticles conjugated with aptamer have been widely
explored for cancer detection. For example, Bagalkot et al. [211] developed a QDaptamer-doxorubicin conjugate nanoparticle as a cancer-targeted imaging, sensing and
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treatment platform (Figure 1.4B). A10 RNA aptamer, which specifically binds to the
extracellular domain of the prostate specific membrane antigen (PSMA), was conjugated
to the surface of fluorescent quantum dots and the anticancer drug doxorubicin was
intercalated into the double-stranded stem of the A10 aptamer. In the conjugate
nanoparticle, fluorescence of doxorubicin was quenched by the aptamer through donorquencher FRET, and the fluorescence of QD was quenched by doxorubicin through
donor-acceptor FRET mechanism. When the nanoparticle enters the prostate cancer cell
and doxorubicin is released, the fluorescence of QD and doxorubicin is re-activated.
Other RNA aptamers conjugated with fluorescent dye chemicals have also been utilized
for breast cancer diagnosis, such as EpCAM aptamer labeled with DY647, TYE665 or
FITC [212].
Conjugating RNA aptamer with radioactive material can also be applied as
diagnostic radiopharmaceuticals to detect cancer cell markers. In a recent study reported
by Gomes et al. [213] a 36 nucleotide long truncated RNA aptamer with 2′F pyrimidine
and 2′-O-methyl purine modification was constructed for targeting to the human matrix
metalloprotease 9 (hMMP-9), which promotes tumor metastasis and is an important
marker of malignant tumors. The 5′-end amine modified RNA aptamer was conjugated to
N-hydroxysuccinimidyl mercaptoacetyltriglycinate (MAG3-NHS), which served as a
chelator for Technetium-99m (99mTc). The

99m

Tc labeled modified RNA aptamer was

able to specifically detect its target in human brain tumors with autoradiography.
With the conjugation of the PSMA RNA aptamer to the surface of gold
nanoparticles (GNPs) [214], a targeted computed tomography (CT) imaging and therapy
system for prostate cancer can also be established (Figure 1.4C). The CT imaging study
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revealed that the PSMA aptamer-conjugated GNPs could generate more than four-fold
greater CT intensity for a PSMA-expressing cell line than a non-PSMA-expressing cell
line, suggesting good specificity in detection of the targeted cancer cells.

RNA nanoparticles for intracellular imaging and detection
An interesting example of applying RNA in intracellular imaging is the Spinach
RNA aptamer, which is the RNA mimic of Green fluorescent protein (GFP). GFP has
been extensively utilized as a reporter protein in cell and molecular biology. Similarly,
the RNA mimics of GFP should also have remarkable applications in biomedical research,
especially for intracellular imaging of RNA. By using the method of systematic evolution
of ligands by exponential enrichment (SELEX), Paige et al. developed a novel class of
RNA aptamers, termed Spinach that bind to fluorophores resembling the fluorophore in
GFP [215] (Figure 1.6A). Upon binding of the targeted fluorophores, these RNA
aptamers were capable of emitting tunable fluorescence with comparable brightness to
enhanced GFP (EGFP) and many other fluorescent proteins. Moreover, the RNAfluorophore complex is resistant to photobleaching. Interestingly, the Spinach RNA
aptamer can be expressed in vivo by fusing to other cellular RNAs, for example, 5S RNA,
to enable live-cell imaging and monitoring of these cellular RNAs. Furthermore,
fluorescent sensors for detecting a variety of small molecules and cellular metabolites,
including adenosine 5′-diphosphate (ADP) and S-adenosylmethionine (SAM), in vitro
and in living cells could also be generated by combining the Spinach aptamer, a
transducer, and a target-binding aptamer [216] (Figure 1.6B).
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Reif et al. [217] recently reported another novel method to enable real-time
monitoring of RNA folding and degradation in living cells based on the pRNA-3WJ. The
authors designed and constructed RNA nanoparticles by incorporating an RNA aptamer
capable of binding to malachite green (MG), the hepatitis B virus ribozyme and the
luciferase siRNA into the pRNA 3WJ. When MG aptamer binds to MG dye, it will emit
fluorescent light only if the aptamer folds correctly. The MG aptamer system can then be
used to monitor the degradation of the constructed RNA nanoparticles by fluorescent
microscopy and fluorescence spectroscopy. By using this novel design, the authors
determined the half-life (t1/2) of the MG aptamer containing pRNA-3WJ inside living
cells to be ∼4.3 h.

RNA as a polymer for biosensor systems
The biomolecular-based detection system has been widely investigated in many
applications including clinical diagnosis, food industry, environmental monitoring
industry, and security industry [218, 219]. Conventionally, biosensors can detect proteins,
nucleic acids such as DNA or RNA sequences, and small organic molecules [219-221].
RNA molecules are well suited to serve as detection tools for small molecules, antibiotics,
peptides, metal ions, and ligands [222, 223] because of their unique folding structures,
functional conformation, predictable base pairing, and high fidelity. These characteristics
of RNA allow for the development of ribozyme or aptamer, and aptazyme-based
biosensors [224-226]. Also, as the target, RNA can be used to develop the biosensor for
the detection of messenger RNA or micro RNA [227-230]. Various detection methods of
RNA-based biosensors were proposed such as electrochemical type, fluorescence type,
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optical type, and electrical type. Also, there are various detection platforms for RNAbased biosensors (Figure 1.7) [231-236]. In this section, we briefly introduce RNA-based
biosensors for biomedical and environmental monitoring applications.
The first proof of concept of using RNA in a biosensor was developed by Breaker
Group [222]. Self-cleaving hammerhead-ribozymes were created with seven different
RNA switches and these immobilized each pixel that responded allosterically to six types
of analytes (Co2+, cGMP, cCMP, cAMP, FMN and theophylline). The platform of
biosensor array was prepared on a polystyrene cell culture plate which was coated with
gold by physical vapor deposition. The ribozyme was immobilized onto gold surface via
a 5′-thiotriphosphate-terminated RNA moiety. When individual analyte was added, the
corresponding RNA biosensor captured the analyte and induced the self-cleavage and
release of the 3′ fragment of the ribozyme. They also showed the quantitative and
qualitative measurement of cAMP in culture media from E. coli strand.
RNA can also serve as the detection analyte to detect viable E. coli as an indicator
organism in drinking water, which was proposed by the Baeumner group [229, 230]. This
RNA-based biosensor was generated with the extraction and amplification of mRNA
molecules from E. coli in 20 min. Viable E. coli in the water were identified and
quantified using a 200 nt target sequence from mRNA. The detection limit of the
biosensor system could detect around 40 viable E. coli in water (5 fmol per sample) using
the electrochemiluminescence (ECL) detection method. They introduced the isothermal
amplification technique, a nucleic acid sequence-based amplification (NASBA) for
mRNA amplification.
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RNA was also applied to develop medical diagnosis biosensors. Theophylline (1,
3-dimethylxanthine) is a common agent in the bronchodilators and used for acute and
chronic asthma. Gothelf group developed a RNA-based electrochemical biosensor for
theophylline in serum with a ferrocence (Fc) redox probe [226, 234]. In this study, the
thiol group-modified and amino group-modified RNA aptamer were immobilized onto
gold substrate via covalent bonding between thiol group and gold substrate. Then, the Fc
redox probe was covalently attached to the 3′-amino group of RNA aptamer through Fccarboxylic acid NHS reaction. Usually, the RNA aptamer stays on the open conformation
in absence of theophylline. However, when the theophylline added to RNA aptamermodified electrode, the aptamer folds into the conformationally restricted hairpin
structure. As a result, this phenomenon changed the electron transfer that was monitored
by cyclic and differential pulse voltammetry. Moreover, specific recognition of dopamine
by the RNA aptamer allows selective amperometric detection of dopamine from 100 nM
to 5 µM range in the presence of competitive neurotransmitters such as catechol,
epinephrine, norepinephrine, and others [233].
In an alternative approach, the Hammond group used a RNA-based fluorescent
biosensor for detecting cyclic di-GMP and cyclic AMP-GMP [227]. The c-di-GMP was
generated by a GEMM (Genes for the Environment, Membranes, and Motility)-I
riboswitch aptamer and the riboswitch ligand mutation can recognize the c-AMP-GMP,
c-di-GMP. The fluorescence turn-on was activated by the 3, 5-difluoro-4hydroxybenzylidene imidazolinone (DFHBI) fluorescent molecule for cell imaging. This
system provided selective and sensitive detection for each cyclic dinucleotide. Thus,
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there are many examples demonstrating that RNA molecules are promising candidates
for biosensor applications.

Application of RNA as a polymer in material sciences
RNA as a polymer for biocomputation systems
Silicon-based computer systems are ubiquitous [237] but new processors to
implement computation, communication, and controls are needed to meet the demands of
various applications. Gordon Moore's Law suggested that due to the increasing demand
of the memory, computer electronic devices on the microprocessor will be doubled every
18 months. Scientists and engineers are wondering whether current computer technology
growth can be continued in the next ten years. They raised the concern that silicon
microprocessor speed and miniaturization will eventually reach limits by current
technology. Thus, molecular-scale computing has been explored since 1994 due to the
predictable ending of Moore's Law for silicon-based computer devices.
In the last few decades, biotechnology has been integrated with nanotechnology
and electrical engineering [238-240]. As a result, the field of bioelectronics has been
created [241] and [242]. Bioelectronics has led to the development of the nanoscale
biochip, biosensor, and biocomputation devices such as information storage devices,
logic gates, field-effect transistors and computation systems (Table 1.2) [243-246].
Typically, bioelectronic devices are composed of a biological actuation portion, and an
electronic signal transduction portion. So far, the biological component is usually
composed of biomolecules, such as protein and DNA [240], [243] and [245]. Recently,
some pioneering groups have suggested that RNA-based bioelectronic devices also
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exhibited the logic gate behavior, processing functions, and biocomputational functions
[181, 247-251]. The advantages of RNA-based computation are summarized in Figure
1.8. Biocomputation approaches for information control, storage, and processing using
RNA-based devices brings new possibilities that embody multiple functions in biological
systems. The development of biological computers composed of artificial RNA
molecules to operate inside living cells or tissues would provide a new avenue. A
combination of these results will pave the way to develop the new-concept of
biocomputer development in the future such as tissue-mimicked computations.

RNA as a polymer for logic gates
In computer science, the ‘logic’ term is defined as circuits which gives an output
corresponding to a set of two input values (True ‘1’, High voltage and False ‘0’, Low
voltage). The logic gate is required to have two input values for performing Boolean
function [242]. Thereby, it gives the logical output to perform the next function. Usually,
man-made computers consist of millions of combinational logic gates. Thus, logic gates
are essential components of the computer. As mentioned in the last section (RNA as a
polymer for biocomputation systems), in the last few decades, the concept of a
biomolecule-based computation system has been proposed or explored to solve the
current limitation of silicon-based computations [247, 252-256]. The first attempt of
molecular-scale computation was developed by Adleman's group in 1994 [252]. They
introduced the encoded DNA molecule to solve the Hamiltonian path problem. This
research established a milestone for the field of biomolecule-based computations. Since
then, several groups proposed the DNA polymer-based logic systems [253, 255, 256].
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The basic operation mechanism of DNA-based logic gate is combinational DNA
hybridization that undergoes conformational change or chemical reaction and includes
pH, temperature, light, electrical, or electrochemical signals [252-256]. The function of
logic gate gives the discrete state change such as structure, fluorescence, absorbance, and
electrochemical or electrical current as the output. Like this, the various types of DNAbased computations have been proposed. DNA, however, is hard to use to perform the
complex functions because of its simple functionality. To develop the new-concept of
biocomputation systems, RNA is a candidate owing to its intriguing characteristics. The
folding and assembly of RNA molecules drive themselves into secondary and tertiary
structures using the formation of hairpin loops, dovetails, bulges, and internal loops [10].
Thereby, RNA has functionality such as aptamer, ribozyme, siRNA, non-coding RNA,
and circular RNA [181]. These various functional groups can be easily applied to the new
concept of logic gate behavior, information storage, information processing, and
computations as the novel elements [257-265].
An autonomous biomolecular-based computer has been proposed to regulate the
gene expression “logically” [249]. The basic computation rule is governed by ‘diagnostic
rule’ for prostate cancer stage detection. If the specific genes relating to prostate cancer
are overexpressed, then ssDNAs will bind to their mRNA and inhibit the protein
synthesis. The level of specific RNA and the concentration of specific molecule which
regulates the point mutations were regarded as an input. The release of short ssDNA
modulated the levels of gene expression for anticancer activity, as the output logically.
The computation module has two states, “positive” and “negative”, in response to the
level of specific gene expression. This biocomputation concept is related with the
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identification of mRNAs of disease-related genes. Thereby, it can be applied to cancer
diagnosis systems based on logic analysis.
A RNAi-based logic evaluator has also been reported to perform Boolean logic
corresponding to input molecules in the human kidney cells [250]. The reported
biological circuit is composed of several mRNA species that encode the same protein but
have different non-coding regions. This protein served as the output. As an input, siRNAs
were used to control the degradation of the target mRNA and the expression of the output
protein. Expressions with up to five logic variables were directly evaluated by this system.

RNA as a polymer for information processor
In computer sciences, the information processor is a unit that receives the input
information and processes it into another form based on programmed functions. RNAbased information processing devices that operate logic gates, signal filtering, and
cooperativity functions have been reported [251, 260, 266]. RNA devices composed of
ribozymes and RNA aptamers received, processed and transmitted the molecular inputs
to express the green fluorescent protein as output. As a sensor part, the RNA aptamer was
introduced and a hammerhead ribozyme was used to process the cleaving of the aptamer.
Also, the transmitter part was composed of sequences that bind to the aptamer and
ribozymes. It was suggested that the RNA aptamer and ribozyme combination can be
used as actuating elements for multi-functional information processor development [251,
266].
An intracellular RNA computation device in a single mammalian cell has also
been reported [260]. Trigger-controlled transcription factors were used to regulate the
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gene expression individually and the RNA-binding protein was used to inhibit the
translation of transcripts on target RNA motifs. This computation biosynthetic circuit can
provide the NOT, AND, NAND, and N-IMPLY expression functions in individual cells.
Moreover, two N-IMPLY expression functions can combine with other cells to operate
XOR gate functions and three logic gates can perform the half-adder and half-subtractor
functions for arithmetic calculation.

RNA as a polymer for resistive biomolecular memory
RNA can also provide several advantages such as ease of construction, well
defined structure and thermodynamic stability for the development of biomolecular
memory devices. Based on the discovery of the ultra-high thermostable pRNA-3WJ, a
pRNA-3WJ/QD hybrid nanoparticle for resistive biomolecular memory application has
been constructed [267]. The QD was used as a semiconducting part for storage of the
electrons and pRNA-3WJ was used as an insulating part and serves as the bridge between
QD and metal substrate. The electrical measurement (I–V) was conducted to this hybrid
structure for resistive memory performances. This study showed the RNA polymer
conjugates can be used directly for molecular memory device fabrication.

Hybrid RNA polymers as semiconductors
Biomolecular hybrids of a conducting polymer [poly (O-methoxy aniline) (POMA)]
and dsRNA have been investigated as semiconductors by Routh et al. in 2009 [268].
Fourier transform infrared (FTIR) spectroscopy indicated that three types of
supramolecular interactions including electrostatic, H-bonding, and pi–pi interactions
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were involved in these hybrid polymers. The circular dichroism spectra of the hybrid
polymers indicated that the dsRNA underwent a small distortion in conformation from
the canonical A-form RNA towards the B-form RNA during the formation of the hybrid
polymers. Ultraviolet–visible spectroscopy revealed that the interaction of POMA on
RNA occurred much faster than that on DNA. Morphological study by TEM further
revealed that these POMA-RNA hybrids exhibited a fibrillar network structure in the
nanometer scale. Conductivity studies revealed that the conductivity values of the
POMA-RNA hybrids were three orders of magnitude higher than that of RNA alone.
Moreover, when RNA concentrations increased in the hybrids, the conductivity values of
the POMA-RNA hybrids also decreased. The I–V curves of the POMA-RNA hybrid
polymers also clearly exhibited a hysteresis loop and demonstrated a semiconducting
nature. Based on these interesting physical and electronic characteristics, the POMARNA hybrids have the potential to be candidates for fabricating biosensors for other
applications.

Conjugation of RNA to graphene
Graphene is a one-atom thick, two-dimensional honeycomb lattice composed of
sp2-bonded carbon atoms. It can be used as a fundamental building block for constructing
other graphite-based structures such as fullerenes and nanotubes [269, 270]. This newly
discovered carbon-based material has been a popular subject in material science and
nanotechnology. It has been used for the sensing of a toxin Microcystin-LR in water
[271-274]. RNA aptamer has been covalently immobilized on graphene oxide and a
polydispersed stable RNA-graphene oxide nanosheet has been constructed [275]. The
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RNA attached to these nanosheets was resistant to nuclease degradation and the
nanosheets competitively absorbed trace amounts of the peptide toxin microcystin-LR
from drinking water. PEI-grafted graphene oxide was also used to deliver siRNA as well
as anticancer drug doxorubicin to cancer cells [276]. RNA has also been used as a
surfactant to exfoliate flakes of graphene from nanocrystalline graphite to produce
transparent and conducting RNA-graphene-based thin films [277], which has a potential
for a variety of electronic applications. Further research in RNA-graphene
nanocomposites may open a new avenue towards many applications of graphene-based
conductive materials.

Conjugation of RNA with other nanoparticles
The conjugation of RNA with nanoparticles such as quantum dot, iron oxide
nanoparticle or gold nanoparticle has been successfully demonstrated by a series of
studies for nanosized imaging, therapy and diagnosis [278-283]. For example, siRNA and
tumor-homing peptides (F3) were conjugated to the PEGylated QD core as a scaffold
[279, 280]. The complex was efficiently delivered to HeLa cells, released from the
endosomal compartment, and triggered knockdown of EGFP signal. This leads to dual
purpose of treatment and imaging. In another case, siRNA was also conjugated to the iron
oxide nanoparticle [281, 283] for dual purpose: (1) in vivo transfer of siRNA and (2)
imaging the accumulation of siRNA in tumor through magnetic resonance imaging (MRI)
and near-infrared in vivo optical imaging (NIRF) using near-infrared Cy5.5 dye. Another
report showed that the conjugation of gold nanoparticle and RNA also increased the
availability of the tethered RNA splicing enhancer [284].
46

In 2007, the pRNA of the phage phi29 DNA-packaging motor was conjugated to
the gold nanoparticles via a thiol group for single particle quantification in bacterial virus
assembly [282]. The pRNA-gold nanoparticle conjugates were bound to procapsid by in
vitro phage assembly. The results demonstrated the feasibility in using RNA-gold
nanoparticle for single molecule imaging and counting of biological machines.

Prospects
RNA is a polymer by nature. Recent technological advances to make RNA
chemically and enzymatically stable [65, 66] and the discovery of unusual thermostability
of some RNA motifs, as well as important biomedical applications [124, 125, 132, 133,
285] have propelled the concept of RNA as a polymeric building block [36] into a new
horizon. The concern of yield and production costs has been and will be addressed
continually by industry scale production and fermentation. It is expected that applications
of RNA as a polymer and as building blocks will appear more and more in therapeutics,
detection, sensing, nanoelectronic devices, and other polymer industries. The anion
nature, the thermodynamic stability, the insulating property, the self-assembly capability
and other novel features such as versatility, molecular-level plasticity, as well as the
potential semiconductor behavior will make RNA unique for exploring new scientific
territories. RNA has been shown to be major components of cells and leading
functionality of life, and it is expected that RNA will also be the momentous material of
daily life in the future.
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Table 1.1. Summary of chemical modifications of RNA.
Chemical Modifications

Advantages

Phosphate backbone
·Phosphorothioate (PS)
·Boranophosphate (BO)
·Phosphonoacetate
(PACE)
·Phosphoramidate
·Methylphosphonate

·Improve nuclease resistance.
·Combine with other modifications
to dramatically improve RNA
property

2’-OH group
·Small
2’-substituents
(e.g. 2’-O-methyl (2’OMe), 2’-fluoro (2’-F), 2’aminoethyl, 2’-deoxy-2’fluoroarabinonu-cleic acid
(2’-F-ANA))
·Bulky 2’-modifications
(e.g. 2’-O-MOE, 2’-Oallyl)

·Significantly improve nuclease
resistance.
·Greatly thermo-stabilizes dsRNA
duplex (e.g. increase Tm 0.5-0.7 °C
per 2’-OMe and 1 °C per 2’-F).
·Particularly, 2’-OMe is nontoxic
and prevents immune activation.
·Bulky
2’-modifications
can
modulate thermos-stability and
duplex asymmetry, and also give
higher binding affinity.

Locked nucleic acid
(LNA)
Unlock nucleic acid
(UNA)

Ribose moiety
·Altritol
nucleic
acid
(ANA)
·Hexitol nucleic acid
(HNA)
·2’-deoxy-2’fluoroarabino-nucleic acid
(2’-F-ANA)
·Cyclohexenyl nucleic
acid
Ribonucleotide base
(5-bromo-, 5-iodo-, 2-thio, 4-thio-uracil, dihydro-,
pseudo, 5-biotinylated, 5aminoallyl-uracil,
diamino-purine)

·LNA enhances the complementary
binding affinity and greatly
improves thermostability by 210 °C per incorporation, as well as
improves nuclease resistance and
reduces RNA immunogenicity.
·Each UNA destabilizes duplex by
5-8 °C to improve local
destabilization of siRNA duplex,
and enhance biostability in vivo.

·Enhance thermostability (e.g. 2’F-ANA increases Tm of RNA
duplex by 0.5-0.8 °C per
modification).
·Improve nuclease resistance.

·Stabilize base-pairing and to
enhance binding specificity.
·Particularly, 2-thio- and pseudouracil reduce cellular immune
response.
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Disadvantages

References

·Destabilize
siRNA duplexes
(e.g. decreases
Tm by 0.5 °C per
PS linkage).
·Extensive
modification
causes cytotoxic
effect.
·Extensive or full
modification will
reduce or fully
deactivate siRNA
potency.
·Bulky 2’modifications are
only tolerated at
limited position
owing to their
distortion of RNA
helix structure.
·LNA would
probably cause
liver toxicity.
·Extensive
modification with
LNA and UNA
generally results
in decreased
activity of siRNA
and failure in
annealing of
dsRNA,
respectively.
·Modification at
seed region would
slightly reduce
siRNA potency.

[158-163]

·Some base
modifications
(e.g. 5-bromoand 5-iodo-uracil)
will affect siRNA
potency.

[140, 178]

[36, 66,
162-170,
174]

[171-176]

[179]

Table 1.2. Classification of RNA polymer-based bioelectronics.

RNA-based bioelectronics

References

Biologic gate

[239, 244]

Biomemory

[239, 244, 267]

Biocomputation devices
[243, 244, 246, 248, 249,
Bioinformation processor
251]
[216, 218, 222, 223, 226Biomedical sensor
228]

Biosensors
Environmental sensor
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[229, 230]
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Figure 1.1. Design and construction of RNA nanostructures. (A) Phi 29 DNA packaging
motor pRNA hexamer [111]. The loop close to the 5’-end of the pRNA is defined as the
right-hand loop, while the loop close to the 3’-end of the pRNA is defined as the lefthand loop. Reprinted with permission from Ref. [111]. Copyright 1998 Elsevier. (B)
pRNA dimer and trimer [107]. Adapted with permission from Ref. [107]. Copyright 2003
American Scientific Publishers. (C) pRNA arrays [113]. Reprinted with permission from
Ref. [113]. Copyright 2004 American Chemical Society. (D) RNA tecto squares [117].
Reprinted with permission from Ref. [117]. Copyright 2004 The American Association
for the Advancement of Science. (E) The RNA nanoring [115]. Reprinted with
permission from Ref. [115]. Copyright 2007 American Chemical Society. (F) The tRNAbased polyhedron [119]. Reprinted with permission from Ref. [119]. Copyright 2010
Nature Publishing Group. (G) Cubic RNA-based scaffolds designed in silico [145].
Reprinted with permission from Ref. [145]. Copyright 2010 Nature Publishing Group. (H)
Triangular RNA–protein complex [128]. Reprinted with permission from Ref. [128].
Copyright 2011 Nature Publishing Group. (I) The self-assembling RNA square [93].
Both the 2D sequence and the crystal structure of the RNA square are shown in the figure.
Reprinted with permission from Ref. [93]. Copyright 2011 The National Academy of
Sciences of the United States of America. (J) RNA microsponges for siRNA delivery
[148]. Reprinted with permission from Ref. [148]. Copyright 2012 Nature Publishing
Group. (K) pRNA nanoparticles fabricated via both toolkit I: hand-in-hand interactions
involving RNA loops and toolkit II: foot-to-foot interactions involving palindrome
sequence and sticky ends [114]. Reprinted with permission from Ref. [114]. Copyright
2013 RNA Society. (L) pRNA nanoparticles fabricated via branch extension tool kit
55

[114]. Reprinted with permission from Ref. [114]. Copyright 2013 RNA Society. (M)
Single stranded RNA origami [137]. Reprinted with permission from Ref. [137].
Copyright 2014 The American Association for the Advancement of Science. (N) Boilingresistant RNA triangles and the array based on RNA triangles [36]. Reprinted with
permission from Ref. [36]. Copyright 2014 American Chemical Society. (O) The selfassembled RNA membrane [153]. Reprinted with permission from Ref. [153]. Copyright
2014 Nature Publishing Group. (P) RNA origami tile and tube [140]. Reprinted with
permission from Ref. [140]. Copyright 2014 John Wiley and Sons.
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Figure 1.2. Construction and functional assays of thermodynamically stable pRNA 3WJ
or pRNA-X nanoparticles. (A) HBV ribozyme cleavage assay showing the catalytic
activity of the HBV ribozyme is retained after its incorporation into pRNA-3WJ
nanoparticles. Cleave products are highlighted in the red box. Representative results from
at least three independent experiments are shown. (B) MG aptamer fluorescence assay
showing the function of the MG aptamer is retained after its incorporation into pRNA3WJ nanoparticles [124]. Representative results from at least three independent
experiments are shown. Adapted with permission from Ref. [124]. Copyright 2011
Nature Publishing Group. (C) Survivin gene knockdown assay showing the gene
silencing activity of the surviving siRNA is retained after its incorporation into pRNA-X
nanoparticles [73]. Representative results from at least three independent experiments are
shown. Reprinted with permission from Ref. [73]. Copyright 2012 Elsevier.
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Figure 1.3. Construction of RNA polygons based on pRNA-3WJ. (A) Construction of
RNA triangle, square and pentagon by tuning the interior pRNA-3WJ angle [92].
Representative results from thirty-nine raw AFM images are shown. Reprinted with
permission from Ref. [92]. Copyright 2014 Oxford University Press. (B) Construction of
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RNA squares with tunable sizes [126]. Representative results from fifty-eight raw AFM
images are shown. Reprinted with permission from Ref. [126]. Copyright 2014 American
Chemical Society.
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Figure 1.4. Functional RNA nanostructures for therapeutics delivery and medical
detection. (A) Schematic illustration shows triggered siRNA delivery based on
RNA/DNA hybrid nanostructures [141]. Control DNA duplexes fluorescently labeled
with Alexa 488 and Alexa 546 were unable to recombine (upper part) and fluorescently
labeled RNA/DNA hybrids were programmed for re-association and FRET occurred
when the siRNA was released (lower part) [141]. Reprinted with permission from Ref.
[141]. Copyright 2013 Nature Publishing Group. (B) QD-aptamer-doxorubicin conjugate
nanoparticles as a cancer-targeted imaging, sensing and treatment platform [211].
Reprinted with permission from Ref. [211]. Copyright 2007 American Chemical Society.
(C) PSMA aptamer-conjugated gold nanoparticles for targeted molecular CT imaging and
therapy of prostate cancer [214]. Reprinted with permission from Ref. [214]. Copyright
2010 American Chemical Society. (D) Spherical nucleic acid scaffold for loading RNA
therapeutics [192]. Spherical nucleic acids are densely packed and highly oriented nucleic
acids covalently conjugated to the surface of a spherical nanoparticle core. Reprinted
with permission from Ref. [192]. Copyright 2014 American Chemical Society.
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Figure 1.5. pRNA nanoparticles for cancer targeting. (A) pRNA-3WJ nanoparticles
target folate-receptor positive tumor xenografts [124]. Upper panel: whole body; lower
panel: organ imaging (Lv, liver; K, kidney; H, heart; L, lung; S, spleen; I, intestine; M,
muscle; T, tumor). Reprinted with permission from Ref. [124]. Copyright 2011 Nature
Publishing Group. (B) pRNA-3WJ nanoparticles target glioma [165]. Folate conjugated63

pRNA nanoparticles with Alexa 647 labeling (FA-Alexa647-pRNA-3WJ) showed
stronger binding to glioma compared with folate-free pRNA nanoparticles (Alexa647pRNA-3WJ). Reprinted with permission from Ref. [165]. Copyright 2015 Impact
Journals, LLC. (C) pRNA-X nanoparticles target folate-receptor positive tumor
xenografts [73]. Reprinted with permission from Ref. [73]. Copyright 2012 Elsevier. (D)
Folate conjugated-pRNA nanoparticles with Alexa 647 labeling (FA-pRNA-Alexa647)
target colorectal cancer metastases [166]. pRNA nanoparticles with Alexa 647 labeling
but without folate (pRNA-Alexa647) was used as a control. Reprinted with permission
from Ref. [166]. Copyright 2015 American Chemical Society.
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Figure 1.6. Spinach RNA aptamer for intracellular imaging and sensing. (A) Live-cell
imaging of Spinach-tagged 5S RNA [215]. Fluorescence and phase images showed the
comparison of HEK293T cells expressing 5S RNA tagged with either Spinach RNA (5SSpinach) or negative control Lambda RNA (5S-Lambda). Fluorescence was detected in
5S-Spinach-expressing cells in the presence of 20 µM DFHBI (+DFHBI), and granule
formation was detected in cells treated with 600 mM sucrose for 30 min (↑Suc). Nuclear
borders assessed by Hoechst 33342 staining were highlighted by white dashed lines [215].
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Representative results from at least three experimental replicates are shown. Reprinted
with permission from Ref. [215]. Copyright 2011 The American Association for the
Advancement of Science. (B) Imaging cellular metabolites in E. coli with sensor RNA
[216]. Upper panel: the sensor RNA comprises Spinach (black), a transducer (orange),
and a target-binding aptamer (blue). Target binding to the aptamer promotes stabilization
of the transducer stem, enabling Spinach to fold and activate DFHBI fluorescence. Lower
left panel: emission spectra of the SAM sensor in the presence or absence of SAM.
Lower right panel: patterns of SAM accumulation after adding methionine to E. coli
expressing the SAM sensor RNA were observed under a fluorescent microscope [216].
Scale bar, 5 µm. Representative results from at least three experimental replicates are
shown. Reprinted with permission from Ref. [216]. Copyright 2012 The American
Association for the Advancement of Science.
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Figure 1.7. The basic constitution of RNA-based biosensor.
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Figure 1.8. Advantages of RNA-based biocomputation.
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Abstract
Since RNA shows an integer of 11 nucleotides per helix turn of 360°, in
comparison to DNA that shows a non-integer of 10.5 nucleotides per helix turn, I propose
that different sizes of RNA 3D structures can be constructed with precise control and the
size of the particle will increase linearly by increasing the nucleotide number as multiples
of eleven. I used the ultra-stable pRNA-3WJ motif with controllable angles and arm
lengths to construct tetrahedral architectures composed purely of RNA via one-pot
bottom-up assembly with high efficiency and thermal stability. By introducing arm sizes
of 22 bp and 55 bp, respectively, I constructed two RNA tetrahedrons with similar global
contour structure, but with different sizes of 8 nm and 17 nm, respectively. AFM and
cryo-EM imaging clearly demonstrated the 3D shapes of RNA tetrahedrons that were
consistent with the designs. The RNA tetrahedrons were also highly amenable to
functionalization. Fluorogenic RNA aptamers, ribozyme, siRNA, and protein-binding
RNA aptamers were integrated into the tetrahedrons by simply fusing the respective
sequences with the tetrahedral core modules. Upon systemic injection, 2'-F modified
RNase resistant RNA tetrahedrons harboring EGFR aptamers specifically targeted
orthotopic breast tumors without getting trapped in healthy organs. The favorable
biodistribution highlight their potentials as safe and specific drug delivery vectors. The
reported design principles can be extended to construct higher order polyhedral RNA
architectures for various applications.
Keywords: RNA nanotechnology; RNA nanoparticle; Phi29 packaging RNA; Three-way
junction; Tetrahedron
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Introduction
The Watson-Crick base pairing properties of DNA and RNA have led to their
development as excellent building blocks for the construction of nanomaterials by bottom
up self-assembly [74, 133-135, 181, 286]. For constructing larger architectures by
directional or angular extension, it is necessary to extend the building blocks with a
defined angle or orientation. This has been challenging for DNA since one helix turn of
360° is 10.5 nucleotides for B-form DNA. A non-integer per helix turn will result in the
twisting of the extension angle or the restriction in orientation control. In RNA, the
number of nucleotides per helix turn is an integer of 11 for A-form RNA, which is a
common structure for most RNA sequences (Appendix 1 Supplementary Figure 1). I
propose that this unique property of RNA will enable RNA structural growth with precise
one directional control, which will facilitate the construction of large size architectures
for materials science, computer device, and biomedical applications.
RNA nanotechnology is an emerging field that involves the design, construction
and functionalization of nanometer-scale particles composed mainly of RNA for
applications in biomedical and material sciences [181]. Previous reports have shown that
a variety of RNA nanostructures can be constructed with defined sizes, shapes and
stoichiometry, including triangles [36], squares [93, 118, 126], bundles [113, 121], 2D
arrays [36, 117], hexamers [54, 111, 116] and 3D cages [119, 122, 145] by bottom-up
self-assembly based on intra- and inter-RNA interactions. We have extensively utilized
the structural features of bacteriophage phi29 packaging RNA [123] to construct varieties
of RNA nanoparticles via loop-loop interactions [111, 113, 114, 125], palindrome
sequence mediated foot-to-foot interactions [113, 114], and three-way junction (3WJ)
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motif [36, 74, 92, 114, 124]. More recently, we constructed 2D polygons such as triangle,
square and pentagon [92] using the pRNA-3WJ as core scaffold at the vertices. Here I
extended our previous 2D work to design and construct 3D RNA nanoparticles with
controllable shape and size.
Tetrahedral geometry is attractive because of its intrinsic mechanical rigidity and
structural stability. It is a pyramid-like structure with four triangular faces and six edges.
Several methods have been used to construct DNA based tetrahedrons, such as an
origami approach based on a long single DNA strand [287], complementary hybridization
of strands using sticky ends [288, 289], and hierarchical assembly of tiles [290]. RNA is
an attractive alternative building block due to its high thermal stability [164, 52] and
versatility in structures [181, 291], well beyond the simplistic canonical Watson-Crick
base pairing in DNA nanostructures. Herein, the well-characterized ultrastable 3WJ motif
[54, 124] was used as the core scaffold to construct tetrahedral architectures. The RNA
tetrahedrons have defined 3D structure as revealed by atomic force microscope (AFM),
as well as by single particle cryo-electron microscopy (cryo-EM) that has long been
found to be very challenging in imaging pure RNA structures without forming complex
with proteins [292]. Moreover, for the functionalization of the RNA tetrahedrons,
aptamers, ribozyme and siRNA were placed at the edges of the RNA tetrahedrons with
high precision without disrupting the overall structure. Importantly, the functional
modules were incorporated prior to the assembly of the RNA tetrahedrons to ensure the
production of homogeneous nanoparticles with high yield. Biodistribution studies
revealed that RNA tetrahedrons functionalized with EGFR targeting RNA aptamer
specifically targeted orthotopic breast tumors without detectable accumulation in healthy
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vital organs. The RNA tetrahedrons are envisioned to have a broad impact in
nanotechnology arena, such as for organizing nanoscale materials with high precision,
encapsulation of functional materials within its hollow cavity, targeted therapy to
diseased cells and as image-guided delivery vectors.

Materials and Methods
RNA tetrahedron design, synthesis, and self-assembly
The crystal structure of the pRNA 3WJ motif (PDB ID: 4KZ2) was used for
designing RNA tetrahedrons utilizing computational programs UCSF Chimera, Swiss
PDB Viewer and the PyMOL Molecular Graphics System. RNA strands were
synthesized by in vitro T7 transcription using corresponding DNA templates generated
by polymerase chain reactions (PCR) following previously reported procedures [125].
DNA oligos for PCR and for the assembly of DNA tetrahedrons were ordered from
Integrated DNA Technologies, Inc. (Coralville, IA). For a 50 µl transcription reaction, 10
µl of DNA template with 10 µl of 5× transcription buffer, 10 µl of 25 mM NTPs solution,
5 µl of 100 mM DTT, 10 µl of T7 RNA polymerase and 5 µl 0.05% (vol/vol) DEPC
water were mixed together and incubated at 37 °C for 4 h. The transcription reaction was
stopped by adding 1 µl of DNase I and incubating at 37 °C for another 30 min to digest
the DNA template. For generating 2’-F modified RNA tetrahedrons, Y693F mutant T7
polymerase and 2’-F modified cytosine (C) and uracil (U) nucleotides were used to
synthesize the corresponding RNA strands. For a 50 µl 2’F transcription reaction, 2.5 µg
of DNA template diluted in 15 µl 0.05% (vol/vol) DEPC water, 5 µl of 10× 2’-F
transcription buffer, 5 µl of 100 mM DTT, 5 µl of 50 mM 2’-F CTP, 5 µl of 50 mM 2’-F
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UTP, 5 µl of 50 mM ATP, 5 µl of 50 mM GTP, and 5 µl of Y639F mutant T7 RNA
polymerase were mixed together and incubated at 37 °C overnight. All synthesized RNA
strands were purified by 8 M urea, 8% denaturing PAGE. RNA tetrahedrons were
assembled in a one-pot manner by mixing the four RNA strands in equimolar
concentrations (100 nM) in 1× Tris buffer (100 mM NaCl, 50 mM Tris, pH 8.0), and
heated to 95 °C for 5 minutes and slowly cooled to 4 °C over 45 minutes using a PCR
machine. The step-wise assembly of the RNA tetrahedrons were verified by native PAGE
gels run in 1× TBM (89 mM Tris, 200 mM boric acid, and 2.5 mM MgCl2) buffer at 90 V,
4 °C. The gels were stained with ethidium bromide (EB) and imaged by Typhoon FLA
7000 (GE Healthcare, Marlborough, MA). For AFM imaging and cryo-EM imaging, the
assembled RNA tetrahedrons were further purified by native PAGE.
The detailed sequences for assembling the designed RNA tetrahedrons are listed
below:
a. RNA sequences of the 8 nm RNA tetrahedron.
5’- GGACUGAUACGAAUCAUCGUGUAGCACCAGCUGUAAUCG
Strand 1

AUGUGUACGGGAAGAGCCUAUGCCCAUCCUACUUUGUU
CUACUAUGGCG -3’
5’– GGUGCUACACGAUGUGUAGCCAGACUUAGCGGAAUGUU

Strand 2

CGUACUUUGUUCAUGCGAGGCCGUCCAAUACCGAAUCAU
CGAUUACAGCU -3’
5’- GGGCAGUUGAGAUGUGUACGAACAUUCCGCUAAGUCUG

Strand 3
GCUACUUUGUUCGUAUCAGUCCCGCCAUAGUAGAAUCAU
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CGUAUCACCAU -3’
5’- GGCCUCGCAUGAAUCAUCUCAACUGCCCAUGGUGAUACG
Strand 4

AUGUGUAGGAUGGGCAUAGGCUCUUCCCGUACUUUGUU
CGGUAUUGGAC -3’

b. RNA sequences of the 17 nm RNA tetrahedron.
5’- GGAUGACAGGUGUCAAUGCACUGAUACGAAUCAUCGUG
UAGCAGAUUCGAUUGUACUCGUCCUCAGGUUCUACAGACGA
Strand 1

GCUGUAAUCGAUGUGUACGGGAAGAGAGUCACUUGCGUGG
CUCCCCUCUACUGCAGUAGUGUAUGCCCAUCCUACUUUGUU
CUACUAUGGCGGCAAGUAUGAUCCAUG -3’
5’- GGACGAGUACAAUCGAAUCUGCUACACGAUGUGUAGCCA
GACUUAGUGUCGUGACCGUACGACCGACUCGAGUCGACGAC

Strand 2

GGAAUGUUCGUACUUUGUUCAUGCGAGGGCGAUAGCGCCU
AGCUGCCUCUGACUGGACCUAGUGUCCAAUACCGAAUCAUC
GAUUACAGCUCGUCUGUAGAACCUGA -3’
5’- GGAGAGCGUAGUCCUGUACGCAGUUGAGAUGUGUACGA
ACAUUCCGUCGUCGACUCGAGUCGGUCGUACGGUCACGACA

Strand 3

CUAAGUCUGGCUACUUUGUUCGUAUCAGUGCAUUGACACCU
GUCAUCCCAUGGAUCAUACUUGCCGCCAUAGUAGAAUCAUC
GUAUCACCAUGAACAUCAUCACAGAC -3’

Strand 4

5’- GGCAGCUAGGCGCUAUCGCCCUCGCAUGAAUCAUCUCAA
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CUGCGUACAGGACUACGCUCUCCGUCUGUGAUGAUGUUCAU
GGUGAUACGAUGUGUAGGAUGGGCAUACACUACUGCAGUA
GAGGGGAGCCACGCAAGUGACUCUCUUCCCGUACUUUGUUC
GGUAUUGGAC ACUAGGUCCAGUCAGA -3’

c. RNA sequences of the different functional modules.
5’- GGAUCCCGACUGGCGAGAGCCAGGUAACGAAUGGAU
MG Aptamer
CC -3’
5’- GGACGCAACUGAAUGAAAUGGUGAAGGACGGGUCC
Spinach Aptamer

AGGUGUGGCUGCUUCGGCAGUGCAGCUUGUUGAGUAGA
GUGUGAGCUCCGUAACUAGUCGCGUCC -3’
5’- GGGACGAAAAAAAACAAAUUCUUUACUGAUGAGUCC

HBV Ribozyme
GUGAGGACGAAACGGGUCAAAAAAAACGUCCC -3’
Streptavidin

5’- GGAUGCGGCCGCCGACCAGAAUCAUGCAAGUGCGUA

Aptamer

AGAUAGUCGCGGGUCGGCGGCCGCAUCC -3’
5’-GCCUUAGUAACGUGCUUUGAUGUCGAUUCGACAGGA

EGFR Aptamer
GGC -3’
Luciferase siRNA 5’- AACUUACGCUGAGUACUUCGAUU -3’
Sense Strand
Luciferase siRNA 5’- UCGAAGUACUCAGCGUAAGUU -3’
Antisense Strand
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Atomic force microscopy
Both 8 nm and 17 nm RNA tetrahedrons were imaged by AFM, following
previously reported procedures [293]. Briefly, RNA tetrahedrons (5-10 µL at 3-5 nM)
were deposited on the aminopropyl silatrane (APS)-modified mica surface and excess
samples were washed with diethylpyrocarbonate (DEPC)-treated water and dried before
imaging. AFM imaging was conducted using the MultiMode AFM NanoScope IV system
(Veeco, Plainview, NY) operated in tapping mode.

Dynamic light scattering measurements
The apparent hydrodynamic sizes and zeta potential of the assembled RNA
tetrahedrons were measured by Zetasizer nano-ZS (Malvern Instruments, Ltd, Malvern,
United Kingdom) at 25 °C, respectively. For size measurements, 500 µl 100 nM RNA
tetrahedron in 1× Tris buffer was used. For zeta potential measurements, 800 µl 100 nM
RNA tetrahedron in 1× Tris buffer was used. The laser wavelength used for the
experiments was 633 nm. The data were obtained from at least three independent
measurements. The intensity distribution was used to calculate the sizes of the
nanoparticles.

Melting temperature measurements
The melting temperature of RNA, 2’-F RNA and DNA tetrahedrons were
measured by the Roche Lightcycler 480 real-time PCR machine, following previously
reported procedures [124, 125]. Briefly, all tetrahedrons were assembled in 20 µl 1× Tris
buffer in the presence of 1× SYBR Green II dye (Invitrogen, Carlsbad, CA) with final
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nanoparticle concentration of 250 nM. The samples were heated to 95 °C for 5 min and
then slowly cooled down to room temperature at a rate of 0.11 °C/s using the Roche
Lightcycler 480 real-time PCR machine. The melting temperature was obtained from at
least three independent measurements.

Cryo-electron microscopy (cryo-EM)
RNA tetrahedron nanoparticles solution (2 µl at 0.3 mg/ml) was applied onto a
glow-discharged 200-mesh R1.2/1.3 Quantifoil grid. The grids were blotted for 3 s and
rapidly frozen in liquid ethane using a Vitrobot Mark IV (FEI, Hillsboro, OR). Then the
girds were transferred to JEM2200FS cryo-electron microscope (JEOL, Tokyo, Japan)
operated at 200 kV with in-column energy filter with a slit of 20 eV for screening.
Micrographs of 17 nm tetrahedron were recorded with a direct detection device (DDD)
(DE-12 3k × 4k camera, Direct Electron, LP, San Diego, CA) operating in movie mode at
a recording rate of 25 raw frames per second at 20,000× microscope magnification
(corresponding to a calibrated sampling of 2.5 Å per pixel) and a dose rate of ~25
electrons/sec/Å2 with a total exposure time of 3 s. Micrographs of 8 nm tetrahedron were
recorded on a 4k × 4k CCD camera (Gatan, Pleasanton, CA) at 60,000× microscope
magnification (corresponding to a calibrated sampling of 1.8 Å per pixel) and a dose rate
of ~30 electrons/sec/Å2 with a total exposure time of 1.5 s. A total 131 images of 17 nm
tetrahedron and 52 images of 8 nm tetrahedron were collected with a defocus range of
2~4 µm.
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Single particle image processing and 3D reconstruction
The image processing software package EMAN2.1, was used for the micrograph
evaluation, particle picking, contrast transfer function correction, 2-D reference-free class
averaging, initial model building and 3-D refinement of the cryo-EM data. Particle
images recorded on DE-20 detector used the averaged sum of 72 raw frames per
specimen area. The final frame average was computed from averages of every three
consecutive frames to correct for the specimen movement (Courtesy of B. Bammes). For
the 17 nm tetrahedron, a total of 1662 particles were boxed to generate the 2D class
averages for building the initial models. At last, 1582 particles were used for final
refinement, applying the tetrahedral symmetry. For the 8 nm tetrahedron, a total of 1346
particles were boxed to generate the 2D class averages for building the initial models. In
total, 1254 particles were used for final refinement, applying the tetrahedral symmetry.
The resolution for the final maps were estimated by the 0.143 criterion of FSC curve
without any mask. 23 Å and 19 Å Gauss low-pass filter were applied to the final 3D maps
displayed in the Chimera software package.

Tilt-pair validation for cryo-EM map
Tilt-pair validation data were collected at two goniometer angles, 0 ° and −10 °,
for each region of the grid. A particle set of 50 particles from two tilt pairs of 17 nm RNA
tetrahedron was used for the validation test. The test was performed using
e2tiltvalidate.py program in EMAN2. More details about the tilt-pair validation are listed
in Table 2.1.
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HBV ribozyme activity assay
HBV ribozyme activity assay was performed according to previously reported
procedures [124, 188]. Briefly, HBV RNA substrate was labeled by Cy5 using Cy5 Label
IT® Kit (Mirus Bio LLC, Madison, WI) and incubated with 50 µL 200 nM RNA
tetrahedrons harboring HBV ribozyme at 37 °C for 1 hour at 4:1 molar ratio. pRNA
conjugated with HBV ribozyme was used as the positive control, while RNA tetrahedron
only and pRNA conjugated with disabled HBV ribozyme (G→A mutation) were used as
negative controls. The cleavage products of the HBV RNA substrate were further
analyzed by 8% denaturing PAGE and imaged by Typhoon FLA 7000 (GE Healthcare,
Marlborough, MA) under the Cy5 channel.

Malachite green (MG) and Spinach aptamer fluorescence assays
Measurements of MG and Spinach aptamer fluorescence emissions in solution
were performed according to previously reported methods [36, 124]. Briefly, 100 µl at
100 nM multifunctional RNA tetrahedrons harboring MG and Spinach aptamers were
incubated with 2 µM MG dye and 2 µM DFHBI (Lucerna, Inc., New York, NY) at room
temperature. pRNA-3WJ harboring MG and Spinach aptamers were used as the positive
control. RNA tetrahedron only and dye only were used as negative controls. Fluorescence
emission spectrum was recorded using a fluorospectrophotometer (Horiba Jobin Yvon,
Edison, NJ), excited at 450 nm (465-750 nm scanning for emission) for Spinach aptamer
and 615 nm (625-750 nm scanning for emission) for MG aptamer.
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Streptavidin (STV) aptamer binding assay
Multifunctional RNA tetrahedrons harboring STV aptamer (50 µL at 400 nM)
were incubated with STV agarose resin (Thermo Scientific, Waltham, MA) in binding
buffer (1× PBS with 10 mM Mg2+) at room temperature for 1 hr. Then the resin was spun
at 500× g for 1 min and the supernatant was collected. Binding buffer (50 µL) was added
to the resin to wash the resin for three times. The wash fractions were also collected.
After washing, biotin (50 µL at 5 mM in 1× PBS with 10 mM Mg2+) was added to the
resin three times to elute the RNA. All the collected supernatant, washing, and elution
fractions were measured by Nanodrop (Thermo Scientific, Waltham, MA) for absorbance
at 260 nm and further analyzed by PAGE. RNA tetrahedrons without STV aptamer were
used as negative control.

Transfection assay for tetrahedron harboring siRNAs
5×104 MCF-7 cells (human breast adenocarcinoma cell line) were grown on 24
well plate (TPP tech, Switzerland) with Eagle's Minimum Essential Medium (EMEM)
(ATCC, Manassas, VA) supplemented with 10% fetal bovine serum (FBS) (Sigma, St.
Louis, MO) and 0.01 mg/ml of bovine insulin (Cell Applications, San Diego, CA) at
37 °C in humidified air containing 5% CO2 overnight. The cells were co-transfected with
1 nM RNA tetrahedrons and both plasmid DNA pGL3 encoding firefly luciferase and
pRT-LK (Promega, Madison, WI) encoding renilla luciferase by lipofectamine2000 (Life
technologies, Carlsbad, CA) following manufacturer’s instructions. Luciferase siRNA (4
nM) was used as the positive control, while 5 nM scramble siRNA was used as the
negative control. Dual luciferase assay (Promega, Madison, WI) was performed to
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evaluate the siRNA silencing effects 48 h post transfection. Briefly, cells were washed
with PBS once, then lysed with 100 µl of passive lysis buffer per well. Luciferase assay
reagent (LARII) (50 µl) was added to 20 µl of cell lysate in a 96 well plate, and the
firefly luciferase activity was measured. Then 50 µl of Stop and Glow buffer was added
to measure the control renilla luciferase activity on a microplate reader (Synergy 4, Bio
Tek Instruments, Inc, Winooski, VT). The firefly luciferase activity was then normalized
with renilla luciferase activity to determine whether luciferase siRNA are still functional
after incorporation into RNA tetrahedrons. At least four independent wells were tested
for each sample.

In vitro binding of RNA tetrahedrons harboring EGFR aptamers
5×104 EGFR-positive MDA-MB-231 cells (human breast adenocarcinoma cell
line) were grown on glass cover slides in 24-well plates in a 1:1 mixture of Dulbecco's
modified Eagle's medium (DME) and Ham's F-12 nutrient mixture (DME/F-12 (1:1)
medium) with 10% FBS at 37 °C in humidified air containing 5% CO2 overnight. RNA
tetrahedrons harboring EGFR aptamers and labeled by Alexa 647 were diluted in 300 µl
Opti-MEM medium to final concentration at 100 nM and incubated with the cells for 1 h
at 37 °C. RNA tetrahedrons without EGFR aptamer at 100 nM in 300 µl Opti-MEM
medium were used as the negative control. After the incubation, the cells were washed
with PBS and then fixed by 4% paraformaldehyde. Cellular actin were stained by Alexa
488 Phalloidin (Life Technologies, Carlsbad, CA) and the Prolong Gold antifade reagent
with DAPI (Life Technologies, Carlsbad, CA) were used to stain the nuclei and mount

82

the cells. The images were obtained by the FluoView FV1000-Filter Confocal
Microscope System (Olympus, Tokyo, Japan).

In vivo targeting of RNA tetrahedrons to tumor-bearing mice
All protocols and procedures involved in the animal experiments were approved
by the University of Kentucky Institutional Animal Care and Use Committee (IACUC).
Female athymic nu/nu mice (4-8 weeks old) were purchased from Taconic Biosciences,
Inc. To generate the orthotopic triple-negative breast cancer (TNBC) xenograft tumors,
2×106 MDA-MB-231 cells were re-suspended in PBS and injected into the mammary fat
pad of the mice. To generate the KB cells (human cervix carcinoma cell line) xenograft,
2×106 KB cells were re-suspended in PBS and injected subcutaneously to nude mice. The
xenograft tumors were apparent within 2 weeks after the implantation. RNA tetrahedrons
harboring EGFR aptamers and Alexa 647 in 1× PBS (100 µL at 2.4 µM) were then
injected into the tumor bearing mice. PBS injected mice were used as negative control.
For the animal trial on the mice bearing KB cells xenograft, RNA tetrahedrons without
EGFR aptamer were also included as control. The mice were sacrificed and dissected 8
hours after injection. The major organs including heart, lung, liver, spleen, kidney as well
as tumors were collected and subjected to biodistribution analysis via fluorescence
imaging using IVIS Spectrum station (Caliper Life Sciences, Waltham, MA) with
excitation at 640 nm and emission at 680 nm.
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Statistical analysis
The results were presented as mean ± standard deviation. Statistical differences
were evaluated using unpaired Student’s t-test, and p<0.05 was considered significant.

Results and Discussion
Design and self-assembly of RNA tetrahedrons
In this study, the pRNA-3WJ motif [54, 124] (Figure 2.1a) was used as a core
module and placed at each of the four vertices to build RNA tetrahedrons (Figure 2.1b).
A total of four RNA strands were designed consisting of four pRNA 3WJ core sequences
and six linking RNA sequences. A 3D model of the RNA tetrahedron (Figure 2.1c) was
then generated using computational modeling software UCSF Chimera [294], Swiss PDB
Viewer (http://www.expasy.org/spdbv/) and PyMOL Molecular Graphics System
(https://www.pymol.org/). The resulting computational model exhibited authentic
tetrahedral conformation. For assembling the RNA tetrahedrons, the four RNA strands
were synthesized by in vitro transcription and then mixed in stoichiometric ratio and
annealed in 1×Tris buffer in a one-pot manner. Step-wise assembly of the complex was
observed by native polyacrylamide gel electrophoresis (PAGE) (Figure 2.1d).

Physicochemical characterization of RNA tetrahedrons
For 3D RNA tetrahedrons, the most convincing structural characterization in their
native state comes from single particle cryo-EM studies. We first analyzed the 3D
structure of the 8 nm RNA tetrahedrons with 2-helix turn per edge (Figure 2.1f). Single
particle 3D reconstruction was applied by analyzing a total of 1254 particles collected
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from cryo-EM images and achieved a final resolution of 19 Å (gold standard criterion,
0.143 Fourier shell correlation, Figure 2.2). The 3D reconstruction data revealed that the
RNA tetrahedron has a clear overall shape consistent with the computational 3D model
(Figure 2.1c), which agrees with the predicted size of 8 nm. The 2D computed
projections of the reconstructed RNA tetrahedron 3D model showed clear match to the
2D class averages of the raw particles, suggesting the reconstructed 3D model truly
represented the native structure and conformation of the designed RNA tetrahedron. The
images from cryo-EM accord with the global images obtained by AFM imaging (Figure
2.1e). However, the central cavity of each tetrahedron was too small to be resolved by
AFM. The observed size discrepancy is due to limitations in the diameter of the AFM tip.
To further characterize the size of the RNA tetrahedrons, dynamic light scattering (DLS)
was performed. DLS assumes that the particles have an average globular geometry in
solution. The apparent hydrodynamic size of the RNA tetrahedron was determined to be
8.5 ± 2.4 nm (Figure 2.3a).
The surface charge of RNA tetrahedrons, measured as zeta potential, was also
evaluated by DLS. As expected, due to the phosphate backbone of nucleotides, RNA
tetrahedrons have a negative surface charge with a single peak at ‒14.9 ± 1.0 mV (Figure
2.3b). This negative surface charge is advantageous for the overall colloid stability of
RNA nanoparticles and prevents forming aggregation in solution. Moreover, negative
surface charge could also reduce the non-specific interaction of the nanoparticles with the
reticuloendothelial system (RES) and minimize non-specific cell entry, which is
attractive for in vivo targeted drug delivery and theranostic applications [295].
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To assess the thermodynamic stability of RNA tetrahedrons, I investigated their
melting temperatures (Tm) by measuring their fluorescence intensities in the presence of
SYBR Green II dye with the change of temperature on a real-time PCR machine. Melting
experiments revealed that the assembled RNA tetrahedron had a very smooth, high-slope
temperature dependent melting curve with a Tm of 71.3 ± 1.8 °C (Figure 2.3c). The high
slope indicates cooperative assembly of the tetrahedron from its four component strands.
Moreover, I compared the melting curve of RNA, 2'-F RNA and DNA tetrahedrons. The
results showed that 2’-F RNA tetrahedrons was the most stable with a Tm of 77.7 ±
2.4 °C, followed by RNA tetrahedron with a Tm of 71.3 ± 1.8 °C, and finally DNA
tetrahedron with a much lower Tm of 58.3 ± 0.5 °C (Figure 2.3d). These results were in
agreement with previously reported thermodynamic stability of nucleic acids with the
order of stability: 2’-F RNA > RNA > DNA [52, 164].
To investigate their enzymatic stability, unmodified and 2’-F modified (U and C
nucleotides) RNA tetrahedrons were incubated in cell culture medium with 10% fetal
bovine serum (FBS) (Figure 2.4). At specific time points, aliquots were extracted and
evaluated by native PAGE. The unmodified RNA tetrahedrons were degraded within 15
minutes, while 2’-F counterparts were stable over an extended period of time, well
beyond 24 hrs. The resistance to serum-mediated degradation combined with the high
thermodynamic stability is particularly attractive for the in vivo application of these RNA
nanoparticles.
To demonstrate the precise tunable sizes of the RNA tetrahedrons, I designed a
larger 17 nm RNA tetrahedron in which every edge of the tetrahedron was extended to 55
bp equal to 5 helix turns (Figure 2.5). This larger nanoparticle has the same overall
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tetrahedral geometry in our design (Figure 2.6a). Upon annealing the four component
strands in one pot self-assembly, the larger RNA tetrahedron assembled with high
efficiency, as revealed by native PAGE analysis (Figure 2.6b). DLS experiments
revealed that the hydrodynamic diameter of the larger RNA tetrahedron was 16.9 ± 1.6
nm, which is in agreement with the designed dimensions (Figure 2.6c). Moreover, AFM
imaging was clearly able to resolve the tetrahedral morphology along with the inner
cavities (Figure 2.6d). Since the RNA tetrahedrons were dried on the APS-modified
mica surface before imaging in air, flattened tetrahedral shapes were observed. The RNA
nanoparticles were also highly homogenous in shape and structure, demonstrating the
robustness of the self-assembly of RNA tetrahedrons. Cryo-EM image further showed the
very clear RNA tetrahedron nanoparticles (indicated by red circles) with the expected
sizes and geometries (Figure 2.6e). Single particle 3D reconstruction of a total of 1582
particles collected from 131 cryo-EM images achieved a resolution of 23 Å (gold
standard criterion, 0.143 Fourier shell correlation, Figure 2.7).

In vitro and in vivo functional assessments of multifunctional RNA tetrahedrons
To evaluate the application of tetrahedrons, four different functional modules
including a hepatitis B virus (HBV) ribozyme, fluorogenic aptamers for Malachite Green
(MG) or Spinach, and a streptavidin-binding aptamer (Figure 2.8a) were incorporated
into the tetrahedron structure. The sequences of the functional modules were simply
fused with the sequences of the 3WJ core, and then synthesized by in vitro transcription.
After annealing the strands, the step-wise self-assembly was evaluated by native PAGE
analysis to confirm the successful assembly of the RNA tetrahedrons (Figure 2.8b).
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Functional assays were then conducted to determine whether the modules retained their
authentic folding and functionalities upon incorporation into the RNA tetrahedrons.
Retention of the HBV ribozyme catalytic activity: The HBV ribozyme is a
hammerhead ribozyme that can target and cleavage the 135-nt HBV genomic RNA
substrate [188]. The HBV ribozyme was fused to the RNA tetrahedron by extending one
of the strands of the nanoparticle. After incubation with the RNA tetrahedron harboring
the HBV ribozyme, the HBV substrate was cleaved into fragments with smaller
molecular weights, as revealed by PAGE analysis (Figure 2.8c). The yield of the
cleavage reaction was comparable with the positive control (pRNA harboring HBV
ribozyme). In contrast, RNA tetrahedron by itself or harboring disabled HBV ribozyme
(G→A mutation in catalytic site) had no catalytic effects. The result confirmed that the
designed multifunctional RNA tetrahedron successfully escorted the HBV ribozyme, and
the catalytic activity was retained after ribozyme sequence was fused to the tetrahedron.
Assessment of the fluorogenic properties of MG and Spinach aptamers: Both MG
[296, 297] and Spinach [215, 216] aptamers are well-characterized for their fluorogenic
properties, which emit fluorescence upon binding of their respective dye targets,
triphenylmethane and DFHBI. To verify that the MG and spinach aptamers incorporated
into the multifunctional RNA tetrahedron are still functional and folded correctly,
fluorescence studies were performed using a fluorospectrophotometer. The fluorescence
emission spectrums showed that both aptamers retained their ability to bind their
respective dyes and emitted strong fluorescence at a similar level to the positive control,
indicating the retention of the correct folding and functionalities of these fluorogenic
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aptamers (Figure 2.8d-e). The fluorogenic modules fused with tetrahedron nanoparticles
can have potential applications for imaging these nanoparticles in cells.
Assay for streptavidin (STV) binding: Upon incubation with STV agarose resins,
the multifunctional RNA tetrahedrons harboring STV aptamer [298] successfully bound
to the resin with high affinity and were eluted by biotin (Figure 2.8f). In contrast, the
negative control tetrahedron did not bind to the resin and also did not show up in the
elution fractions. The results indicated that the fusion with RNA tetrahedron did not
interfere with the native structure and function of the STV aptamer. Moreover, in PAGE
analysis of the eluted multifunctional nanoparticles harboring MG and Spinach aptamer,
they still retained their fluorogenic properties, indicating that the RNA tetrahedron
structure promoted the correct folding of the two aptamers after fusion into the RNA
nanoparticle (Figure 2.9). The results demonstrated that the fused STV aptamer could be
potentially employed as a handle to specifically purify the assembled multifunctional
RNA tetrahedrons by using STV agarose resins.
Assay for luciferase gene silencing: Dual-luciferase reporter assay was utilized to
study the gene silencing effects of the RNA tetrahedron harboring four siRNAs targeting
the same region of the Firefly luciferase gene (Figure 2.10). The Renilla luciferase,
which was not the target of the luciferase siRNA, served as an internal control. The
relative ratio of the expression level of the firefly luciferase to the Renilla luciferase was
used to evaluate the targeted gene silencing effect in MCF-7 cells upon transfection. The
results revealed that the tetrahedron harboring four luciferase siRNAs with 1 nM
concentration achieved ~90% gene silencing, which is similar to the positive control of
luciferase siRNA only at 4 nM concentration. In contrast, the tetrahedron only and
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scrambled control did not show any noticeable gene silencing effects (Figure 2.11b).
These results demonstrated that luciferase siRNA still retained their gene silencing ability
after incorporation into the RNA tetrahedrons, suggesting that RNA tetrahedrons could
serve as a vehicle for intracellular siRNA delivery.
Cellular binding and entry of RNA tetrahedrons harboring EGFR aptamers: For
effective cancer therapy, it is critical to guide therapeutics to specific cancer cells. The
Epidermal Growth Factor Receptor (EGFR) family of Receptor Tyrosine Kinases (RTK)
are highly prevalent in both primary tumors and metastatic breast cancer cells, making
them an ideal candidate for targeted therapies [299]. RNA aptamers have been developed
to bind to EGFR receptors [300-303] with high selectivity and sensitivity. Here I
incorporated EGFR targeting RNA aptamers into RNA tetrahedrons (Figure 2.12) and
evaluated their cellular binding by confocal microscopy (Figure 2.11a). Alexa 647 (red)
labeled RNA strand was incorporated into tetrahedrons for fluorescence imaging.
Tetrahedrons without EGFR aptamer were used as negative control. Confocal imaging
showed that tetrahedron nanoparticles with EGFR aptamers strongly bound to EGFR (+)
MDA-MB-231 cells (Figure 2.11a), as revealed by the co-localization of the Alexa 647labeled RNA (red) and cellular actin (green) (Figure 2.11a). In contrast, negative control
“naked” tetrahedrons without the EFGR aptamer showed negligible cellular binding. The
results suggest that the EFGR aptamer could facilitate the binding of RNA tetrahedrons
to EGFR-expressing cancer cells.
In vivo targeting in xenograft cancer mouse models: For studying the in vivo
cancer-targeting properties of the RNA tetrahedrons, we generated orthotopic breast
cancer mouse models by injecting MDA-MB-231 cells directly into the mammary fat pad
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of athymic nude mice [174] to generate xenografts. Nuclease-resistant 2’-F RNA
tetrahedrons harboring EGFR aptamers and Alexa 647 were systemically injected into
mice and biodistribution monitored by whole body imaging. The mice were sacrificed 8
hours post injection and their organs were collected for ex vivo imaging (Figure 2.11c).
RNA tetrahedrons were not detected in any other organs except the breast tumor,
indicating that the nanoparticles were cleared from normal organs quickly and did not
accumulate in the liver, lung, spleen or kidney after systemic injection. In another
confirmatory animal trial by using EGFR-expressing KB cells xenograft mouse model,
the similar cancer-targeting ability of the RNA tetrahedrons was also observed (Figure
2.13). Previous biodistribution experiment of pRNA 3WJ RNA nanoparticles harboring
EGFR aptamer also showed similar results [174]. The cancer-targeting ability of the
RNA tetrahedrons would make this delivery system an attractive candidate for future
targeted cancer imaging studies and/or cancer therapy.

Conclusion
In conclusion, here I report the design and self-assembly of multifunctional 3D
RNA tetrahedrons based on the ultrastable pRNA-3WJ motif. The constructed RNA
tetrahedrons have defined 3D structures as revealed by both AFM and single particle
cryo-EM. The size of the RNA tetrahedrons can be easily tuned by changing the number
of RNA base pairs per edge. Melting experiments revealed its high thermodynamic
stability. Aptamers, ribozyme and siRNA were successfully incorporated into the RNA
tetrahedron with their correct folding and optimal functionality. Cellular binding and
biodistribution study showed that the RNA tetrahedron functionalized with EGFR91

aptamer targeted orthotopic breast tumors without detectable accumulation in other
healthy organs. These results suggest that 3D RNA tetrahedron nanoparticles have the
potential to escort imaging modules and therapeutics for in vivo cancer diagnosis and
therapy. Moreover, since the current study only used in vivo fluorescent imaging to study
the biodistribution, it should be note that it is difficult to accurately quantify the exact
percentage of nanoparticles distributed into the tumor. In the future, radiolabeled RNA
nanoparticles should be used to accurately quantify the biodistribution profile and also
get a clear picture regarding how the RNA nanoparticles was metabolized and cleared
from the body.
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Figure 2.1. Design and assembly of 8 nm RNA tetrahedrons. (a) 2D sequence of pRNA
monomer showing the central pRNA-3WJ motif. The 22-nucleotide core sequence (with
red color) of pRNA-3WJ are used to construct RNA tetrahedrons. (b) 2D sequences and
(c) 3D computational model of RNA tetrahedrons. (d) 7% native PAGE gel showing
step-wise assembly of RNA tetrahedrons. '+' indicates the presence of the strands. M:
ultra low range DNA Ladder. Representative results from at least three independent
experiments are shown. (e) AFM images of 8 nm RNA tetrahedrons. Representative
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results from twenty-one raw AFM images are shown. (f) Single particle cryo-EM 3D
reconstruction of 8 nm RNA tetrahedrons. A total of 1346 particles were used to generate
the 2D class averages for building the initial models. A total of 1254 particles were used
for the final refinement of the model by applying the tetrahedral symmetry.
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Figure 2.2. (a) Cryo-EM raw images of the 8 nm RNA tetrahedrons. A representative
image from 52 raw images of 8 nm RNA tetrahedron was shown. (b) Reference free 2D
class averages of the 8 nm RNA tetrahedrons. (c) 0.143 Fourier shell correlation. A total
of 1346 particles were used to generate the 2D class averages for building the initial
models. A total of 1254 particles were used for the final refinement of the model by
applying the tetrahedral symmetry.
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Figure 2.3. Physiochemical characterization of RNA tetrahedrons. Dynamic Light
Scattering (DLS) assay showing (a) the hydrodynamic size and (b) the zeta potential of
RNA tetrahedrons. Representative results from three independent measurements are
shown. (c) Melting curve of RNA tetrahedron complex and each of the four component
strands. Representative results from three independent measurements are shown. (d)
Comparison of melting curves for RNA, 2'-F and DNA tetrahedrons. Representative
results

from

three

independent
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measurements

are

shown.

Figure 2.4. Serum stability assay of 2’-F RNA tetrahedron and unmodified RNA
tetrahedron. (a) 2’-F RNA tetrahedrons and (b) unmodified RNA tetrahedrons were
incubated in 10% FBS for different time points. (c) Quantification of intact particles in
panels A and B using Image J. Data was from one experiment. Similar serum stability
assays have been performed for other 2’F-modified RNA nanoparticles for numerous
times, and similar results were observed and published previously [124, 125, 174].
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Figure 2.5. 2D sequence of the larger RNA tetrahedron with 55 bp per edge. The 22nucleotide core sequence of pRNA-3WJ was highlighted in red color.
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Figure 2.6. Design, assembly and characterization of 17 nm RNA tetrahedrons. (a)
Schematic showing tunable size conversion (from 22 bp per edge to 55 bp per edge) of
RNA tetrahedrons. (b) 6% native PAGE gel showing step-wise assembly of larger RNA
tetrahedrons. '+' indicates the presence of the strands. M: 100 bp DNA ladder.
Representative results from at least three independent experiments are shown. (c) DLS
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assay showing the hydrodynamic size of larger RNA tetrahedrons. Representative results
from three independent measurements are shown. (d) AFM images of 17 nm RNA
tetrahedrons. Representative results from sixteen raw AFM images are shown. (e) CryoEM images and 3D reconstruction of 17 nm RNA tetrahedrons. A representative image
(left) from 131 raw images of 17 nm RNA tetrahedron was shown. A total of 1662
particles were used to generate the 2D class averages for building the initial models. A
total of 1582 particles were used for final refinement by applying the tetrahedral
symmetry.
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Figure 2.7. (a) Reference free 2D class averages of the raw 17 nm RNA tetrahedrons. (b)
0.143 Fourier shell correlation of the 17 nm RNA tetrahedron. (c) Tilt-pair validation of
3D structure of the 17 nm RNA tetrahedron. A total of 1662 particles were used to
generate the 2D class averages for building the initial models. A total of 1582 particles
were used for final refinement by applying the tetrahedral symmetry. A particle set of 50
particles from two tilt pairs of 17 nm RNA tetrahedron was used for the validation test.
The test was performed using e2tiltvalidate.py program in EMAN2.
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Figure 2.8. Functional characterization of multifunctional RNA tetrahedrons. (a)
Schematic showing multifunctional RNA tetrahedrons harboring HBV ribozyme, MG
aptamer, Spinach aptamer and STV aptamer. (b) 7% native PAGE gel showing step-wise
assembly of multifunctional RNA tetrahedrons. '+' indicates the presence of the strands.
Representative results from at least two independent experiments are shown. (c)
Ribozyme activity assay showing cleavage of 135 nt substrate. Representative results
from at least three independent experiments are shown. Fluorogenic assay demonstrating
fluorescence emission of (d) MG aptamer and (e) Spinach aptamer. Data was from one
experiment, and the fluorogenic properties of MG aptamer and Spinach aptamer were
further confirmed by PAGE (Figure 2.9). (f) Streptavidin (STV) aptamer binding assay
using STV affinity column. The error bars represent standard deviation from three
independent measurements. The binding property of STV aptamer was further confirmed
by PAGE (Figure 2.9). ***: p < 0.001 versus corresponding control value, unpaired
Student's t-test.
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Figure 2.9. 7% native PAGE assay of multifunctional RNA tetrahedrons with (top) and
without (bottom) Streptavidin aptamer after binding, washing and elution from the STV
column. The gels were visualized by ethidium bromide staining (left), Spinach aptamer
fluorescence (middle) and MG aptamer fluorescence (right). Data was from one
experiment, and the purpose of this experiment is to confirm the previous studies of the
fluorogenic properties of MG aptamer (Figure 2.8D) and Spinach aptamer (Figure 2.8E)
as well as the binding properties of Streptavidin aptamer (Figure 2.8F).
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Figure 2.10. 2D sequence of the RNA tetrahedron harboring luciferase siRNAs. Total
four luciferase siRNAs were incorporated into one RNA tetrahedron.
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Figure 2.11. In vitro and in vivo evaluation of RNA tetrahedrons harboring siRNA and
cancer-targeting aptamers. (a) Confocal images showing RNA tetrahedron (with and
without EGFR aptamers) binding to MDA-MB-231 cells. Representative results from at
least three technical repeats are shown. Similar cell binding experiment of pRNA 3WJ
RNA nanoparticles harboring EGFR aptamer was conducted by Dr. Dan Shu, and similar
results were observed and published previously [174]. (b) Luciferase siRNA silencing
effects assayed by dual luciferase assay. The error bars represent standard deviations
from at least four independent wells. Representative results from at least two independent
experiments are shown. ****: p < 0.0001 versus plasmid only control, unpaired Student's
t-test. (c) Biodistribution assay in orthotopic MDA-MB-231 tumor-bearing mice after
systemic tail vein injection of RNA tetrahedrons harboring EGFR aptamers. Data was
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from one experiment, and the biodistribution experiment was repeated and further
confirmed in KB xenograft mouse model (Figure 2.13). Similar biodistribution
experiment of pRNA 3WJ RNA nanoparticles harboring EGFR aptamer was also
conducted by Dr. Dan Shu, and similar results were observed and published previously
[174].
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Figure 2.12. 2D sequence of the RNA tetrahedron harboring EGFR aptamers
(highlighted in the purple boxes) and Alexa 647 fluorescent probe (highlighted in the red
box).
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Figure 2.13. Biodistribution of tetrahedron nanoparticles with EGFR aptamer in KB
xenograft mouse model. PBS saline and tetrahedron without EGFR aptamer treated mice
were used as control. Data was from one experiment, and the purpose of this experiment
is to confirm the previous biodistribution study on MDA-MB-231 xenograft mouse
model (Figure 2.11c).
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Table 2.1. (Related to Figure 2.7) Tilt geometry computed for tilt pair of images, using
the final 3D model of the17 nm RNA Tetrahedron.

Image Pair
Total Particle Pairs

50

Particle Pairs in Cluster

24

Fraction in Cluster

48%

Mean Tilt Angle

14.8

RMSD Tilt Angle

5.73

Mean Tilt Axis

-168.8

RMSD Tilt Axis

50.33

Tilt Angle via Microscope

15
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Chapter 3: Controllable Self-assembly of Molecularly Defined RNA
Cages with Cube and Dodecahedron Shapes based on Stable pRNA
Three-way Junction for Therapeutics Delivery
This chapter is adapted from a manuscript entitled “Controllable Self-assembly of
Molecularly Defined RNA Cages based on Stable pRNA Three-way Junction for
Therapeutics Delivery” by Hui Li, Sijin Guo, Kaiming Zhang, Luda Shlyakhtenko, Wah
Chiu and Peixuan Guo. The manuscript is in preparation for submission to Advanced
Materials. Special thanks to Dr. Kaiming Zhang for help in preparing Figure 3.1, 3.6 and
3.11, Sijin Guo for help in preparing Figure 3.12, Dr. Luda Shlyakhtenko for help in
preparing Figure 3.5 and 3.9. Author contribution: Sijin Guo performed the ELISA
experiments. Dr. Kaiming Zhang performed the cryo-EM imaging and single particle
reconstruction based on the cryo-EM raw data under the supervision of Dr. Wah Chiu. Dr.
Luda Shlyakhtenko performed the AFM studies. Hui Li conceived the idea of building
RNA cube and dodecahedron nanoparticles based on pRNA-3WJ, designed the 2D
sequence and 3D computational model of RNA cube and dodecahedron nanoparticles,
performed all the other experiments, analyzed all the data and drafted the manuscript. Dr.
Peixuan Guo led and supervised the whole study and provided financial support.
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Abstract
Over the past decade, RNA has been shown to be a unique and programmable
biopolymer that can be exploited to self-assemble nanoscale objects with sophisticated
structures and rich functionalities. Herein, I report the design and construction of
molecularly defined RNA cages with cube and dodecahedron shapes based on the stable
pRNA 3WJ. The RNA cages can be easily self-assembled by single-step annealing. The
RNA cages were further characterized by gel electrophoresis, cryo-electron microscopy
and atomic force microscopy, confirming the spontaneous formation of the RNA cages. I
also demonstrated that the constructed RNA cages could be used to deliver model drugs
such as immunomodulatory CpG DNA into cells and elicit enhanced immune responses.
The RNA cages can be further explored to be a new generation of molecularly defined
nanocarriers for drug delivery.

Keywords: RNA nanotechnology; RNA nanostructures; Cage; Cube; Dodecahedron
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Introduction
RNA nanotechnology is an emerging research field that focuses on utilizing RNA
as a unique and programmable biopolymer to self-assemble nanoscale objects with
sophisticated structures and rich functionalities [181]. Similar to DNA, most of RNARNA interactions are based on Watson-Crick base pairings and these base pairings are
largely predictable. However, in contrast to DNA, RNA-RNA interactions also involves
many non-canonical base pairings, and RNA can form complicated secondary structures
such as single-stranded loops, bugles, hairpins, pseudoknots and junctions [12, 29-31]. In
addition, RNA is one of the most important biomolecules in a cell and plays a critical role
in normal physiology as well as various diseases. Previous research has shown that a
variety of 2D and 3D RNA nanostructures including triangles [36], squares [93, 118, 126],
pentagons [92], tetrahedrons [304], polyhedrons [119] and prisms [122] can be
successfully constructed based on utilizing naturally-occurring RNA structures and
motifs as basic building blocks. These RNA nanostructures can also be easily
functionalized by incorporating functional groups such as aptamers, siRNAs and
ribozymes [36, 126, 304]. These functionalized RNA nanostructures have the potential
for many applications in biomedical and material sciences such as drug delivery, disease
diagnosis and tissue engineering [181, 286]. Here I report the design and construction of
molecularly defined RNA cages with cube and dodecahedron shapes based on the stable
pRNA 3WJ [54]. To demonstrate the versatility of the stable pRNA 3WJ as a basic
building block for RNA nanostructures, I designed and constructed an extended pRNA
3WJ and then cryo-EM was used to characterize the extended pRNA 3WJ. The core
motif of the pRNA 3WJ was then used to construct RNA cages with cube and
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dodecahedron shapes. The assembled RNA cages have defined 3D structures as revealed
by AFM and cryo-EM. I also demonstrated that the constructed RNA cages could be used
to deliver model drugs such as immunomodulatory CpG DNA [305] into cells and elicit
enhanced immune responses.

Materials and Methods
RNA design, synthesis, and self-assembly
The extended pRNA 3WJ was designed by extending the three branches of the
pRNA 3WJ by sixty perfectly base-paired nucleotides. The NanoEngineer program [306]
was used to facilitate the design of the RNA cages. Six RNA strands were designed for
assembling the RNA cube, while twelve RNA strands were designed for assembling the
RNA dodecahedron. Each RNA strand represents one face of the RNA cube or
dodecahedron. The nucleotide sequence of the individual RNA strand was designed
based on the pRNA 3WJ sequence and perfectly base-paired double-stranded RNA
sequences. RNA strands were synthesized by in vitro T7 transcription following
previously reported procedures [125]. Briefly, DNA templates for generating the RNA
strands were made by polymerase chain reactions (PCR). DNA oligo for PCR were
directly ordered from Integrated DNA Technologies, Inc. (Coralville, IA). For a 50 µl
transcription reaction, 10 µl of DNA template with 10 µl of 5× transcription buffer, 10 µl
of 25 mM NTPs solution, 5 µl of 100 mM DTT, 10 µl of T7 RNA polymerase and 5 µl
0.05% (vol/vol) DEPC water were mixed together and incubated at 37 °C for 4 h. The
transcription reaction was stopped by adding 1 µl of DNase I and incubating at 37 °C for
another 30 min to digest the DNA template. For generating 2’-F modified RNA
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tetrahedrons, Y693F mutant T7 polymerase and 2’-F modified cytosine (C) and uracil (U)
nucleotides were used to synthesize the corresponding RNA strands. For a 50 µl 2’F
transcription reaction, 2.5 µg of DNA template diluted in 15 µl 0.05% (vol/vol) DEPC
water, 5 µl of 10× 2’-F transcription buffer, 5 µl of 100 mM DTT, 5 µl of 50 mM 2’-F
CTP, 5 µl of 50 mM 2’-F UTP, 5 µl of 50 mM ATP, 5 µl of 50 mM GTP, and 5 µl of
Y639F mutant T7 RNA polymerase were mixed together and incubated at 37 °C
overnight. After transcription, the RNA strands were purified by 8 M urea, 8% denaturing
PAGE, respectively.
The detailed sequences for assembling the designed structures are listed below:
a. RNA sequences for assembling the extended pRNA 3WJ:
Strand 1: Extended 3WJ-a
5’-GGGACAGCACACAGAGCAGCAGCUUGAGACUCAGCGUACUUCUGGCAA
GGUACGGUACUUUUGUCAUGUGUAUGUUGGGCGCAGACGGCGAUACCUAG
UAGUCACCUAGUGCUCUAUCGUAGAAGUGUAGCAUGACGCC -3’
Strand 2: Extended 3WJ-b
5’- GGCGUCAUGCUACACUUCUACGAUAGAGCACUAGGUGACUACUAGGUA
UCGCCGUCUGCGCCCACAUACUUUGUUGAUUGGAUGAGAUCACUUGUGAA
UCUGGUGAUCCAUGUGCCAGCGUGCGACGUAUAGUGAGCC -3’
Strand 3: Extended 3WJ-c
5’- GGCUCACUAUACGUCGCACGCUGGCACAUGGAUCACCAGAUUCACAAG
UGAUCUCAUCUAGUCAAUCAUGGCAAAAGUGCCGUACUUUGCCAGAAGUA
CGCUGAGUCUCAAGCUGCUGCUCUGUGUGCUGUCCC -3’
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The extended pRNA 3WJ was self-assembled in a one-pot manner by mixing the
corresponding RNA strands in equimolar concentrations (1 µM) in 1× annealing buffer
(10mM Tris-HCl, 50mM NaCl, 1mM EDTA, pH=8.0) and heated to 95 °C and slowly
cool down to room temperature. For cryo-EM imaging, the assembled extended pRNA
3WJ were further purified by native PAGE.
b. RNA sequences for assembling the RNA cube:
Strand 1:
5’- GGUGCUACACGAUGUGUAGCCAGACUUAGCGGAAUGUUCGAUGUGUAC
GGGAAGAGCCUAUGCCCAUCCAUGUGUACAUGCGAGGCCGUCCAAUACCG
AUGUGUACGAUUACAGCU -3’
Strand 2:
5’- GGCUCUUCCCGUACUUUGUUCUGUGUCGUCCAAGACUGUCGAAAUCAU
GUUACAGUGCCCAUACUCGACAUACUAACUCAACUGCCCAUGGUGAUACG
UUGUUUCAUGGAUGGGCAUA -3’
Strand 3:
5’- GGGCAGUUGAGUUGUUUCAUGAGUAUACCACGAUCUGCUCGAUACUUU
GUUCGUACUCCGUCUUCCUCAACCUAAUCAUCGGUAUUGGACGGCCUCGCA
UGUACUAACGUAUCACCAU -3’
Strand 4:
5’- GGAUCAGCUCAUACUAAGACUACGUGUACACUUGCAACUUUGUUUCAU
CGUGUAGCACCAGCUGUAAUCGUACUUUGUUAGGUUGAGGAAGACGGAGU
ACGAAUCAUCAGUAGCAGGC -3’
Strand 5:
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5’- GGACGACACAGAAUCAUCGAACAUUCCGCUAAGUCUGGCUACUAAAGU
UGCAAGUGUACACGUAGUCUUGUUUCAUUACCGACGUAUGCGUGAUGCUA
UACUUUGUUUCGACAGUCUU -3’
Strand 6:
5’- GGCACUGUAACAUGUGUAUAGCAUCACGCAUACGUCGGUAAUGUGUAU
GAGCUGAUCCGCCUGCUACUGAUGUGUAUCGAGCAGAUCGUGGUAUACUC
AUGUGUAUGUCGAGUAUG -3’
c. RNA sequences for assembling the RNA dodecahedron
Strand 1:
5’- GGUGCUACACGAUGUGUAAGUCGCCACGUGAGACACGUGCAUGUGUAC
UGUGUCGUCCAAGACUGUCGAAUGUGUACGGGAAGAGCCUAUGCCCAUCC
AUGUGUAGCCAGACUUAGCGGAAUGUUCGAUGUGUACGAUUACAGCU -3’
Strand 2:
5’- GGACGACACAGUACUUUGUUUACCGACGUAUGCGUGAUGCUAAAUCAU
CGUACUCCGUCUUCCUCAACCUAAUCAUGACUACGUGUACACUUGCAACUU
ACUUUGUUAGCUCGUCUAGCACCAUAUGAGAAUCAUUCGACAGUCUU -3’
Strand 3:
5’- GGUAUGAGCUGUUACUUUGUUCAUGCGAGGCCGUCCAAUACCGUACUU
UGUUUAGCAUCACGCAUACGUCGGUAAAUCAUGCACGUGUCUCACGUGGC
GACUUACUUUGUUUCGUGAGACGGACACGUCUCGAAAUCAUCAAUGUCAC
G -3’
Strand 4:
5’- GGUACGCAUGCUACUUUGUUGCCUAGACAUGAAGACUGACCUUACUUU
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GUUUCGAGACGUGUCCGUCUCACGAAAUCAUCGUGUAGCACCAGCUGUAA
UCGUACUUUGUUGCACUAACAUCGCGGAUCGACAAAUCAUGACAGAC
AUGA -3’
Strand 5:
5’- GGGCAGUUGAGUACUUUGUUUGACGCGACCUAACAUGAGCACUACUUU
GUUUGUCGAUCCGCGAUGUUAGUGCAAUCAUCGAACAUUCCGCUAAGUCU
GGCUACUUUGUUUGCUCUCGGAAGAGUCCAAGAUAAUCAUCGUAUCA
CCAU -3’
Strand 6:
5’- GGAUCAGCUCAAAUCAUGUGAUCGUGUAACGCACCGAGUUACUUUGUU
AUCUUGGACUCUUCCGAGAGCAAAUCAUGGAUGGGCAUAGGCUCUUCCCG
UACUUUGUUCUCAUAUGGUGCUAGACGAGCUAAUCAUCAGUAGCAGGC -3’
Strand 7:
5’- GGAUGUACAGAUACUUUGUUAGGUUGAGGAAGACGGAGUACGAUGUGU
ACGGUAUUGGACGGCCUCGCAUGAAUCAUCACCGACUGUCUGAGAUGACG
UAAUCAUCAGUGACUACCGCAUGCGUCAGUACUUUGUUCAGCUCCAGAU -3’
Strand 8:
5’- GGACUUCGCCUUACUUUGUUACGUCAUCUCAGACAGUCGGUGAUGUGU
AACAGCUCAUACCCGUGACAUUGAUGUGUAAGGUCAGUCUUCAUGUCUAG
GCAAUCAUGACAGCGAACUGUGGACAGUAGAAUCAUUCGACCUGAGA -3’
Strand 9:
5’- GGUGAGUACUGUACUUUGUUCUACUGUCCACAGUUCGCUGUCAUGUGU

118

AGCAUGCGUACCUCAUGUCUGUCAUGUGUAGUGCUCAUGUUAGGUCGCGU
CAAAUCAUGCUAGUUCACCGACUCGAGUCUAAUCAUGACCGUCAGAU -3’
Strand 10:
5’- GGUGAACUAGCAUGUGUACUCAACUGCCCAUGGUGAUACGAUGUGUAA
CUCGGUGCGUUACACGAUCACAUGUGUAAUGAUCCAUGCUGAUGACGAGC
AAUCAUCGUUACUAAGCUGAUGCGAGACUACUUUGUUAGACUCGAGUC -3’
Strand 11:
5’- GGCUGUCCUUCUACUUUGUUGCUCGUCAUCAGCAUGGAUCAUUACUUU
GUUUGAGCUGAUCCGCCUGCUACUGAUGUGUAAGUUGCAAGUGUACACGU
AGUCAUGUGUAUCUGUACAUCCAUCUGGAGCUGAAUCAUCAUCACAGACA
-3’
Strand 12:
5’- GGUAGUCACUGAUGUGUAAGGCGAAGUCCUCUCAGGUCGAAUGUGUAC
AGUACUCACCAUCUGACGGUCAUGUGUAGUCUCGCAUCAGCUUAGUAACG
AUGUGUAGAAGGACAGCCUGUCUGUGAUGAUGUGUACUGACGCAUGC -3’
d. DNA sequences for assembling RNA cube harboring CpG DNA
CpG DNA strand 1:
5'- TCCATGACGTTCCTGACGTTTTTTTGGTGCTACACGATGTGTAGCCAGACT
TAGCGGAATGTTCGATGTGTACGGGAAGAGCC -3’
CpG DNA strand 2:
5'- TCCATGACGTTCCTGACGTTTTTTTTATGCCCATCCATGTGTACATGCGAG
GCCGTCCAATACCGATGTGTACGATTACAGCT -3’
CpG DNA strand 3:
119

5'- TCCATGACGTTCCTGACGTTTTTTTGGCACTGTAACATGTGTATAGCATCA
CGCATACGTCGGTAATGTGTATGAGCTGATCC -3’
CpG DNA strand 4:
5'- TCCATGACGTTCCTGACGTTTTTTTGCCTGCTACTGATGTGTATCGAGCAG
ATCGTGGTATACTCATGTGTATGTCGAGTATG -3’
The RNA cube or dodecahedron was self-assembled in a one-pot manner by
mixing the corresponding RNA strands in equimolar concentrations (0.3 µM for RNA
cube and 0.5 µM for RNA dodecahedron) in 1× Tris buffer and heated to 95 °C and
slowly cool down to room temperature. The RNA cube harboring CpG DNA was selfassembled in a one-pot manner by mixing the corresponding RNA and DNA strands in
equimolar concentrations (5 µM) in 1× annealing buffer (10mM Tris-HCl, 50mM NaCl,
1mM EDTA, pH=8.0) and heated to 95 °C and slowly cool down to room temperature.
The step-wise self-assembly of the RNA cages was verified by PAGE or agarose gels.
The gels were stained with ethidium bromide (EB) and imaged by Typhoon FLA 7000
(GE Healthcare, Marlborough, MA). For AFM imaging, the assembled RNA cube or
dodecahedron was further purified by native PAGE. For cryo-EM imaging, the
assembled RNA cube was further purified by native PAGE, while the RNA
dodecahedron was further purified by an Amicon Ultra-0.5 mL centrifugal filter (100K
molecular weight cut-off).

Cryo-electron microscopy of the extended pRNA 3WJ
2 µl of extended pRNA 3WJ solution (0.3 mg/ml) was applied onto a glowdischarged 200-mesh R1.2/1.3 Quantifoil grid. The grids were blotted for 1.5 s and
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rapidly frozen in liquid ethane using a Vitrobot Mark IV (FEI, Hillsboro, OR). Then the
grid was transferred to JEM2200FS cryo-electron microscope (JEOL, Tokyo, Japan)
operated at 200 kV with in-column filter for screening. Micrographs were recorded on a
4k×4k CCD camera (Gatan, Pleasanton, CA) at 50,000× microscope magnification
(calibrated sampling of 2.16 Å per pixel) and a dose rate of ~13 electrons/sec/Å2 with a
total exposure time of 4 s. Ninety-eight images were collected with a defocus range of
2~4 µm.

Single particle image processing and 3D reconstruction of the extended pRNA 3WJ
The image processing software package EMAN2 was used for the micrograph
evaluation, particle picking, contrast transfer function (CTF) correction, 2D referencefree class averaging, initial model building and 3D refinement of the cryo-electron
microscopy data. A total of 4702 particles were boxed to generate the 2D class averages
for building the initial models. In total, 4340 particles were used for final refinement,
applying the icosahedral symmetry. The resolution for the final maps was estimated by
the 0.143 criterion of FSC curve without any mask. A 30 Å Gauss low-pass filter was
applied to the final 3D map displayed in the Chimera software package.

Cryo-electron microscopy of the RNA cube
For cryo-electron microscopy, 2 µl of RNA cube cage sample (0.45 mg/ml) was
applied onto a glow-discharged 200-mesh R1.2/1.3 Quantifoil grid. The grid was blotted
and rapidly frozen in liquid ethane using a Vitrobot IV (FEI, Hillsboro, OR).
Micrographs were recorded with a direct detection device (DDD) (DE-20 4k×5k camera,
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Direct Electron, LP, San Diego, CA) operating in movie mode at a recording rate of 25
raw frames per second at 40,000× microscope magnification (corresponding to a
calibrated sampling of 1.64 Å per pixel) and a dose rate of ~20 electrons per second per
Å2 with a total exposure time of 3 s. A total of 149 images of RNA cube were collected
with a defocus range of 2~4 µm.

Single particle image processing and 3D reconstruction of the RNA cube
The image processing software package EMAN2 was used for the micrograph
evaluation, particle picking, CTF correction, 2-D reference-free class averaging, initial
model building and 3-D refinement of the cryo-electron microscopy data. A total of 5106
particles were boxed to generate the 2D class averages for building the initial model.
Finally, 4371 particles were used for final refinement, applying the octahedron symmetry.
The resolution for the final map was estimated by the 0.143 criterion of FSC curve
without any mask. Sixteen Å Gauss low-pass filter was applied to the final 3D map
displayed in the Chimera software package.

Cryo-electron microscopy of the RNA dodecahedron
RNA dodecahedron nanoparticles solution (2 µl at 1 mg/ml) was applied onto a
glow-discharged 200-mesh R1.2/1.3 Quantifoil grid. The grids were blotted for 1.5 s and
rapidly frozen in liquid ethane using a Vitrobot Mark IV (FEI, Hillsboro, OR). Then the
grid was transferred to JEM2200FS cryo-electron microscope (JEOL, Tokyo, Japan)
operated at 200 kV with in-column filter for screening. Micrographs were recorded on a
4k × 4k CCD camera (Gatan, Pleasanton, CA) at 40,000× microscope magnification
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(calibrated sampling of 2.83 Å per pixel) and a dose rate of ~20 electrons
electrons/sec/Å2 with a total exposure time of 3 s. Fifty-five images were collected with
a defocus range of 2~5 µm.

Single particle image processing and 3D reconstruction of the RNA dodecahedron
The image processing software package EMAN2 was used for the micrograph
evaluation, particle picking, CTF correction, 2-D reference-free class averaging, initial
model building and 3-D refinement of the cryo-electron microscopy data. A total of 1598
particles were boxed to generate the 2D class averages for building the initial models. At
last, 991 particles were used for final refinement, applying the icosahedral symmetry. The
resolution for the final maps was estimated by the 0.143 criterion of FSC curve without
any mask. A 27 Å Gauss low-pass filter was applied to the final 3D map displayed in the
Chimera software package.

Atomic force microscopy
The RNA cube or dodecahedron samples (5-10 µL at 3-5 nM) were deposited on
the aminopropyl silatrane (APS)-modified mica surface and excess samples were washed
with DEPC-treated water and dried before imaging. AFM images were obtained by using
the MultiMode AFM NanoScope IV system (Veeco, Plainview, NY) operated in tapping
mode following previously published procedures [293].
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Determine the level of immunomodulation by RNA cube nanoparticles harboring
CpG DNA via enzyme-linked immunosorbent assay (ELISA)
RAW 264.7 cells were plated into 24-well plates with the density of 2.5 × 105
cells per well and cultured overnight. RNA cube nanoparticles harboring different
numbers of CpG ODNs (10 µl at 5 µM in 1× annealing buffer (10mM Tris-HCl, 50mM
NaCl, 1mM EDTA, pH=8.0)) were diluted in 300 µl Opti-MEM medium (Life
Technologies, Carlsbad, CA) and then incubated with the RAW 264.7 cells for 8 hours at
37 °C in humidified air containing 5% CO2. Then the cell culture supernatant of each
well was collected and stored at -80 °C freezer until use. The concentration of TNF-α and
IL-6 in the supernatant was determined by enzyme-linked immunosorbent assay (ELISA)
by using Mouse ELISA MAX™ Deluxe sets (BioLegend, Inc., San Diego, CA),
following protocols provided by the manufacturer. At least three independent wells were
tested for each nanoparticle and control samples.

Statistical analysis
The results were presented as mean ± standard deviation. Statistical differences
were evaluated using unpaired Student’s t-test, and p<0.05 was considered significant.

Results and Discussion
Design, construction and characterization of extended pRNA three-way junction as
a flexible building block for RNA nanostructures
The pRNA 3WJ has been demonstrated by previous studies as a
thermodynamically stable RNA motif and has been widely used in constructing RNA
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nanostructures as a fundamental building block [36, 73, 92, 114, 124, 304]. However,
because the size of the pRNA 3WJ is relative small (~ 4 nm), it is difficult to directly and
clearly observe the pRNA 3WJ under electron microscope. In order to better characterize
the pRNA 3WJ, I extended the three branches of the pRNA 3WJ by sixty perfectly basepaired nucleotides, respectively, to make a larger RNA 3WJ that is large enough to be
observed by electron microscope. The designed extended pRNA 3WJ is still composed of
three RNA strands with length of 139 nucleotides, 138 nucleotides and 134 nucleotides.
To characterize the extended pRNA 3WJ in detail, cryo-electron microscope was applied
to directly observe its structure (Figure 3.1). Cryo-EM is a powerful technique for
imagining three-dimensional (3D) structure of biological macromolecules under their
native states [292]. Cryo-EM images 2D class averages and single particle reconstruction
showed very clear extended pRNA 3WJ with expected three-branched shape and
dimension. Moreover, in the raw images of the cryo-EM results, different conformations
of the extended pRNA 3WJ with different angles among the three RNA branches were
observed, suggesting conformational flexibility of the pRNA 3WJ. Importantly, as
demonstrated in the following sections of this chapter, this conformational flexibility can
be exploited to build novel 3D RNA nanostructures such as cubes and dodecahedrons by
adjusting the angles among the three RNA branches.

Design and self-assembly of the RNA cube cages
A typical cube structure has eight vertexes, six square faces and twelve edges. A
3D computational model of the RNA cube was first generated using the software
NanoEngineer (Figure 3.2a). The resulting computational model exhibited authentic
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cubic conformation and the eight RNA 3WJs can be clearly observed in the model. For
designing the RNA cages with cube shape, eight pRNA 3WJs (four of them are reverse
pRNA 3WJs) are positioned into the vertexes and twelve double-stranded RNAs are
positioned into the edges of the cube to link the individual pRNA 3WJs. A total of six
RNA strands were designed to construct the RNA cube, while each RNA strand
represents one square face of the RNA cube (Figure 3.3). For assembling the RNA cube,
the designed six RNA strands were synthesized by in vitro transcription and then mixed
in stoichiometric ratio and annealed in 1×TMS buffer in a one-pot manner. Step-wise
assembly of the RNA cubic cages was observed by a PAGE gel, confirming the
formation of the high molecular weight RNA cubes (Figure 3.4).

Design and self-assembly of the RNA dodecahedron cages
A typical dodecahedron structure has twenty vertexes, twelve faces and thirty
edges. Similar to the RNA cube, a 3D computational model of the RNA dodecahedron
was generated using the same software NanoEngineer (Figure 3.2b). The resulting
computational model exhibited authentic dodecahedron conformation and the twenty
RNA 3WJs can be clearly observed in the model. For designing the RNA cages with
dodecahedron shape, twenty pRNA 3WJs are positioned into the vertexes and thirty
double-stranded RNAs are positioned into the edges of the dodecahedron to link the
individual pRNA 3WJs. A total of twelve RNA strands were designed to construct the
RNA dodecahedron, while each RNA strand represents one face of the RNA
dodecahedron (Figure 3.5). For assembling the RNA dodecahedron, the designed twelve
RNA strands were synthesized by in vitro transcription and then mixed in stoichiometric
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ratio and annealed in 1×TMS buffer in a one-pot manner. Step-wise self-assembly of the
RNA dodecahedron cages was clearly observed by running an agarose gel, suggesting the
formation of the high molecular weight RNA dodecahedron (Figure 3.6).

Imaging of the RNA cube cages by atomic force microscopy
Atomic force microscopy (AFM) has been extensively used to characterize a
variety of nucleic acid nanostructures [293]. AFM was also applied to characterize the
RNA cube cages. Before AFM imaging, the self-assembled RNA cube was deposited on
an APS-modified mica surface, washed with water and dried in room temperature. AFM
studies of the RNA cube clearly revealed the shape of the cube, which was similar to its
theoretical prediction (Figure 3.7). The height of the RNA cube was found to be around
7-8 nm, which was consistent to the height of the RNA cube after drying (the RNA cube
was collapsed on the mica surface after drying, which gave a distorted dimension).

Imaging of the RNA cube cages by cryo-electron microscopy
To further confirm the formation of the RNA cube cages, cryo-electron
microscopy (EM) was applied to direct image the RNA cube cages. Cryo-EM images
showed very clear RNA cubes with expected dimensions. The single particle 3D
reconstruction data revealed that the RNA cube has a clear overall shape and
conformation in agreement with the computational 3D model and the predicted size of 10
nm (Figure 3.8). The six faces of the cube cage can be clearly observed in the
reconstructed 3D model. The 2D computer projections of the reconstructed RNA cube
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model showed good match to the 2D class averages of the raw images, suggesting the
reconstructed 3D model correctly represented the native structure of the RNA cube.

Imaging of the RNA dodecahedron cages by atomic force microscopy
Similar to the RNA cube cages, AFM was also applied to characterize the RNA
dodecahedron cages. Before AFM imaging, the self-assembled RNA dodecahedron was
deposited on an APS-modified mica surface, washed with water and dried in room
temperature. AFM studies of the RNA dodecahedron clearly revealed the shape of the
cube, which was in agreement to its theoretical prediction (Figure 3.9). The height of the
RNA dodecahedron was found to be around 8 nm, which was consistent to the distorted
dimension of the RNA dodecahedron after drying. Moreover, the nuclease-resistant 2’Fmodified RNA dodecahedrons were also imaged by AFM and similar images were
observed under AFM (Figure 3.10). It should be noted that a sharper AFM tip was used
for imaging the 2’F-modified RNA dodecahedron, so the resolution of the image of the
2’F-modified RNA dodecahedron was higher and more details of the inner cavities were
observed. Overall, the AFM result suggests that 2’F-modification did not significantly
change the conformation of the RNA dodecahedron.

Imaging of the RNA dodecahedron cages by cryo-electron microscopy
To further confirm the successful self-assembly of the RNA dodecahedron cages,
cryo-electron microscopy (EM) was also applied to direct image the RNA dodecahedron
cages. Cryo-EM images showed very clear RNA dodecahedrons with expected shapes
and sizes. The single particle 3D reconstruction data revealed that the assembled RNA
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dodecahedron has a clear overall 3D conformation in agreement with the computational
3D model and the predicted size of 20 nm (Figure 3.11). The twelve faces of the
dodecahedron cage can be clearly observed in the reconstructed 3D model. The 2D
computer projections of the reconstructed RNA dodecahedron model showed good match
to the 2D class averages of the raw images, confirming the reconstructed 3D model truly
represented the native structure of the RNA dodecahedron.

Immunomodulation in macrophage cells by CpG DNA escorted by RNA cages
The synthetic CpG ODN are a type of DNA molecule that could induce potent
immune response both in vitro and in vivo [305, 307]. Herein, based on the hypothesis
that 3D display of CpG DNA by nanoparticles will create synergistic effect and enhance
the immune response, I utilized the constructed RNA cube to deliver CpG DNA by
incorporating 4 CpG DNA oligos to the 4 edges of each RNA cube. RNA cubes
harboring CpG DNA were then incubated with macrophage-like RAW 264.7 cells, and
the cell culture supernatant was collected to determine the TNF-alpha and IL-6 cytokine
level by ELISA. The ELISA assay showed that CpG DNA delivered by the RNA cube
induced significantly enhanced immune response, and the induced immune response is
strongly dependent on the number of immunostimulatory molecules per RNA cube
(Figure 3.12). More CpG DNA molecules incorporated into the RNA cube, stronger
immune responses were observed, while the RNA cube without CpG DNA induced
negligible immune response. These results suggested the designed RNA cube has the
potential to be employed as a novel vehicle for immunoactive CpG DNA delivery.
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Conclusion
In this study, I reported the successful bottom-up self-assembly of molecular
defined RNA cages with cube and dodecahedron shapes by using the stable pRNA 3WJ
as the basic building block. The constructed RNA cages have defined 3D structures as
revealed by both cryo-EM and AFM. Comparing with previously reported RNA cages
[119, 122, 145], the RNA cages reported here has more regular and defined shapes.
Moreover, since the thermodynamic stable pRNA 3WJ was used as the building block to
build the RNA cages, it is expected that the constructed cages will also have remarkable
thermodynamic stability. Furthermore, I also found that the designed RNA cube cages
could be used to deliver immunostimulatory CpG DNA to macrophage-like RAW 264.7
cells and elicit enhanced immune response. The extent of the induced immune response is
also strongly dependent on the number of CpG DNA molecules loaded into the RNA
cube. This study showcased that the reported RNA cages have the potential to be
explored in the future as molecularly defined nanocarriers for therapeutics delivery.
Another appealing future research direction is to develop RNA cages with tunable 3D
conformation (for example, 3D RNA cube with different length, width and height) and
investigate the effect of different 3D shapes on the intracellular fate and in vivo behaviors
of these RNA cages.
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Figure 3.1. Cryo-EM characterization of the extended pRNA 3WJ nanoparticles. (a) A
representative raw image showing a typical microscopic view of the extended pRNA
3WJ nanoparticles under cryo-EM. Scale bar: 50 Å. A total of ninety-eight raw images
were collected with a defocus range of 2~4 µm. (b) Forty representative raw particles
extracted from ninety-eight raw cryo-EM images of the extended pRNA 3WJ
nanoparticles. (c) 2D class averages of the extended pRNA 3WJ nanoparticles based on
the cryo-EM data. (d) Reconstructed 3D map of the extended pRNA 3WJ nanoparticles
based on the cryo-EM data. Four views of the 3D map at four different angles (90 °
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rotation) are shown in the figure. Scale bar: 260 Å. A total of 4702 particles were used to
generate the 2D class averages for building the initial models, and 4340 particles were
used for final refinement by applying the icosahedral symmetry.
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Figure 3.2. Computation models of (a) RNA cube and (b) RNA dodecahedron designed
by NanoEngineer program. Two views from two different angles are shown for the RNA
cube model and RNA dodecahedron model, respectively. The RNA cube was composed
of six different RNA strands and contains eight 3WJs in its vertexes, while the RNA
dodecahedron was composed of twelve different RNA strands and contains twenty 3WJs
in its vertexes.
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Figure 3.3. 2D sequence design of the RNA cube. The RNA cube was composed of six
different RNA strands (1-6) highlighted with six different colors. The 5’ and 3’ end of the
individual RNA strand is labeled in the figure. The pRNA 3WJ motif is highlighted in
orange color (Rev denotes the reverse pRNA 3WJ sequence).
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Figure 3.4. 6% native TBM PAGE showing the step-wise self-assembly of the designed
RNA cube. 100 bp DNA ladder is used as the molecular weight marker. The final product
(cube 1+2+3+4+5+6) showed a distinct band (highlighted in the red square),
demonstrating correct assembly of the designed RNA cube. Representative results from
three independent experiments are shown.
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Figure 3.5. 2D sequence design of the RNA dodecahedron. The RNA dodecahedron was
composed of twelve different RNA strands (1-12) highlighted with twelve different
colors. The 5’ and 3’ end of the individual RNA strand is labeled in the figure. The
pRNA 3WJ motif is highlighted in orange color.
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Figure 3.6. 2.5% agarose gel showing the step-wise self-assembly of the RNA
dodecahedron. 100bp DNA ladder is used as the molecular weight marker. The final
product (dodecahedron 1-12) showed a distinct band (highlighted in the red square),
demonstrating correct assembly of the designed RNA dodecahedron. Representative
results from three independent experiments are shown.
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Figure 3.7. AFM characterization of the RNA cube. Left panel shows a typical AFM
view of the RNA cube. Right panel shows the magnified view of individual RNA cube.
Note that the RNA cube was collapsed on the mica surface after drying, which gave a
distorted dimension. Representative results from eight raw AFM images are shown.
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Figure 3.8. Cryo-EM characterization of the RNA cube with single particle
reconstruction. (a) A representative raw cryo-EM image with box highlighting individual
RNA cube. Scale bar: 100 Å. A total of 149 raw images of RNA cube were collected
with a defocus range of 2~4 µm. (b) Classes of the RNA cube as observed by cryo-EM
with corresponding projections of the reconstructed 3D RNA cube model. (c) 2D class
averages (top), starting 3D model (middle) and refined 3D model of the RNA cube
(bottom). Two views of the refined 3D model at two different angles (30 ° rotation) are
shown in the figure. Scale bar: 100 Å. A total of 5106 particles were used to generate the
2D class averages for building the initial model, and 4371 particles were used for final
refinement by applying the octahedron symmetry.
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Figure 3.9. AFM characterization of the RNA dodecahedron. Left panel shows a typical
AFM view of the RNA dodecahedron. Right panel shows the magnified view of
individual RNA dodecahedron. Note that the RNA dodecahedron was collapsed on the
mica surface after drying, which gave a distorted dimension. Representative results from
thirty-six raw AFM images are shown.
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Figure 3.10. AFM characterization of the 2’F-modified RNA dodecahedron. Left panel
shows a typical AFM view of the 2’F-modified RNA dodecahedron. Right panel shows
the magnified view of individual 2’F-modified RNA dodecahedron. Note that the 2’Fmodified RNA dodecahedron was collapsed on the mica surface after drying, which gave
a distorted dimension. It should also be noted that a sharper AFM tip was used for
imaging the 2’F-modified RNA dodecahedron, so the resolution of the image of the 2’Fmodified RNA dodecahedron was higher and more details of the inner cavities were
observed. Representative results from fifteen raw AFM images are shown.
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Figure 3.11. Cryo-EM characterization of the RNA dodecahedron with single particle
reconstruction. (a) A representative raw cryo-EM image with box highlighting individual
RNA dodecahedron. Scale bar: 500 Å. A total of fifty-five raw images were collected
with a defocus range of 2~5 µm. (b) Reconstructed 3D RNA dodecahedron model. Two
views of the reconstructed 3D model at two different angles (90 ° rotation) are shown in
the figure. Scale bar: 200 Å. (c) Classes (denoted as C) of the RNA dodecahedron as
observed by cryo-EM with corresponding projections (denoted as P) of the reconstructed
3D RNA dodecahedron model. A total of 1598 particles were used to generate the 2D
class averages for building the initial models and 991 particles were used for final
refinement by applying the icosahedral symmetry.
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Figure 3.12. Determination of the level of immunomodulation by RNA cube
nanoparticles harboring CpG DNA via ELISA. (a) Determination of the level of TNF-α
after incubating RNA cube nanoparticles harboring CpG DNA with macrophage RAW
264.7 cells. The error bars represent standard deviations from three independent wells.
***: p < 0.001 versus 200 nM DNA CpG only control, unpaired Student's t-test. ****: p
< 0.0001 versus 200 nM DNA CpG only control, unpaired Student's t-test. The induction
of TNF-α in RAW 264.7 cells by 50 nM RNA cube harboring 4 CpGs, 50 nM RNA cube
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only control and 200 nM DNA CpG only control was independently repeated one more
time with triplicate independent wells for each sample and similar results were observed.
(b) Determination of the level of IL-6 after incubating RNA cube nanoparticles harboring
CpG DNA with macrophage RAW 264.7 cells. The error bars represent standard
deviations from three independent wells. **: p < 0.01 versus 200 nM DNA CpG only
control, unpaired Student's t-test. ***: p < 0.001 versus 200 nM DNA CpG only control,
unpaired Student's t-test. ****: p < 0.0001 versus 200 nM DNA CpG only control,
unpaired Student's t-test. The induction of IL-6 in RAW 264.7 cells by 50 nM RNA cube
harboring 4 CpGs, 50 nM RNA cube only control and 200 nM DNA CpG only control
was independently repeated one more time with triplicate independent wells for each
sample and similar results were observed.
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Chapter 4: Bottom-up Self-assembly of Molecularly Defined RNA
Nanowire
This chapter is adapted from a manuscript entitled “Bottom-up Self-assembly of
Molecularly Defined RNA Nanowire” by Hui Li, Kaiming Zhang, Wah Chiu and
Peixuan Guo. The manuscript is in preparation for submission to Small. Special thanks to
Dr. Kaiming Zhang for help in preparing Figure 4.2 and 4.3. Author contribution: Dr.
Kaiming Zhang performed the TEM and cryo-EM imaging under the supervision of Dr.
Wah Chiu. Hui Li conceived the idea of building RNA nanowire via the modular multidomain strategy, designed the 2D sequence and 3D computational model of RNA
nanowire, performed all the other experiments, analyzed all the data and drafted the
manuscript. Dr. Peixuan Guo led and supervised the whole study and provided financial
support.

Copyright © Hui Li 2016
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Abstract
Since the proof-of-concept of RNA nanotechnology in 1998, RNA has been
shown to be an exceptional and smart biopolymer that can be employed to create
nanostructures with various conformations and diverse functionalities. In this study, I
report the design and construction of a molecularly defined RNA nanowire that was only
assembled from four different 44-nucleotide long single-stranded RNAs by using the
modular multi-domain strategy. The RNA nanowire can be easily constructed by singlestep annealing. The RNA nanowire was further characterized by cryo-electron
microscopy, negative staining transmission electron microscopy, atomic force
microscopy and fluorescent microscopy, confirming the spontaneous self-assembly of the
RNA nanowire. Interestingly, I also found that the RNA nanowire can self-grow to
micrometer-scale wire-shaped structure, expanding the horizon of RNA nanostructures to
RNA microstructures. The reported RNA nanowire can be further explored as the carrier
for drug delivery or the extracellular matrix for tissue engineering or the conductive
nanowire after coating with conductive metals.

Keywords: RNA nanotechnology; RNA nanostructures; Nanowire
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Introduction
RNA nanotechnology is an emerging research field that utilizes RNA as a unique
and smart biomaterial to create nanostructures with various conformations and diverse
functionalities [181]. Previous research has shown that a variety of 2D and 3D RNA
nanostructures with defined shapes and sizes can be successfully constructed and
functionalized [36, 54, 93, 111, 113, 116-119, 121, 122, 126, 147]. These RNA
nanostructures have the potential for many useful applications in biomedical and material
sciences such as drug delivery and tissue engineering [286]. Here I report the design and
construction of molecularly defined RNA nanowire with micrometer length by using the
modular multi-domain strategy [308]. The modular multi-domain strategy has been used
to assemble DNA tubes and DNA ribbons with tunable width [308]. In my study, I
applied this modular multi-domain strategy to RNA nanotechnology. Only four different
44-nucleotide long single-stranded RNAs were designed and used to assemble the RNA
nanowire. The assembled RNA nanowire has defined 3D structure as revealed by cryoEM, negative staining TEM, AFM and fluorescent microscopy. Interestingly, I also found
that the RNA nanowire can self-grow to micrometer-scale wire-shaped structure based on
non-covalent RNA base pairing interactions, expanding the horizon of RNA
nanostructures to RNA microstructures. The reported RNA nanowire can be further
explored as the carrier for drug delivery, the extracellular matrix for tissue engineering or
the conductive nanowire after coating with conductive metals.
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Materials and Methods
RNA nanowire design, synthesis, and self-assembly
The NanoEngineer program [306] was used to facilitate the design of the
molecularly defined RNA nanowire. The modular multi-domain strategy previously
reported for assembling DNA tubes and DNA ribbons was employed to design the RNA
nanowire. In addition, different from the DNA double helix, 11 nucleotides per helix turn
for RNA double helix were used in the design. RNA strands were synthesized by in vitro
T7 transcription following previously reported procedures. DNA templates for generating
the RNA strands were made by polymerase chain reactions (PCR). DNA oligo for PCR
were directly purchased from Integrated DNA Technologies, Inc (Coralville, Iowa, USA).
For a 50 µl transcription reaction, 10 µl of DNA template with 10 µl of 5× transcription
buffer, 10 µl of 25 mM NTPs solution, 5 µl of 100 mM DTT, 10 µl of T7 RNA
polymerase and 5 µl 0.05% (vol/vol) DEPC water were mixed together and incubated at
37 °C for 4 h. The transcription reaction was stopped by adding 1 µl of DNase I and
incubating at 37 °C for another 30 min to digest the DNA template. After transcription,
the RNA strands were purified by 8 M urea and 8% denaturing PAGE. The RNA
nanowire was self-assembled in a one-pot manner by mixing the four different RNA
strands in equimolar concentrations (1.4 µM) in 1× TMS buffer and heated to 95 °C and
slowly cooled down to room temperature. The step-wise self-assembly of the RNA
nanowire was further verified by a 3% agarose gel. The gel was stained with ethidium
bromide (EB) and imaged by Typhoon FLA 7000 (GE Healthcare, Marlborough, MA).
The detailed sequence for assembling the RNA nanowire are listed below:
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Nanowire Strand 1:
5’- GGUGCUACACG CGAUUACAGCU UGUCGAGUAC CGGGCAGUUG AG -3’
Nanowire Strand 2:
5’- GGUUCAGACCG CGGGAAGAGCC CGUGUAGCAC CAGCUGUAAU CG -3’
Nanowire Strand 3:
5’- GGUGCUGUGUC AGCUGUCAGAA CGGUCUGAAC CGGCUCUUCC CG -3’
Nanowire Strand 4:
5’- GGUACUCGACA CUCAACUGCCC GACACAGCAC CUUCUGACAG CU -3’

Atomic force microscopy
The RNA nanowire (10 µl at 0.02 mg/ml) was first deposited on a mica surface
and excess samples were washed with water and dried on room temperature before
imaging. AFM images were obtained by using a Bruker AXS Dimension Icon
Atomic/Magnetic Force Microscope with ScanAsyst (Bruker, Billerica, MA) operated in
tapping mode.

Fluorescent microscopy
One RNA strand for assembling the RNA nanowire was labeled by Cy3 by using
the Label IT® Nucleic Acid Labeling Reagents kit (Mirus Bio LLC, Madison, WI).
Fluorescent RNA nanowire was assembled by mixing three unlabeled RNA strands with
one Cy3-labled RNA strand in equimolar concentrations (8 µM) in 1× TMS buffer. The
mixture was heated to 95 °C and cooled to room temperature. The assembled RNA
nanowire (1 µL at 8 µM) was further diluted in 1× TMS buffer by 10 times and deposited
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on glass slide and observed under 40 × or 20 × objective lens using a fluorescent
microscope (Olympus Corporation, Tokyo, Japan).

Electron microscopy
RNA nanowire sample (6 µl at 0.09 mg/ml) was transferred onto the EM grid and
then the grid was negatively stained with 2% (w/v) uranyl acetate for 10 s. Electron
micrographs were recorded with a JEOL 2100 transmission electron microscope (JEOL,
Tokyo, Japan). For cryo-electron microscopy, 2 µl of nanowire sample (0.45 mg/ml) was
applied onto a glow-discharged 200-mesh R3.5/1 Quantifoil grid. The grid was blotted
and rapidly frozen in liquid ethane using a Vitrobot IV (FEI, Hillsboro, OR).
Micrographs were recorded on a 4k × 4k CCD camera (Gatan, Pleasanton, CA) at
40,000× microscope magnification (corresponding to a calibrated sampling of 2.83 Å per
pixel) and a dose rate of ~20 e-/s/Å2 with a total exposure time of 3 s.

Results
Design and self-assembly of the RNA nanowire
RNA nanowire was designed by adopting the modular multi-domain strategy
previously reported for assembling DNA tubes and DNA ribbons [308]. However, in
contrast with DNA that has 10.5 nucleotides per helix turn, the number of nucleotides per
helix turn is an integer of 11 for A-form RNA. As a result, I have used 11-nucleotide
sequence as a single domain in our RNA nanowire design. By using the NanoEngineer
program, I first built the computational model of the RNA nanowire (Figure 4.1a). A
total of four single-stranded RNA strands were designed consisting of four single
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domains per RNA strand. The detailed 2D sequence of the RNA nanowire is shown in
Figure 4.1b. It is expected that these designed RNA domains will base pair with their
corresponding domains and spontaneously grow in size and finally form RNA nanowire
with micrometer-scale length. For assembling the RNA nanowire, the four RNA strands
were synthesized by in vitro transcription and then mixed in stoichiometric ratio and
annealed in 1×TMS buffer in a one-pot manner. Step-wise assembly of the RNA
nanowire was observed by a 3% agarose gel, confirming the formation of the high
molecular weight RNA nanowire (Figure 4.1c).

Imaging of the RNA nanowire by cryo-electron microscopy and negative staining
transmission electron microscopy
To further confirm the formation of the RNA nanowire, cryo-electron microscopy
(EM) was applied to direct image the RNA nanowire. Cryo-EM is a useful technique for
characterizing the native structure of biological macromolecules including RNA
molecules [292]. I expected that cryo-EM imaging would provide meaningful data to
show the native structure of the constructed RNA nanowire. Cryo-EM images indeed
showed very clear long RNA nanowires with expected width and dimensions (Figure
4.2). From the cryo-EM images, it could also be observed that two or more RNA
nanowires could intertwine to from higher order structures. This is plausible since the
assembly buffer contains magnesium ions, which could shield part of the negative charge
of the RNA phosphate backbone and induce intertwining of RNA nanowires.
Moreover, transmission electron microscopy (TEM) was also used to characterize
the RNA nanowire under negative staining by 2% (w/v) uranyl acetate. Similar to the
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results obtained by cryo-EM, long RNA nanowires were also observed under negative
staining TEM as expected (Figure 4.3).

Imaging of the RNA nanowire by fluorescent microscopy
Because it was found that the length of the RNA nanowire was in the micrometer
range as revealed by EM and AFM, I speculated that RNA nanowire could also be
imaged by fluorescent microscopy. For preparing the fluorescently labeled RNA
nanowire, one RNA strand was labeled with Cy3 and subsequently mixed with the other
three non-labeled RNA strands. Under the fluorescent microscope, the RNA nanowire
can be clearly observed with expected micrometer length, further confirming its
successful self-assembly (Figure 4.4a).

Imaging of the RNA nanowire by atomic force microscopy
Atomic force microscopy (AFM) has been widely used to characterize nucleic
acid nanostructures [293]. I also applied AFM to characterize the self-assembled RNA
nanowire. Before AFM imaging, the self-assembled RNA nanowire was deposited on a
mica surface, washed with water and dried in room temperature. AFM studies of the
RNA nanowire clearly revealed the shape of the nanowire, which was similar to its
theoretical prediction (Figure 4.4b). The height of the RNA nanowire was found to be
around 4 nm, which was consistent with the height of the RNA nanowire under dried
condition.
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Discussion and Conclusion
As a central molecule in molecular biology, RNA not only plays an indispensable
role in modulating gene expression and maintain the normal flow of genetic information,
but also can form delicate 3D structures with defined shape and atomic level precision.
Previous work in RNA nanotechnology has demonstrated that a range of 2D and 3D
nanostructures can be successfully constructed based on utilizing naturally occurring
RNA motifs and/or computational design [36, 54, 93, 111, 113, 116-119, 121, 122, 126,
147]. Specifically, there are some notable previous studies that applied RNA to build
array- or filament-like structures based on non-covalent RNA-RNA interactions [113,
121]. For example, Shu et al. reported in 2004 that nanometer scale 3D RNA arrays could
be constructed by linking pRNA molecules into a chain-like structure via foot-on-foot
interactions based on palindrome sequences as well as loop–loop interactions [113]. The
formation of the array was analyzed by PAGE and the structure of the array was further
confirmed by AFM imaging. Moreover, Nasalean et al. reported in 2006 that micrometerscale RNA filaments could be successfully constructed in a controlled manner by using
H-shaped RNA molecules involving RNA 4WJ, specific hairpin loops and loop–
receptors [121]. Under TEM, the RNA filaments were clearly visualized, confirming the
successful self-assembly of the designed structure. In this current study, I reported the
bottom-up self-assembly of molecular defined RNA nanowire by applying the modular
multi-domain strategy [308] in RNA nanotechnology. The modular multi-domain
strategy was firstly reported by Yin et al. in DNA nanotechnology to synthesize DNA
tubes with monodisperse and programmable circumferences [308]. However, comparing
with DNA, RNA is more structurally diverse and has important biological functionalities
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that cannot be replaced by DNA. In this regard, I set out to explore the feasibility to
design and assemble RNA nanowires via the modular multi-domain strategy [308].
Notably, since the number of nucleotides per helix turn is 11 for A-form RNA (DNA has
10.5 nucleotides per helix turn), I designed multiple 11-nucleotide sequences as the
modular domains for the self-assembly of the RNA nanowire. As revealed in a series of
characterization experiments including cryo-EM, negative staining TEM, fluorescent
microscopy and AFM, the constructed RNA nanowire has a defined wire-like 3D
structure that is in agreement with its theoretical predication. Comparing with previously
reported RNA array and RNA filaments, this newly designed RNA nanowire was selfassembled purely based on RNA base pairing and did not involve any naturally occurring
RNA motifs or junctions. Notably, only four artificially designed short RNA strands were
used to assembly the RNA nanowire. In summary, this study showcases the expanding of
the horizon of RNA nanostructures to RNA microstructures by incorporating the modular
multi-domain strategy previously used in DNA nanotechnology [308]. How to control the
width and length of the assembled RNA nanowire will be an interesting direction for
future studies. Moreover, the reported RNA nanowire can be further explored for a
variety of applications such as the carrier for drug delivery, the extracellular matrix for
tissue engineering or the conductive nanowire after coating with conductive metals.
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Figure 4.1. The design and self-assembly of the molecularly defined RNA nanowire. (a)
The computational model of the RNA nanowire designed by NanoEngineer program. (b)
2D sequence of the RNA nanowire. The RNA nanowire was assembled from four
different 44-nucleotide long single-stranded RNAs. The 5’ and 3’ end of the individual
single-stranded RNA is labeled in the figure. (c) 3% agarose gel examine the selfassembly of the RNA nanowire. 100 bp DNA ladder is used as the molecular weight
marker. The final product (nanowire 1+2+3+4) showed bands with high molecular
weight (highlighted in the red square), demonstrating successful assembly of the designed
RNA nanowire. Representative results from three independent experiments are shown.
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Figure 4.2. Cryo-EM imaging of the RNA nanowire. Left panel shows a typical cryo-EM
view of the RNA nanowire (scale bar: 100 nm). Right panel shows the magnified view of
the RNA nanowire (scale bar: 20 nm). Nanowire structures are clearly visible in the
images. Representative results from a total of seven raw cryo-EM images are shown.
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Figure 4.3. TEM imaging of the negatively stained RNA nanowire. Two representative
TEM images from a total of seven raw TEM images are shown. Nanowire structures are
clearly visible in the images. It is also notable that two or more RNA nanowires could
intertwine to from higher order structures. Scale bar: 200 nm.
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Figure 4.4. Fluorescent microscopy and AFM imaging of the RNA nanowire. (a)
Fluorescent microscopy imaging of the RNA nanowire deposited on a glass slide. Scale
bar: 50 µm. A representative image from a total of eleven raw fluorescent microscopy
images is shown. (b) AFM imaging of the RNA nanowire deposited on mica surface.
Scale bar: 910 nm. A representative image from a total of sixteen raw AFM images is
shown. Nanowire structures are clearly visible in both fluorescent microscopy and AFM
images.

160

Chapter 5: Engineering RNA Nanoparticles for Potent
Immunomodulation
Part of this chapter was reproduced (with some modification) with permission
from Emil F. Khisamutdinov†, Hui Li†, Daniel L. Jasinski†, Jiao Chen, Jian Fu and
Peixuan Guo. “Enhancing immunomodulation on innate immunity by shape transition
among RNA triangle, square and pentagon nanovehicles.” Nucleic Acids Res. 2014 Nov
1; 42(15):9996-10004. †: Joint First Authors. Special thanks to Dr. Emil F.
Khisamutdinov for help in preparing Figure 5.1 and 5.7, Daniel L. Jasinski in Figure 5.2d,
5.4 and 5.6a, Dr. Jiao Chen in Figure 5.3b, 5.3c and 5.4, and Dr. Luda Shlyakhtenko in
Figure 5.2c. Author contribution: Dr. Emil F. Khisamutdinov and Daniel L. Jasinski
designed and constructed RNA polygon nanoparticles based on the tunable angle of
pRNA-3WJ. Hui Li conceived the idea of using RNA polygon nanoparticles to deliver
CpG oligos to immune cells, designed and constructed RNA triangles harboring CpG
oligos, performed cell and animal testing of RNA polygon nanoparticles harboring CpG
oligos. Dr. Jiao Chen provided assistance to the ELISA experiments and animal
experiments under the supervision of Dr. Jian Fu. Dr. Emil F. Khisamutdinov, Hui Li,
Daniel L. Jasinski and Dr. Peixuan Guo analyzed all the data and drafted the manuscript.
Dr. Peixuan Guo led and supervised the whole study and provided financial support.
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Abstract
Modulation of immune response through cytokine induction is a vital process in
vaccine development and immune therapy. It is desirable to develop potent and non-toxic
immunomodulators to promote successful cancer immunotherapy. In this study, I report
the development of novel immunomodulators by engineering rationally designed RNA
nanoparticles based on the pRNA of the bacteriophage phi29 DNA packaging motor.
RNA nanoparticles with triangular, square and pentagonal shape could be successfully
constructed by stretching the angle of the pRNA three-way junction from 60° to 90° or
108°. When immunoactive CpG oligodeoxynucleotides (ODNs) were incorporated into
the RNA nanoparticles by DNA-RNA hybridization, their immunomodulation effect for
cytokine TNF-α and IL-6 induction was greatly enhanced both in vitro and in vivo, while
RNA nanoparticle controls induced unnoticeable cytokine induction. Moreover, the RNA
nanoparticles were delivered to macrophages specifically and the degree of
immunostimulation greatly depended on the size, shape, and the number of payload per
RNA nanoparticles. Stronger immune response was observed when the number of
adjuvants per nanoparticle was increased, demonstrating the advantage of shape
transition of the nanoparticles from triangle into pentagon, which can carry five adjuvants.
This finding demonstrates that RNA nanotechnology such as developing RNA
nanoparticles based on pRNA has great potential to develop novel immunomodulators for
cancer immunotherapy.

Keywords: RNA nanotechnology; pRNA; CpG; Immunomodulator; Immunotherapy
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Introduction
Cancer and infectious diseases such as influenza and human immunodeficiency
virus infection / acquired immunodeficiency syndrome (HIV/AIDS) are still huge threats
to public health worldwide [309, 310]. Prophylactic and treatment vaccines could offer
promising opportunities for controlling these diseases [311, 312]. However, despite tens
of years of extensive research, such vaccines are still far away from completely
controlling these diseases due to either low effectiveness or safety issues. New strategies
and approaches in designing and developing new vaccines and adjuvants targeting these
diseases are urgently needed. CpG oligodeoxynucleotides (ODNs) are a type of
immunostimulatory DNA molecules containing the CpG motif which is unmethylated
cytosine-phosphate-guanine dinucleotide with optimized flanking sequence [305].
Previous reports have shown that CpG DNA strongly activates mammalian innate
immune system by interacting with various immune cells via endosomal Toll-like
receptor 9 (TLR9) [305, 313]. The therapeutic potential of CpG DNA has also been
explored in a number of clinical applications, including vaccine adjuvants, anticancer
agents, immunoprotective agents and anti-allergic agents [307, 314]. Recently, several
groups have reported the utilization of nucleic acid nanostructures to deliver
immunostimulatory CpG DNA. However, most of the published reports were using
DNA nanostructures such as DNA tetrahedron [315], DNA polypod-like structures [316]
or DNA origami structure [317].
In this study, I demonstrated that rationally designed RNA nanoparticles, based
on the pRNA of the bacteriophage phi29 DNA packaging motor [123], have the potential
to serve as a new generation of delivery system for immunomodulators such as CpG
163

DNA. By stretching the angle of the pRNA three-way junction from 60° to 90° or 108°,
RNA nanoparticles with triangular, square and pentagonal shapes could be successfully
constructed. When immunoactive CpG ODNs were further incorporated into the RNA
triangular, square and pentagonal nanoparticles by DNA-RNA hybridization, their
immunomodulation effect for cytokine TNF-α and IL-6 induction was greatly enhanced
both in vitro and in vivo, while RNA nanoparticle controls induced unnoticeable cytokine
induction. Moreover, the RNA nanoparticles were delivered to macrophages specifically
and the degree of immunostimulation greatly depended on the size, shape, and the
number of payload per RNA nanoparticles. Stronger immune response was observed
when the number of adjuvants per nanoparticle was increased, demonstrating the
advantage of shape transition of the nanoparticles from triangle into pentagon which can
carry five adjuvants. This finding suggested that RNA nanotechnology such as
developing RNA nanoparticles based on pRNA has great potential to develop novel
immunomodulators. To the best of my knowledge, I reported the first time the use of
RNA nanostructures derived from bacterial phage Phi29 pRNA to deliver CpG DNA.

Materials and Methods
RNA nanoparticles design, synthesis, and self-assembly
The 3WJ crystal structure of the pRNA molecule (PDB ID: 4KZ2) [54] was
primarily used for designing polygon models using Swiss PDB viewer, as previously
described [36]. RNA strands for corresponding nanoparticles were synthesized by in vitro
T7 transcription using polymerase chain reaction (PCR) generated DNA templates. DNA
oligo for PCR were directly ordered from Integrated DNA Technologies, Inc. (Coralville,
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IA). For generating 2’-F modified RNA polygons, Y693F mutant T7 polymerase and 2’F modified cytosine (C) and uracil (U) nucleotides were used to synthesize the
corresponding RNA strands. RNAs were further purified by denaturing 8M urea 8%
PAGE. Cy5 whole chain labeled RNA was prepared by using Cy5 Label IT® Kit (Mirus
Bio LLC, Madison, WI). Cy3-labeled CpG DNA was ordered from Integrated DNA
Technologies, Inc. (Coralville, IA). In this Cy3-labeled CpG DNA, Cy3 was conjugated
to the 5’ end of the DNA through a phosphate bond. RNA nanoparticles self-assembly
was examined by running a 2% agarose gel. The gel was stained with ethidium bromide
(EB) and imaged by Typhoon FLA 7000 (GE Healthcare, Marlborough, MA).
The detailed sequence to construct the RNA triangle harboring three CpG ODNs
are listed below:
Sequence Name
Triangle-A
RNA

Triangle-B
RNA

Triangle-C
RNA

Triangle-D

Sequence
5’- GGGCCGUCAAUCAUGGCAAGUGUCCGCCAUACUUUG
UUGCACGCCCUCGGAAUGCAAUACGACUGUA -3’
5’ - GGGCGUGCAAUCAUGGCAACGAUAGAGCAUACUUUG
UUGGCUGGCCUAGUUGGAAAUGGCGGUAUG G -3’
5’ - GGCCAGCCAAUCAUGGCAAUAUACACGCAUACUUUG
UUGACGGCCCAGUUAAACAUCGCAUGUGCUU -3’
5’- GGACACUUGUCAUGUGUAUGCGUGUAUAUUGUCAUG
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RNA

UGUAUGCUCUAUCGUUGUCAUGUGUAUGGC -3’

CpG-A DNA

5’- TCCATGACGTTCCTGACGTTTTTTTTACAGTCGTATT
GCATTCCGA -3’

CpG-B DNA

5’- TCCATGACGTTCCTGACGTTTTTTTCCATACCGCCATT
TC CAACTA -3’

CpG-C DNA

5’- TCCATGACGTTCCTGACGTTTTTTTAAGCACATGCGA
TGTTTAACT -3’

The detailed sequences to construct the shape transition (triangle to square to
pentagon) nanoparticles harboring CpG ODNs are listed below:
Sequence

Sequence

Name
CPG-TRI-A

5’- GGGAGCCGUCAAUCAUGGCAAGUGUCCGCCAUA

(for triangle)

CUUUGUUGCACGCUCUCUCGGAAUGCAAUACGACUGUA -3’

CPG-TRI-B

5’- GGGAGCGUGCAAUCAUGGCAACGAUAGAGCAUACUUU

(for triangle)

GUUGGCUGGUCUCUAGUUGGAAAUGGCGGUAUGG -3’

CPG-TRI-C

5’- GGGACCAGCCAAUCAUGGCAAUAUACACGCAUACUUU

(for triangle)

GUUGACGGCUCUCAGUUAAACAUCGCAUGUGCUU -3’

TRI-D

5’- GGACACUUGUCAUGUGUAUGCGUGUAUAUUGUC
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(for triangle)

AUGUGUAUGCUCUAUCGUUGUCAUGUGUAUGGC -3’

CPG-SQR-A

5’- GGGAGCCGUCAAUCAUGGCAAGUGUCCGCCAUA

(for square)

CUUUGUUGCACGCUCUCUCGGAAUGCAAUACGACUGUA -3’

CPG-SQR-B

5’- GGGAGCGUGCAAUCAUGGCAAGCGCAUCGCAUACUUU

(for square)

GUUGCGACCUCUCAUUGAUCUAUGAUCGUACGAU -3’

CPG-SQR-C

5’- GGGAGGUCGCAAUCAUGGCAACGAUAGAGCAUACUUU

(for square)

GUUGGCUGGUCUCUAGUUGGAAAUGGCGGUAUGG -3’

CPG-SQR-D

5’- GGGACCAGCCAAUCAUGGCAAUAUACACGCAUACUUU

(for square)

GUUGACGGCUCUCAGUUAAACAUCGCAUGUGCUU -3’

SQR-F

5’- GGACACUUGUCAUGUGUAUGCGUGUAUAUUGUC

(for square)

AUGUGUAUGCUCUAUCGUUGUCAUGUGUAUGCGAUGCGC
UUGUCAUGUGUAUGGC -3’

CPG-PENT-A 5’- GGGAGCCGUCAAUCAUGGCAAGUGUCCGCCAUACUUU
(for pentagon)

GUUGUAGGGUCUCAUGUUAAGUAACGUCUAGAAU -3’

CPG-PENT-B 5’- GGGACCCUACAAUCAUGGCAAAUAUGCGCCAUACUUU
(for pentagon)

GUUGCACGCUCUCGAAAGCUUGUAGCUAUAGUUA -3’
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CPG-PENT-C 5’- GGGAGCGUGCAAUCAUGGCAAGCGCAUCGCAUACUUU
(for pentagon)

GUUGCGACCUCUCAUUGAUCUAUGAUCGUACGAU-3’

CPG-PENT-D 5’- GGGAGGUCGCAAUCAUGGCAACGAUAGAGCAUACUUU
(for pentagon)

GUUGGCUGGUCUCUAGUUGGAAAUGGCGGUAUGG -3’

CPG-PENT-E

5’- GGGACCAGCCAAUCAUGGCAAUAUACACGCAUACUUU

(for pentagon)

GUUGACGGCUCUCAGUUAAACAUCGCAUGUGCUU -3’

PENT-F

5’- GGACACUUGUCAUGUGUAUGCGUGUAUAUUGUCAUGU

(for pentagon)

GUAUGCUCUAUCGUUGUCAUGUGUAUGCGAUGCGCUUGU
CAUGUGUAUGGCGCAUAUUUGUCAUGUGUAUGGC -3’

CPG-A

5’- TCCATGACGTTCCTGACGTTTTTTTTACAGTCGTAT
TGCATTCCGA -3’

CPG-B

5’- TCCATGACGTTCCTGACGTTTTTTTCCATACCGCCA
TTTCCAACTA -3’

CPG-C

5’- TCCATGACGTTCCTGACGTTTTTTTAAGCACATGCG
ATGTTTAACT -3’

CPG-D

5’- TCCATGACGTTCCTGACGTTTTTTTATCGTACGATC
ATAGATCAAT -3’
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CPG-E

5’- TCCATGACGTTCCTGACGTTTTTTTATTCTAGACGT
TACTTAACAT -3’

CPG-F

5’- TCCATGACGTTCCTGACGTTTTTTTTAACTATAGCT
ACAAGCTTTC -3’

RNA polygons were assembled in one pot by mixing equimolar concentrations
(final concentration of 1 µM) of the corresponding RNA strands in 1× TMS buffer (50
mM TRIS pH = 8.0, 100 mM NaCl, and 10 mM MgCl2). Samples were annealed for 1 h
by controlled slow cooling from 80 °C to 4 °C.

Dynamic light scattering
Apparent hydrodynamic sizes of RNA nanoparticles (10 µM) in 50µL 1× TMS
buffer were measured by Zetasizer nano-ZS (Malvern Instruments, Ltd, Malvern, United
Kingdom) at 25 °C. The laser wavelength was 633 nm. The intensity distribution was
used to calculate the sizes of the nanoparticles.

Atomic force microscopy imaging
RNA triangles harboring CpG DNAs were imaged by AFM following previously
reported methods [293]. Briefly, the RNA samples were diluted with 1 × TMS buffer to a
final concentration of 3-5 nM. Then, the droplet of samples (5-10 µL) was immediately
deposited on APS-modified mica surface. After 2 min incubation on the surface, excess
samples were washed with DEPC-treated water and dried under a flow of Argon gas.
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AFM images in air were acquired using MultiMode AFM NanoScope IV system
(Veeco/Digital Instruments, Santa Barbara, CA) operating in tapping mode.

Cell cultures
Mouse macrophage-like RAW 264.7 cells were grown in Dulbecco's Modified
Eagle's Medium supplemented with 10% fetal bovine serum, 1% penicillin–streptomycin
at 37 °C in humidified air containing 5% CO2. Cells were then seeded on 24-well plates
or 96-well plates at the density of 5 × 105 cells/mL and cultured overnight before use.

Cytokine secretion from RAW 264.7 cells
RAW 264.7 cells were plated into 24-well plates with the density of 2.5 × 105
cells per well and cultured overnight. Then RNA nanoparticles harboring different
numbers of CpG ODNs were diluted in Opti-MEM medium (Life Technologies
Corporation, Carlsbad, CA) and then added to the cells. The cells were continually
cultured for 8 hours at 37 °C in humidified air containing 5% CO2, and the cell culture
supernatant were collected and stored at -80 °C until use. The concentration of TNF-α
and IL-6 in the supernatant were determined by enzyme-linked immunosorbent assay
(ELISA) using Mouse ELISA MAX™ Deluxe sets (BioLegend, Inc., San Diego, CA),
following protocols provided by the manufacturer. At least three independent wells were
tested for each nanoparticle and control samples.
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Confocal microscopy imaging
RAW 264.7 cells were seeded on glass coverslips in 24-well plates and cultured at
37 °C in humidified air containing 5% CO2 overnight. The culture medium was removed
and the cells were washed with Opti-MEM medium twice to remove dead cells. RNA
nanoparticles harboring Cy3-labeled CpG DNA or Cy3-labled CpG DNA only were
diluted in Opti-MEM medium and added to the cells. After 4 hour incubation at 37 °C in
humidified air containing 5% CO2, the cells were washed twice with PBS and fixed with
4% formaldehyde. ProLong® Gold Antifade Reagent with DAPI (Life Technologies
Corporation, Carlsbad, CA) was used to stain the cell nucleus and mount the samples.
Alexa Fluor® 488 phalloidin (Life Technologies Corporation, Carlsbad, CA) was used to
stain actin. The images were obtained by using Olympus FV1000 confocal microscope or
Olympus fluorescent microscope (Olympus Corporation, Tokyo, Japan).

Flow cytometry assay
RAW 264.7 cells were detached from the cell culture flask by using a cell scraper.
The cells were washed with Opti-MEM medium and aliquot in 1.5 mL eppendorf tubes at
the density of 5 × 105 cells per tube. RNA nanoparticles harboring Cy3-labled CpG DNA
or Cy3-labled CpG DNA only were diluted in Opti-MEM medium and incubated with the
cells at 37 °C for 1.5 hour. The cells were vertexed every 30 minutes during the
incubation. After washing with PBS, the cells were resuspended in PBS and the intensity
of fluorescence was determined by FACSCalibur flow cytometer (BD Biosciences, San
Jose, CA).
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Serum stability assay of RNA polygons harboring CpG DNA
Preassembled complexes (1 µM) of RNA triangle, square and pentagon (2’-F
modified) harboring DNA CpG were incubated in RPMI-1640 medium containing 10%
fetal bovine serum. Aliquots (10 µL) were taken at 0 hr, 1 hr, 3 hr, 6 hr, 8hr and 16 hr
time points after incubation at 37 °C, followed by analysis using 6% native PAGE gels.
The gel was further stained with ethidium bromide (EB) and imaged by Typhoon FLA
7000 (GE Healthcare, Marlborough, MA).

Cytotoxicity assay
The cytotoxicity of RNA nanoparticles harboring CpG ODNs was evaluated by
the MTT assay kit (Promega, Madison, WI), according to the protocol provided by the
manufacturer. Briefly, RAW 264.7 cells were seeded at 96 well plates and cultured at
37 °C in humidified air containing 5% CO2 overnight. RNA nanoparticles harboring CpG
ODNs and controls were dissolved in fresh cell culture medium at the indicated
concentrations and added to the cells for incubation at 37 °C for 24 hours. Then 15 µL of
the dye solution was added to each well, followed by 4 hour incubation at 37 °C, Next,
100µl of the solubilization solution was added to each well and the plate was future
incubated at room temperature on a plate shaker until the formazan crystals were
completely solubilized. The absorbance was measured at 570 nm using a microplate
reader. The cell viability was calculated relative to the absorbance of the cell only control
(viability of cell only control = 1). At least three independent wells were tested for each
sample.
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For cytotoxicity assay on KB cells, RNA nanoparticles harboring CpG ODNs and
control samples were incubated with KB cells for 16 hours (two independent wells for
each sample). After 16 hours, cell viability was examined by the MTT assay kit (Promega,
Madison, WI), following the previously described procedure.

Cytokine secretion from mice
Male CD-1 mice (4-5 week old) were purchased from Charles River Laboratories.
All animal procedures were approved by the Institutional Animal Care and Use
Committee at University of Kentucky and were performed in accordance with guidelines
issued by the National Institutes of Health for the care of laboratory animals. For in vivo
immunostimulation, RNA triangular nanoparticles harboring CpG ODN, RNA triangular
nanoparticles, or CpG ODN were dissolved in PBS and administrated to the mice via tail
vein injection at 2 mg/kg (CpG ODN per body weight). The same volume of PBS was
injected as a control. Blood samples were collected 3 hours post-injection by cardiac
puncture. Serum was prepared by centrifugation at 12800 g for 10 min. Serum TNF-α
and IL-6 levels were determined by enzyme-linked immunosorbent assay (ELISA) using
Mouse ELISA MAX™ Deluxe sets (BioLegend, Inc., San Diego, CA), following
protocols provided by the manufacturer. Two independent measurements of the cytokine
levels from serum aliquots of the tested mouse were performed.

Statistical analysis
The results were presented as mean ± standard deviation. Statistical differences
were evaluated using unpaired Student’s t-test, and p<0.05 was considered significant.
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Results
Design of RNA triangles harboring CpG DNA
The structural features of the recently discovered ultrastable pRNA 3WJ module
from the bacteriophage Phi 29 DNA packaging motor [54] were utilized for in silico
design of the RNA triangles (Figure 5.1a). The particular angle of the 3WJ formed by
H1 and H2 is 60 °, which can be used to build a triangular shape nanoparticle [36] as the
normal triangle also has the internal angle of 60 ° (Figure 5.1b). Each RNA triangle
contained a pRNA 3WJ motif at each vertex. Each triangle was composed of three
external short RNA strands and one internal long RNA strand. For the construction of
RNA triangles harboring CpG DNA, I designed extended external short strands with
sticky ends for RNA-DNA hybridization. I hypothesized that the RNA sticky ends will
base pair with the CpG DNA with DNA sticky ends and form hybrid RNA-DNA
nanoparticles. A schematic design of the RNA triangle nanoparticle harboring 3 CpG
DNAs is shown in Figure 5.2a. In Figure 5.2a, the RNA sequence for the assembly of
the RNA triangle is marked in blue color, and RNA sticky ends for DNA-RNA
hybridization is marked in green color, and CpG DNA is marked in red color. I
hypothesized that when these designed RNA and DNA strands mixed together, a
triangular RNA nanoparticle with CpG DNA at each end will be successfully selfassembled.
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Construction and physicochemical characterization of RNA triangles harboring
CpG DNA
RNA triangles harboring CpG DNA were assembled in one pot by mixing
equimolar concentrations (final concentration of 1 µM) of four RNA strands and three
DNA strands in 1X TMS buffer. To evaluate the step-wise self-assembly of the designed
RNA nanoparticles, Cy5-labeld RNA triangle D strand and a 2% agarose gel was used
(Figure 5.2b). Specifically, the image under Cy5 channel demonstrated the participation
of triangle D strand in all the assembly intermediates as well as the final products. The
image under EB channel showed the successful assembly of the designed RNA
nanoparticle.
To further evaluate the size and shape of the resulting RNA assemblies, structural
characterization of RNA triangles harboring CpG DNA was conducted by atomic force
microscopy (AFM). AFM images revealed that the shapes of resulting RNA
nanoparticles were similar to their predicted 3D models (Figure 5.2c). In addition, the
elongated arms of each RNA nanoparticle are clearly visible, demonstrating the
successful incorporation of the designed DNA strands into the RNA triangles. The
estimated average size was found to be around 20 nm. However, this value does not
reflect the true size of the designed RNA nanoparticles due to the AFM tip convolution.
DLS was performed to determine the apparent hydrodynamic size for RNA
triangles harboring three CpG ODNs (Figure 5.2d). The diameter was found to be 14.2 ±
0.8 nm based on the intensity distribution, which agreed with its corresponding 3D model.
However, there was a difference between the sizes determined by AFM and DLS. This
could be attributed to the different mechanism in determining nanoparticle size as DLS
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calculates the average size of nanoparticles in solution assuming that the nanoparticles
have globular shapes, while AFM imaging can produce larger images of the nanoparticles
because of the size of the used AFM tip. However, the sizes determined by the two
techniques were in agreement with our designed dimension of the nanoparticles.

Evaluation of the interaction between RNA triangles harboring CpG DNA and
macrophage cells
CpG oligonucleotide is a ligand for TLR-9 [305, 313], and previous studies have
found that it can be used as vaccine adjuvant or immunotherapy reagent for disease
control and treatment [307, 314, 318]. To evaluate whether the RNA triangles can
enhance the efficacy of CpG DNA, I further studied the interaction of the designed RNA
nanoparticles with macrophage cells. Using the mice microphage-like RAW 264.7 cells
as the model, I evaluated the cell binding and entry by using flow cytometry (Figure
5.3a). The flow cytometry experiment revealed that RNA triangle nanoparticles
significantly enhance cellular binding and entry of CpG DNA. Moreover, the level of
inflammatory cytokine TNF-α excretion by the cells when they were incubated with the
RNA triangles and CpG DNA was measured by using the enzyme-linked immunosorbent
assay (ELISA) (Figure 5.3b). As shown in Figure 5.3b, compared with cells treated with
triangle only and CpG DNA only, cells treated with CpG DNA loaded triangle showed
significantly increased TNF-α level. And this activity also shows good dosage-response
relationship (Figure 5.3c), as higher concentration of nanoparticles induced higher level
of TNF-α.
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Comparison of the modulation effect of RNA triangle, square, and pentagon
nanoparticles harboring CpG DNA
By increasing the number of external strands and the propagation of the central or
internal strand, the tension on the inter-helical angle of the pRNA three-way junction
could be increased to 90 ° and 108 °, allowing for the structural transition of RNA
triangles to squares and pentagons. To evaluate whether the different shape of RNA
polygons could affect the immunomodulation effect, we designed and constructed new
RNA polygons harboring different numbers of CpG DNAs. Similar to the experiments
described above, the immunostimulatory efficacy of different RNA polygons was
evaluated by measuring the release of cytokines after addition to mouse macrophage-like
RAW 264.7. The triangular RNA nanoparticle coupled with only one CpG exhibited the
highest level of cytokine induction for both TNF-α and IL-6 comparing to square and
pentagonal RNA nanoparticles (Figure 5.4a). Upon increasing the number of CpG per
nanoparticle there is opposite effect, as pentagonal RNA nanocarrier showed the highest
level of the induction of both TNF-α and IL-6 (Figure 5.4b). The results suggest that the
cytokine release by CpG coupled to RNA polygons with different shape remarkably
increases the immunostimulatory activity compared to CpG alone. RNA nanoparticles
with the size of about 10-nm such as the triangle with a single CpG induced the greatest
amount of TNF-α and IL-6. In addition, the induction of cytokines is highly dependent on
the number of CpG per polygon. With the increasing number of CpG per polygon,
stronger immune response is observed, demonstrating the advantage of the transition of
triangle into pentagon which can carry five CpG (Figure 5.4c). Moreover, I also
evaluated the toxicity of the tested RNA nanoparticles by MTT assay. The toxicity assay
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revealed that no significant cytotoxicity was induced on RAW 264.7 cells upon the
incubation with the tested RNA nanoparticles (Figure 5.5). Furthermore, a similar
cytotoxicity assay was performed one more time by using KB cells, and similar results
were observed (Appendix 3, Supplementary Figure 3).

Comparison of cellular uptake by different RNA polygons harboring CpG DNA
Previously, it has been demonstrated that the CpG oligonucleotide can be readily
recognized by TLR9 on the endosomal membrane of macrophages, resulting in cellular
uptake of the CpG adjuvants [319, 320]. To investigate whether there is a difference
between the efficiency of RNA polygons binding to the cells, I quantified the cellular
uptake of polygons-CpG by using the flow cytometric assay [124, 125]. Figure 5.6a
demonstrates the binding of different RNA polygons-CpG to the RAW 264.7 cells in a
dose-dependent manner. Results demonstrate that there is an increase in binding
efficiency from triangle to pentagon with more CpGs. Overall, RNA polygons-CpG
complexes have significantly more binding efficiency to cells compared to CpG only.
This observation was further confirmed by confocal microscope images (Figure
5.6b) revealing that RNA nanoparticle harboring CpGs are localized in the cytoplasm
exclusively and there are much higher amounts of triangular nanoparticles inside the cell
compared to free CpG, suggesting that RNA nanoparticles could efficiently enhance the
cellular uptake of the CpG adjuvants.
Collectively, both flow cytometry and confocal microscope imaging results
demonstrate that all RNA nanoparticles with different shape and harboring CpGs have
much stronger binding and cellular entry to the macrophage-like RAW 264.7 cells
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compared to free CpGs. In addition, cellular uptake is highly dependent on the number of
CpG per polygon. With the increasing number of CpG per polygon, more efficient cell
entry is observed (Figure 5.6a), demonstrating the advantage of the transition of triangle
into pentagon which can carry five CpG. Notably, all RNA polygons-CpG complexes
still can be detected in the gel after 16 h incubation in 10% fetal bovine serum (FBS)
indicating robustness of the assembled complex in extracellular environment (Figure 5.7).

Enhancement of modulation effect in vivo by immunological CpG DNA adjuvant
incorporated into RNA nanoparticles
To examine whether RNA nanoparticles retain their immunostimulatory activity
in vivo, CpG DNA containing triangle, free triangle and free CpG DNA were
administered to CD-1 mice by injection into the tail vein at 2 mg/kg (CpG
oligonucleotide per body weight), following determination of cytokine TNF-α and IL-6
levels after 3 hour post administration in collected blood serum. Figure 5.4d shows that
free triangle nanoparticle and free CpG did not induce any cytokine production, whereas
the complex triangle-CpG resulted in elevated levels of both cytokines. The difference in
immunostimulatory activity of triangle-CpG was estimated to be 10-fold comparing to
free CpG in vivo. These data are in agreement with the in vitro stimulation of murine
RAW 264.7 cells. Furthermore, a confirmatory follow-up animal trial was also performed
by using square-CpG nanoparticles, and similar immunostimulatory activity were
observed (Appendix 2, Supplementary Figure 2).
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Discussion
Previous studies have demonstrated that rationally designed RNA nanoparticles
can be used as potent multifunctional nanocarriers for delivery of therapeutics [73, 124,
125]. In this study, I demonstrated that rationally designed RNA polygons have the
potential to serve as multivalent nanocarriers of vaccine adjuvants and particularly of
CpG ODNs [305]. The designed RNAs self-assemble into distinct non-toxic
homogeneous nanoparticles. I also found that size and shape of the RNA nanostructures
are important factors for the induction of immune responses. There is a correlation
between the RNA size and the number of CpGs that can be incorporated. The highest
level of secretion of pro-inflammatory cytokines TNF-α, IL-6 was obtained with the
smallest triangle nanoparticle harboring one CpG compared to square and pentagon
nanoparticles. However, upon increasing the numbers of CpG per RNA nanoparticle the
cytokines induction was affected more by pentagon. This study illustrates the importance
of the size and shape of RNA nanoparticles for improvement of activity of CpG based
vaccines targeting infectious diseases and cancer cells as well as for an increase immuneresponse by the innate and adaptive immune systems. The RNA nanoparticles harboring
CpGs are effective, versatile and easy to manufacture, offering new solutions to address
the unmet needs in current vaccines and adjuvants development.
In summary, the development of RNA nanoparticles for delivering CpG DNA as
novel vaccine adjuvants can provide several advantages: (1) The RNA nanoparticle-based
adjuvants have defined size, structure and stoichiometry. (2) Due to the multivalent
nature of RNA nanoparticles, multiple antigen and adjuvants could be incorporated into
one nanoparticle for achieving synergistic or enhanced immune repose such as cytokine
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induction and antibody production. (3) Nanosize of the particles will facilitate tissue
penetration and target to important immune tissues or organs such as lymph nodes for
achieving targeted and enhanced immune stimulation. (4) Multiple targeting ligands
could be incorporated into one particle for achieving better targeting to immune cells
such as B cells, T cells, dendritic cells and macrophages. (5) RNA nanoparticles are also
thermodynamically stable. For example, the three-way junction RNA nanoparticles are
resistant to denaturation in 8 M urea and do not dissociate at ultra-low concentrations
[124]. (6) The cellular uptake of the RNA nanoparticle-based adjuvants is greatly
enhanced compared to CpG DNA only. The immune response induced by the RNA
nanoparticle-based adjuvants is also greatly enhanced compared to CpG DNA only.
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a

b

Figure 5.1. Structural features of the pRNA 3WJ motif. (a) Secondary structure of 3WJ
motif with base pairs annotated using Leontis-Westhof nomenclature [321]. (b) Tertiary
structure of 3WJ motif with indication of ∠AOB ~ 60 ° angle formed between H1 and
H2. Angle corresponds to inner angles of polygons.
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Figure 5.2. Design, construction and characterization of RNA triangles harboring CpG
DNA. (a) Schematic illustration of the design and self-assembly of RNA triangles
harboring CpG DNA. (b) 2% agarose gel showing the step-wise self-assembly of the
designed RNA nanoparticles. Cy5 channel showing the incorporation of Cy5 Triangle D
strands into the RNA nanoparticles. EB channel showing the step-wise self-assembly of
the total RNA and DNA strands. Representative results from at least two independent
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experiments are shown. (c) AFM images of RNA triangles harboring CpG DNA.
Representative results from a total of ten raw AFM images are shown. (d) The size of
RNA triangles harboring CpG DNA determined by DLS. Representative results from
three independent measurements are shown.
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Figure 5.3. Evaluation of the interaction between RNA triangles harboring CpG DNA
and macrophage-like RAW 264.7 cells. (a) Evaluation of the cell binding and entry by
flow cytometry. Representative results from at least two independent experiments are
shown. (b) Determination of TNF-α level in cell culture supernatant by ELISA. The error
bars represent standard deviations from three independent wells. ****: p < 0.0001 versus
150 nM DNA CpG only control, unpaired Student's t-test. The induction of TNF-α by
triangle-CpG, triangle only control and CpG DNA only control was independently
repeated two additional times with triplicate independent wells for each sample and
similar results were observed. (c) Concentration study of RNA triangles harboring CpG
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DNA. The error bars represent standard deviations from three independent wells. *: p <
0.05 versus 12.5 nM Triangle-CpG control, unpaired Student's t-test. ***: p < 0.001
versus 12.5 nM Triangle-CpG control, unpaired Student's t-test.
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Figure 5.4. Effect of cytokine induction in macrophage-like RAW 264.7 cells and mice
by RNA polygons harboring CpG DNA and RNA polygons control. (a) Induction of
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TNF-α in RAW 264.7 cells by 50 nM RNA polygons harboring one CpG or multiple
CpGs. The error bars represent standard deviations of measurements from three
independent wells. **: p < 0.01 versus 250 nM DNA CpG only control, unpaired
Student's t-test. ****: p < 0.0001 versus 250 nM DNA CpG only control, unpaired
Student's t-test. The induction of TNF-α in RAW 264.7 cells by 50 nM RNA square
harboring 4 CpGs, 50 nM RNA square only control and 200 nM DNA CpG only control
was independently repeated at least three additional times with triplicate independent
wells for each sample and similar results were observed. (b) Induction of IL-6 in
RAW264.7 cells by 50 nM RNA polygons harboring one CpG or multiple CpGs. The
error bars represent standard deviations from three independent wells. **: p < 0.01 versus
250 nM DNA CpG only control, unpaired Student's t-test. ***: p < 0.001 versus 250 nM
DNA CpG only control, unpaired Student's t-test. ****: p < 0.0001 versus 250 nM DNA
CpG only control, unpaired Student's t-test. The induction of IL-6 in RAW 264.7 cells by
50 nM RNA square harboring 4 CpGs, 50 nM RNA square only control and 200 nM
DNA CpG only control was independently repeated at least three additional times with
triplicate independent wells for each sample and similar results were observed. (c)
Increase of TNF-α induction in RAW 264.7 cells with increasing number of CpGs per
RNA square or pentagon. The error bars represent standard deviations from three
independent wells. For RNA square samples: ***: p < 0.001 versus 200 nM DNA CpG
only control, unpaired Student's t-test. ****: p < 0.0001 versus 200 nM DNA CpG only
control, unpaired Student's t-test. For RNA pentagon samples: **: p < 0.01 versus 250
nM DNA CpG only control, unpaired Student's t-test. ****: p < 0.0001 versus 250 nM
DNA CpG only control, unpaired Student's t-test. (d) Immunostimulatory activity by
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triangle-CpG nanoparticles in animal model. The error bars represent the range from two
independent measurements of the cytokine levels from serum aliquots of the tested mouse.
**: p < 0.01 versus 2 mg/kg DNA CpG only control, unpaired Student's t-test. ***: p <
0.001 versus 2 mg/kg DNA CpG only control, unpaired Student's t-test. A confirmatory
follow-up animal trial was performed by using square-CpG nanoparticles, and similar
results were observed (Appendix 2, Supplementary Figure 2).
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Figure 5.5. Effect of RNA triangle harboring CpG DNA, triangle control and CpG DNA
only control on RAW 264.7 cell viability. The cells were incubated with different
concentrations (200 nM, 100 nM, 50 nM and 25 nM) of RNA triangles only, RNA
triangles harboring 3 CpGs and CpG only. The error bars represent standard deviations
from three independent wells. *: p < 0.05 versus cell only control, unpaired Student's ttest. ns: non-significant, unpaired Student's t-test. A similar cytotoxicity assay was
performed one more time by using KB cells, and similar results were observed (Appendix
3, Supplementary Figure 3).
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Figure 5.6. Comparison of RNA polygon-CpG complexes binding to the RAW 264.7
cells. (a) The plot represents the summary of the flow cytometry data showing RNA
nanoparticles binding to the cell in a dose dependent manner. Data was from one
experiment, and four different concentrations of each sample and CpG DNA only control
were tested in this experiment. The cell binding of triangle-3CpGs and CpG DNA only
control was assayed by flow cytometry for two additional times and similar results were
observed. (b) Confocal images showing the binding comparison of the triangle-CpG and
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CpG only control to the RAW 264.7 cells by co-localization of nucleus (blue), actin
(green), and CpGs (red) signals. Representative results from two independent
experiments are shown.
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Figure 5.7. Serum stability assay of RNA polygons harboring CpG DNA. Preassembled
complexes (1 µM) of 2’-F modified RNA triangle, square and pentagon harboring CpG
DNA were incubated in RPMI-1640 medium containing 10% fetal bovine serum.
Aliquots (10 µL) were taken at 0 hr, 1 hr, 3 hr, 6 hr, 8hr and 16 hr time points after
incubation at 37 °C, followed by analysis using 6% native PAGE gels. Data was from
one experiment. A similar serum stability assay was performed one more time for RNA
triangle harboring CpG DNA, and similar results were observed. Moreover, similar
serum stability assays have also been performed for other 2’F-modified RNA
nanoparticles for numerous times, and similar results were also observed and published
previously [124, 125, 174].
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Chapter 6: Conclusions and Perspectives
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In the final chapter of this dissertation, I review the main conclusions of this
dissertation and discuss the directions of future work in RNA nanotechnology and RNA
nanomedicine.

Conclusions
The emerging field of RNA nanotechnology, which is the study of RNA
nanostructures constructed by utilizing inter-RNA interactions, has opened a new arena in
nanotechnology and nanomedicine. Indeed, RNA can offer several advantages for
building controllable nanostructures with diverse applications. On one hand, RNA is
almost as simplistic as DNA in terms of base pairing. Like DNA, RNA also has four
different bases A, C, U and G, and most interactions between these bases can be
predicted. On the other hand, RNA also has diverse folding and functions like protein.
For example, many bulges, loops, pseudoknots and non-canonical base pairing exist in
RNA structures that are critical to their biological activities [12, 29-32]. Moreover, many
new biological functions have been discovered recently with RNA especially non-coding
RNA [322]. For example, siRNA [323] and miRNA [324, 325] can be used to silence
specific genes. Ribozymes can catalyze specific biochemical reactions [326, 327].
Riboswitches [328] and long non-coding RNAs [329] play important roles in gene
regulation. Guide RNAs (gRNAs) can direct Cas9 (CRISPR associated protein 9)
nucleases to edit genes at specific genomic loci [330]. All of these advantages make RNA
nanotechnology a very intriguing and promising research field. In this dissertation, I have
presented the design and construction of several RNA nanostructures with defined shapes
and sizes, and studied their potential applications in nanotechnology and nanomedicine:
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•

First, I reported the design and self-assembly of multifunctional 3D RNA
tetrahedrons based on the pRNA-3WJ motif [304]. The assembled RNA
tetrahedrons have defined 3D structures as revealed by both AFM and cryo-EM.
The size of the RNA tetrahedrons can be easily tuned by changing the number of
RNA base pairs per edge. Several functional modules including aptamers,
ribozyme and siRNA were successfully incorporated into the RNA tetrahedron. In
vitro cell binding showed that the RNA tetrahedron functionalized with EGFRaptamer has strong binding to EGFR-positive cells. In vivo biodistribution study
showed that the RNA tetrahedron functionalized with EGFR-aptamer targeted to
cancer xenografts in mouse models. These results indicated that 3D RNA
tetrahedron nanoparticles have the potential to deliver imaging modules and
therapeutics for cancer diagnosis and therapy.

•

Secondly, I reported the design and self-assembly of RNA cube and
dodecahedron cages with defined shapes and sizes by using the pRNA 3WJ as the
basic building block. The assembled RNA cages have distinct 3D structures as
revealed by cryo-EM and AFM. In addition, the designed RNA cube cages can be
applied to deliver immunoactive CpG DNAs to macrophage cells and elicit
enhanced immune responses.

•

Thirdly, I reported the design and bottom-up self-assembly of the RNA nanowire
with the length of several micrometers by using the modular multi-domain
strategy [308]. The constructed RNA nanowire has been characterized by cryoEM, negative staining TEM, fluorescent microscopy and AFM. This study
demonstrated the expanding of the toolboxes of RNA nanostructures to RNA
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microstructures. Comparing with previously reported RNA array and RNA
filaments, this newly designed RNA nanowire was self-assembled purely based
on RNA base pairing and only four artificially-designed short RNA strands were
needed to assembly the RNA nanowire.
•

Fourthly, I reported the design and construction of RNA polygons to serve as
multivalent nanocarriers of vaccine adjuvants and particularly of CpG DNA [92].
The designed RNA and DNA strands self-assembled into distinct homogeneous
nanoparticles with triangular, square or pentagonal shapes. I also found that size
and shape of the RNA nanostructures played important roles in the induction of
immune responses. This finding demonstrated that rationally designed RNA
nanoparticles have great potential to be developed as novel immunomodulators or
vaccine adjuvants.

Perspectives
RNA is not only an informational molecule that can transfer genetic information,
but also a structural molecule that can be utilized for programmable self-assembly by
engineering its sequence. In addition, RNA molecules can be designed to form artificial
nanostructures with defined chemistry, structure, size and stoichiometry for applications
in nanotechnology and nanomedicine [286]. In the future, one new direction of research
is to expand the structural and functional diversity of 3D RNA nanostructures by
exploring novel RNA motifs and RNA folding pathways. In addition, it is also possible to
employ RNA-binding proteins to build artificial RNA-protein chimeric nanostructures
that equipped with both RNA-based functionality and protein-based functionality [128].
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It will be also interesting to explore the possibility to incorporate classic methodologies
in DNA nanotechnology (such as the DNA origami technique [331] and computer-aided
design of DNA nanostructures by utilizing specialized software [332]) into RNA
nanotechnology. It is expected that RNA mimics of DNA motifs widely used in DNA
nanotechnology such as the DNA 4WJ [333] and DNA double-crossover molecules [334]
will also play important roles in the construction of artificial RNA nanostructures. To
obtain a more thorough understanding of the 3D conformation of the designed RNA
nanostructures, high-resolution AFM, cryo-EM, X-ray diffraction and nuclear magnetic
resonance (NMR) spectroscopy can be applied to characterize these RNA nanostructures
with the aim to acquire atomic-level details. From an application perspective, one
intriguing research direction is to test drug loading to these artificial RNA nanostructures.
Particularly, 3D RNA nanoparticles may have the potential to encapsulate and protect a
range of different therapeutics including nucleic acid therapeutics, small molecule
therapeutics and protein therapeutics. For example, nucleic acid therapeutics such as
siRNA and miRNA can be loaded into RNA nanoparticles via sticky end-mediated
cohesion, while small molecule therapeutics such as paclitaxel and doxorubicin can be
loaded via covalent conjugation or non-covalent binding to the RNA double helix. In
addition, it will also be appealing to combine RNA nanoparticles with other
nanotechnology approaches and investigate whether other nanotechnology approaches
can improve the pharmacological properties of RNA nanoparticles. For instance, it will
be interesting to encapsulate RNA nanoparticles into liposomes [335] or exosomes [336]
and study the intracellular traffic and fate of liposome/exosome-encapsulated RNA
nanoparticles. Furthermore, for the successful clinical application of RNA nanoparticles,
198

the production of clinical-grade RNA nanoparticles in large scale under Good
Manufacturing Practice (GMP) regulation [337] will also be an important prerequisite.
Currently, there are two mainstream approaches to produce RNA molecules: 1) in vitro
transcription based on corresponding DNA templates [338]; 2) solid-phase synthesis
based on phosphoramidite chemistry [339]. It is expected that automation of these
synthesis procedures will greatly reduce the cost and improve the efficiency for largescale production of RNA molecules. Another alternative approach for RNA production is
the expression of recombinant RNA molecules in bacterial cells such as Escherichia coli
[331, 340]. Since recombinant protein technology has been widely used in the modern
biotechnology industry for manufacturing protein therapeutics [341], the future
improvements of recombinant RNA technology also has the potential to pave the way for
producing highly pure RNA molecules for clinical applications.

Copyright © Hui Li 2016
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Appendix 2

Supplementary Figure 2: Immunostimulation by square-CpG nanoparticles in mice.
CpG DNA containing square nanoparticles, free square nanoparticles and free CpG DNA
were dissolved in PBS and administered to CD-1 mice by injection into the tail vein at 2
mg/kg (CpG oligonucleotide per body weight). Blood samples were collected 3 hours
post-injection by cardiac puncture. Serum was prepared by centrifugation at 12800 g for
10 min. The levels of both TNF-α and IL-6 in serum were determined by ELISA. The
error bars represent the standard error of the mean (SEM) from the measurements of six
mice per treatment group. **: p < 0.01 versus 2 mg/kg DNA CpG only control, unpaired
Student's t-test. Data was collected in collaboration with Sijin Guo and Mengshi Ma.
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Appendix 3

Supplementary Figure 3: Effect of RNA triangle harboring CpG DNA, triangle control
and CpG DNA only control on KB cell viability. KB cells were incubated with 100 nM
or 300 nM triangle, triangle-3CpGs, and CpG DNA only respectively for 16 hours. After
16 hours, cell viability was examined by MTT assay. The error bars represent the range
of measurement from two independent wells. ns: non-significant compared with cell only
control, unpaired Student's t-test.
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